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General introduction
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1
GenerAl introDuction
This PhD thesis, ‘Assessment of facial function in peripheral facial palsy’, describes a series 
of investigations focused on assessing facial function in humans and animals with pe-
ripheral facial palsy.
facial nerve
The facial nerve is one of the twelve human cranial nerves. Cranial nerves are part 
of our peripheral nervous system and arise from the brain and brainstem, they exit 
through their different skull base foramina (Figure 1). Cranial nerves control motor and 
sensory functions and consist of different types of nerve fibers with their specific func-
tions.1, 2 The facial nerve itself contains motor, sensory, and even parasympathetic fibers; 
the function and type of fibers of the facial nerve are shown in Table 1. As peripheral 
nerves, cranial nerves consist of fascicles bundled in a layer of epineurium. A fascicle 
itself is covered with perineurium, holding the axons together. Axons are covered with 
endoneurium (Figure 2). The course of the facial nerve from brainstem to end organ is 
divided in six segments; intracranial, internal meatal, labyrinthine, tympanic, mastoid, 
and extratemporal. Distal to the ganglion geniculi collateral branches arise from the 
facial nerve, beginning with the stapedial nerve and chorda tympani. Near the stylo-
mastoid foramen, the posterior auricular nerve splits off from the main trunk of the facial 
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figure 1. Inferior view of the brain and brainstem showing the twelve cranial nerves (by Patrick J. Lynch, 
medical illustrator).
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table 1. Facial nerve function and fibers
function 
(short)
function (detailed) nerve fiber 
modality
general function nerve fiber 
modality
motor innervation of muscles of facial expression, 
musculus stapedius, stylohyoidius, and 
posterior belly of the musculus diagastricus
special visceral 
efferent
innervate muscles that 
develop from the branchial 
arches
sensory taste from anterior two thirds of the tongue special visceral 
afferent
transmit smell, vision, 
taste, balance, and hearing 
information
sensory information from external auditory 
meatus, lateral pinna, mastoid, mucosa of 
pharynx, nose, and palate
general somatic 
afferent
transmit somatic sensation 
from the head, neck, sinuses 
and meninges
visceral parasympathic autonomic innervation of the 
lacrimal gland, oral and nasal mucosa, and 
submandibular and sublingual glands
general visceral 
efferent
innervate the viscera, glands, 
and smooth muscles
Referenties: Binder DK. Cranial Nerves: Anatomy, Pathology, Imaging. New York: Thieme; 2010. Schünke M. 
Prometheus Anatomische Atlas. Houten: Bohn Stafleu van Loghum; 2006.
figure 3. Intratemporal course of the facial nerve.4
figure 2. Layers of a peripheral nerve.3
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nerve, and the digastric and stylohyoid branches leave the main trunk (Figure 3). After 
passing through the stylomastoid foramen, the facial nerve terminates into the follow-
ing branches: temporal, zygomatic, buccal, mandibular, and cervical branches. Usually 
it first divides into two trunks: a superior (temporofacial) and an inferior (cervicofacial) 
trunk (Figure 4).5 However branching can vary inter-individually.6 The most important 
muscles of facial expression which are innervated by the facial nerve are the frontalis, 
orbicularis oculi, orbicularis oris, zygomaticus, levator labii superioris, depressor anguli 
oris, buccinator, corrugator, and platysma (Figure 5).
Fig. 3. The distal branches of the facial nerve (motor). (DeJong RN: The Neurologic Exam, 4th 
ed, p 179. Hagerstown, Harper & Row, 1979) 
pagina 1 van 1Fig. 3.
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figure 4. Extratemporal branches of the facial nerve.7
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peripheral facial palsy
The facial nerve is the most commonly paralyzed nerve in the human body. A lesion 
of the facial nucleus or facial nerve itself causes a palsy of the ipsilateral face (Figure 
6). A peripheral palsy can be distinguished from a central palsy by observation of eye 
closure and/or raising the eye brows. In case of a central disorder, the eye will still be 
able to close and the eye brow to raise, because of cross innervations by the cerebral 
cortex. The most visible part of a facial palsy is the reduction or absence of unilateral 
facial mimicry. Patients experience the inability to close the eye, to raise the eye brow, 
to smile, they may suffer oral incompetence, and they have problems with eating, drink-
ing and/or articulation. Other disabilities arise from interruption of innervation of the 
lacrimal gland, nasal mucosa, submandibular and sublingual glands, taste of the tongue 
and the sensation of the external auditory meatus, lateral pinna, mastoid, mucosa of 
pharynx, nose and palate. In addition to physical complaints, patients suffer significant 
psychosocial consequences, sometimes leading to complete social isolation.8 Bilateral 
facial palsy occurs in less than 1% of patients.9
figure 6. Patient with right sided facial palsy. (With permission.)
Etiology
Peripheral facial palsy has myriad possible etiologies: idiopathic (Bell’s palsy), traumatic 
(skull base fracture or direct trauma to the nerve), iatrogenic (e.g. temporomandibular 
joint surgery), infectious (such as otitis media, Lyme disease, Herpes Zoster (Ramsay-
Hunt syndrome)), congenital (e.g. Möbius syndrome), cerebellopontine angle pathol-
ogy, parotid tumours, etcetera. Schaitkin and May found more than 100 possible causes 
in a review of the medical literature between 1990 and 1996.10
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Bell’s palsy
The majority of facial palsy patients are diagnosed ‘per exclusionem’ with a Bell’s palsy 
(about 50%).8, 11 Bell’s palsy is named after a Scottish anatomist/surgeon, Sir Charles Bell. 
Bell’s palsy has a rapid onset, is mainly unilateral, is typically self-limiting (two to three 
weeks), and recovers usually pretty well (three to four months). Complete recovery is seen 
in approximately 70% of patients with complete palsy and up to 94% in patients with 
incomplete palsy.12 The exact pathophysiology of Bell’s palsy is still unknown, however 
there are indications of herpes simplex involvement.13 The incidence in the Netherlands 
is estimated on 1 per 5,000 adults (four times less in the pediatric population) counting 
for approximately 3000 new cases per annum in the Netherlands.8
Classification of nerve injury
Facial nerve injury can be described using a five level scale according to Sunderland.14 
Neuropraxia, a level 1 injury, is the least serious degree; there is no axonal degeneration, 
only inability of the nerve to conduct an impulse across the lesion. This type of lesions 
generally resolve completely without sequelae in three weeks. Second degree injury is 
termed axonotmesis, a state in which axons undergo Wallerian degeneration because 
of compressed arterioles. It takes generally three weeks to three months for these in-
juries to recover completely without sequelae. In third degree injuries, axons and the 
endoneurium surrounding the individual axons are lost. Aberrant regeneration develops 
because regenerating axons enter endoneural tubules different than their original path-
ways. Recovery is generally delayed by two to four months. Disruption of perineurium 
surrounding nerve fascicles is rated as fourth degree injury. Complete transsection of the 
nerve, including the epineurium, is fifth degree injury (neurotmesis). Nerve repair or nerve 
grafting is necessary for recovery in the last two types of injury. Another classification 
is Seddon’s classification15; describing only three categories: neuropraxia (Sunderland 
degree I), axonotmesis (Sunderland degree II), and neurotmesis (Sunderland degree V).
synkinesis
Synkinesis can be encountered after recovery of a facial palsy and is a phenomenon of 
involuntary movement in one area of the face during voluntary movement in another 
area of the face. For example, eye closure during speaking or eating. Synkinesis can be 
very disfiguring, but painful as well. Three possible mechanisms for the development 
of synkinesis are described. The first, and most widely accepted, proposed mechanism 
is that of aberrant regeneration. In third degree injury (Sunderland’s classification), the 
axons and endoneurium surrounding the individual axons are lost. During regeneration 
axons might regrow in endoneural tubes other than their original ones, innervating dif-
ferent muscle groups. A second mechanism is the stimulation of neighbor axons due to 
loss of myelin. A last possibility is hyper excitability of the facial nucleus itself.16
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Assessment
Starting at the first visit of a patient with peripheral facial palsy, assessment of facial func-
tion is important. Assessment of facial function should be repeated during follow-up visits 
to register any changes. Natural recovery and results of different treatment options should 
be evaluated. Outcomes research is very important, leading to personalized treatment 
options, to improved outcome quality, and minimization of costs of our interventions.17
Clinical grading scales
Traditionally, the degree of facial palsy was graded by the physician, making use of several 
grading scales. The best known and most common clinical grading scale for peripheral 
facial palsy is the House-Brackmann grading system, developed by John W. House and 
Derald E. Brackmann in 1985.18 This system grades the facial function from 1 (normal facial 
function) to 6 (complete paralysis) (Table 2). The American Academy of Otolaryngology-
Head and Neck Surgery adopted this grading system as their gold standard. Limitations 
of the House-Brackmann grading system include the lack of synkinesis assessment and 
zone specific evaluation. A more enhanced facial grading system is the Sunnybrook facial 
grading system developed in Canada in 1996 (Figure 7).19 This system comprises evalua-
tion of resting symmetry, degree of voluntary movement of facial muscles, and degree 
of synkinesis. Different regions of the face are evaluated separately. A total score will be 
calculated: zero representing the worst score and one hundred the best. Other examples 
of clinical grading scales are these of Botman and Jongkees, May, Peitersen, Smith, Adour 
and Swanson, Janssen, Yanagihara, and Stennert.20 A survey in the Sir Charles Bell Society 
showed that 60% of the members uses the House-Brackmann grading system and 51% 
uses the Sunnybrook facial grading system (which means some use both). Five percent 
did not use any grading scale, another 5% uses personal notes or rulers.21 Overall the Sun-
nybrook grading system is prefered by professionals in the field of facial function because 
it has been demonstrated to be reproducible with low inter- and intra- observer variability, 
as well as sensitive enough to track changes over time and following interventions.21
table 2. House-Brackmann grading system
Grade Description
1 Normal function.
2 Mild dysfunction. Normal symmetry at rest. Slight weakness. Complete eye closure.
3
Moderate dysfunction. Noticeable asymmetry at rest. Obvious weakness, not disfiguring. Complete 
eye closure.
4
Moderate-to-severe dysfunction. Obvious asymmetry at rest. Obvious disfiguring weakness. 
Incomplete eye closure.
5
Severe dysfunction. Disfiguring asymmetry at rest. Barely perceptible motion. Incomplete eye 
closure.
6 Total paralysis.
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Diagnostics
Laboratory testing
Serologic studies can be performed to test for infectious causes (e.g. Lyme, HIV, syphilis). 
In acute onset unilateral facial palsy, without any other symptoms, routine laboratory 
testing is not recommended by the guideline of the American Academy of Otolaryn-
gology – Head and Neck Surgery, neither the Dutch guideline.12, 22 Under certain cir-
cumstances (identifiable risk factors or atypical presentation) laboratory testing may be 
indicated.
Imaging studies
In acute onset unilateral facial palsy routine imaging is not recommended by the 
guideline of the American Academy of Otolaryngology – Head and Neck Surgery, nor 
the Dutch guideline.12, 22 Both guidelines recommend to perform magnetic resonance 
imaging (MRI) in any case not typical for Bell’s palsy, and in cases without any signs of 
recovery after three months. In cases where an otologic cause is suspected, a computed 
tomography (CT) can be performed.
Electrodiagnostic testing
Electromyography (EMG) is the recording of both spontaneous depolarizations and the 
response to voluntary muscle contraction by the insertion of a needle electrode in the 
figure 7. Sunnybrook facial grading system.
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affected muscle. EMG is described to be predictive of recovery of facial palsy.23 EMG 
findings are classified according to Seddon (see paragraph Classification of nerve injury) 
into neuropraxia, axonotmesis, or neurotmesis. Electroneuronography (ENoG) is the 
recording of electrical depolarization of facial muscles following electrical stimulation 
of the facial nerve using surface electrodes. The facial nerve can be stimulated distally of 
the stylomastoid foramen. There is a place for electrodiagnostic testing in patients with 
complete facial palsy (e.g. to decide if facial nerve decompression should be considered, 
see paragraph Management). Latency and amplitude are used as variables. Preferably, 
these values are compared to the other, healthy, side. The amplitude of the compound 
muscle action potential (CMAP) reflects the number of axons in the nerve. After axonot-
mesis it takes several days before the distal part of the affected axons can no longer be 
stimulated. Axonal degeneration (Wallerian degeneration) takes several days. The time 
course depends on the distance between lesion and stimulation location.
Other diagnostics
Hearing and vestibular testing can be performed to determine whether the inner ear, 
cochlear or vestibular nerve are involved.
management
Management of peripheral facial palsy is a multidisciplinary matter. Otorhinolaryngolo-
gists, facial plastic surgeons, neuro-otologists, ophthalmologists, and physical therapists 
can be involved. Proper diagnosis is the first and most important step in management of 
patients with peripheral facial palsy (see paragraph Etiologies and Diagnostics).
Bell’s palsy
There is no international consensus on the treatment of idiopathic peripheral facial 
palsy. In the Netherlands, the guideline for idiopathic peripheral facial palsy recom-
mends treatment with corticosteroids for patients with House Brackmann IV or more 
(incomplete eye closure). The Dutch guideline does not provide a recommendation on 
treatment with antiviral medication because of the lack of evidence.22 The guideline of 
the American Academy of Otolaryngology – Head and Neck Surgery recommends to 
prescribe oral steroids within 72 hours of symptom onset for Bell’s palsy patients 16 
years and older, and clinicians may offer oral antiviral therapy in addition to oral ste-
roids.12 A Cochrane review on corticosteroids for Bell’s palsy concludes that the available 
evidence from randomized controlled trials shows significant benefit from treating Bell’s 
palsy with corticosteroids.24 However, while some investigators describe a benefit to the 
administration of antiviral medications25, another Cochrane review on antiviral treat-
ment for Bell’s palsy shows no significant benefit from anti-herpes simplex antivirals 
compared with placebo in producing complete recovery from Bell’s palsy.26
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Mime therapy
A specific type of physical therapy applied in facial palsy treatment, is mime therapy. 
Mime therapy includes an extended history taking, auto-massage of face and neck, 
breathing and relaxation exercises, co-ordination exercises, inhibition of synkinesis, 
emotional expression exercises, and information about treatment and prognosis.11 
Mime therapy was developed in 1974 in Amsterdam, The Netherlands, by Jan Bronk 
(mime actor) and Pieter Devriese (otolaryngologist).27 Carien Beurskens (mime thera-
pist) showed in her Ph.D. thesis (2003) that mime therapy improves facial symmetry in 
patients with longstanding peripheral facial palsy, and that this results in improvements 
in secondary sequalae: facial stiffness, dysfunction in eating, drinking, speaking and 
rinsing, non-wellbeing, psychosocial problems, and lack of emotional readability. These 
findings were the results of the Nijmegen Mime Therapy Study, a randomized controlled 
trial to evaluate the effectiveness of mime therapy.11
Neuromuscular retraining
Another type of physical therapy applied to patients with facial paralysis is neuromuscu-
lar retraining. In this approach, patients learn to coordinate symmetrical movement by 
inhibiting synkinesis using specific motor training; surface electromyographic feedback 
and specific mirror exercises provide sensory information that enhances neural adap-
tion.9
Facial nerve decompression
In complete facial palsy, electroneuronography should be performed after three but up 
until twelve days. In cases where the facial nerve is degenerated by 90 percent compared 
with the contralateral side, nerve decompression should be considered. These cases 
rarely concern Bell’s palsy, but there might be a indication for facial nerve decompres-
sion in traumatic facial palsy or in Ramsay Hunt syndrome. There is a certain window in 
which the decompression should be performed, varying from two to four weeks in the 
current literature.28
static reconstructions
Brow region
Various options for static reconstruction exist starting cranially; correction of unilateral 
brow ptosis can bring more symmetry in a patients face. Brow ptosis can cause visual field 
deficits, hygiene issues caused by overhanging skin, ocular fatigue due to compensatory 
hyperactivity of the frontalis muscle, and esthetic unsatisfying asymmetry.29 Different 
techniques to elevate the brow are described; external and endoscopic approaches.9 
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Another option is to denervate the contralateral frontalis muscle in order to obtain more 
symmetry, using botulinum toxin.
Periocular region
Since the levator palpebrae superioris muscle is not innervated by the facial nerve (but 
by the third cranial nerve, the oculomotor nerve) patients do not experience ptosis with 
facial paralysis. The eye closes incompletely because of loss of the orbicularis oculi func-
tion. Incomplete eye closure leads to keratopathy (corneal dryness, exposure keratitis, 
corneal ulcerations). Patients with incomplete eye closure can use ophthalmic drops 
and cover their eye during the night using sticky tape, glass or plastic coverage. A more 
definitive, but still reversible, solution is the placement of an eyelid weight made of 
gold or platinum. The correct weight of the implant can first be tested by taping a test 
implant on the outside of the upper eyelid. This taped weight can also be used in cases 
where rapid recovery of eyelid closure is expected. Complications of lid loading include 
astigmatism, bulging, migration, extrusion, and pseudoptosis.9, 30 Injection of hyaluronic 
acid gel and autogenic cartilage have been described as alternative, non-invasive lid 
loading techniques.31, 32 The traditional tarsorrhaphy (sewing the eyelids partially to-
gether) is now obsolete as a first treatment option, except in cases of corneal ulceration 
and impending vision loss, which occurs most commonly in the setting of concomitant 
corneal anesthesia.9 To treat incomplete eye closure, a palpebral spring may be inserted. 
A spring is a bended 0.010-inch orthodontic stainless steel wire. When elevating the 
upper eyelid, the levator force overcomes the spring force. When the levator muscle 
relaxes, during blink, the positive spring force pushes the eyelid down.33 Paralysis of the 
lower eye lid leads to ectropion and more profound incomplete eye closure. Medial and 
lateral canthoplasty or lower lid elevation may correct this lower lid ectropion.
Nasal region
The nasal valve and nasolabial fold are important functional and esthetic facial land-
marks. Nasal valve collapse can lead to nasal obstruction. A fascia lata sling can be at-
tached to the lateral nasal ala, tunneled subdermally and attached to the deep temporal 
fascia with a superolateral vector.34, 35 Patients can also suffer from a lack of nasolabial 
fold or an hyperprominence of the nasolabial fold. In both cases a lift technique with su-
tures to the temporal region can be performed. In case of introducing a nasolabial fold, 
the sutures are placed medial of the nasolabial fold. When effacing an hyperprominent 
nasolabial fold, the sutures are placed laterally of the nasolabial fold.36
Mouth region
Dynamic reconstruction is the gold standard for smile reanimation. However in the 
elderly or patients with a lot of comorbidity, a fascia lata sling can be used to lift the oral 
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commissure. Paralysis of the depressor anguli oris and depressor labii inferioris results 
in an asymmetric smile. Contralateral lower lip chemodenervation is an option to obtain 
symmetry. Treatment of the neck is described in the paragraph Chemodenervation.
Dynamic reconstructions
The best method of facial reanimation is primary facial nerve repair. Interposition of a 
cable nerve graft to bridge larger defects gives comparable results. In cases in which 
direct nerve reconstruction or grafting are no option, several options remain.
Indirect facial nerve reconstruction
Second best, after direct repair or grafting, are interventions that make use of native 
facial musculature. When patients present within two years (preferable one year) after 
loss of muscle function, a nerve transfer can be considered. Nerve fibers from other 
cranial nerves can be used to grow into the peripheral branches of the facial nerve. For 
example the hypoglossal facial nerve has been used for this purpose (with or without 
interpositional jump graft). A disadvantage of this last technique is the risk of unilateral 
decrease in tongue motility.37 The massetric branch of the trigeminal nerve, the spinal 
accessory nerve, temporal nerve branches, and motor branches of the cervical plexus 
can be used for indirect reconstructions as well.28 Cross-face nerve grafting is another 
option (contra-indicated when there is concern for loss of contralateral facial nerve loss, 
e.g. in neurofibromatosis type 2).
Muscle transfers
In patients with longstanding facial palsy atrophy of the facial musculature takes place. 
In these cases regional or free muscle transfers can be performed. For example, the 
gracilis muscle can be used for microneurovascular free muscle transplantation. The 
gracilis transplant can be innervated by a cross face nerve graft or the ipsilateral mas-
setric nerve, or both. The latissimus dorsi, serratus anterior, rectus abdominus, extensor 
digitorum brevis and extensor hallucis brevis have been used as well.38 Regional options 
are the temporalis, masseter and digastric muscles.
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synkinesis management
Chemodenervation
As mentioned before (Static reconstructions), chemodenervation can be used to 
denervate contralateral muscles to achieve more facial symmetry. Another indication 
for chemodenervation is synkinesis. Chemodenervation can be achieved by the use of 
botulinum toxin. This toxin is produced by a bacteria of the Clostridium species. Seven 
different strains of Clostridium have been described (A – G), each producing its own neu-
rotoxin. Botulinum toxin blocks the release of acetylcholine, and inhibits signal transfer 
at the neuromuscular junctions. This effect lasts for three to six months, after which new 
axon terminals have developed.8 Injections are given subcutaneously. The effect will be 
noticed in two to five days.9
Platysmectomy
A more definitive solution than chemodenervation, for platysmal synkinesis, is a platys-
mectomy. In this procedure a horizontal band (one centimeter in vertical direction) of 
the muscle is removed. Resection of a platysmal strip decreases tension and synkinesis 
from the neck, and improves quality of life.39
Selective neurectomy
Treatment of synkinesis with Botulinum toxin type A can get less effective because of 
antibody development. In these cases we can switch to Botulinum toxin type B. When 
antibodies develop against this botox type, a selective neurectomy can be performed 
for ocular synkinesis. This procedures is devided in two steps. The first step comprises 
figure 8. Summary of facial reanimation options (adapted from Ramakrishnan et al.28)
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dissection of the facial nerve branches (four to six branches), under general anesthesia. 
The second step is precise titration of the neurectomy: while the patient is awake the ex-
act amount of branches disruption is determined; enough to decrease ocular synkinesis 
while avoiding incomplete eye closure.40
outline and goals of this thesis
The research described in this thesis is focused on assessment of facial function and 
quality of life in peripheral facial palsy. chapter 2 presents three studies using the rat 
model. The rat is widely used to study facial nerve function in an animal model. The rat 
facial nerve is anatomically comparable to the human facial nerve41 (Figure 9). Muscles 
producing whisking are innervated by branches of the facial nerve, meaning that mea-
surement of whisking movement can be used to assess recovery of whisking function.42 
The rat model is mainly used to test interventions to accelerate and improve facial nerve 
regeneration. Electrical stimulation and pharmacological agents have been studied as 
well as direct repair and cable grafting techniques.43-47
In chapter 2.1, inspired by studies of Angelov et al.49, 50, we studied whisking recovery 
after mechanical stimulation during facial nerve regeneration. To quantify the most 
beneficial amount and frequency of mechanical stimulation we used an automated 
stimulation device, the Whisk Assist (WA), instead of manual stimulation. The WA deliv-
ers controlled and quantifiable patterns of mechanically driven whisking.51 Our goal was 
to determine whether automated mechanical stimulation of the whisker pad improved 
whisking recovery after facial nerve transaction and repair in a rat model.
Shortly after, we found evidence for autonomic contraction of facial muscles in chroni-
cally denervated rats. We hypothesized that parasympathetic fibers of the infraorbital 
division of the trigeminal nerve were the source of motor innervation causing whisker 
figure 9. Extratemporal branches of the rat facial nerve.48
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movement in rats with complete facial nerve discontinuity. chapter 2.2 describes a 
series of experiments to test this hypothesis.
Another method to assess facial nerve regeneration in a rat model is to study the 
whisking musculature. In chapter 2.3 we investigated two potential reporter muscles 
to characterize facial nerve regeneration. Contraction of sling muscles located at the 
base of each individual whisker follicle (intrinsic pad muscles) results in whisker protrac-
tion.52, 53 These sling muscles are extremely small and difficult to study. Contraction of 
the extrinsic pad muscles together with elastic tissue recoil results in whisker retrac-
tion.52, 53 The levator labii superioris muscle (LLS) is an extrinsic pad muscle. The sling 
muscles are mainly innervated by the buccal and marginal mandibular branches of the 
facial nerve, whereas the LLS is mainly innervated by the zygomatic branch of the facial 
nerve.48 The dilator naris muscle (DN) seems to receive its motor supply through the buc-
cal and marginal mandibular branches of the facial nerve. The DN is primarily involved 
in nostril dilatation, in addition to nose deflection and reflection during sniffing.54 Our 
goal was to identify the source of innervations of the LLS and DN by testing their basic 
electrophysiological and mechanical response while electrically stimulating individual 
facial nerve branches. Our hypothesis was that the DN receives its motor supply from 
the same branches as those that innervate the intrinsic whisker pad, and thus may 
therefore represent a more appropriate reporter for studies of whisking recovery after 
facial nerve manipulation.
chapter 3 addresses quantitative assessment of facial function in humans after facial 
palsy. The last decades several quantitative, sometimes automated, assessment tools 
have been developed. In chapter 3.1 a systematic review is provided on these quantita-
tive assessment tools. Our goal was to summarize and evaluate the various quantitative 
assessment tools for facial function in peripheral facial palsy in the current literature. We 
aimed to make a step forward in choosing a gold standard assessment tool. In chapter 
3.2 we wanted to define an objective, easy to perform, rapid method for the assessment 
of ocular synkinesis by employing both the Facial Assessment by Computer Evaluation 
software and a modification of the Glasgow Facial Palsy Scale. chapter 3.3 describes a 
study that evaluates three-dimensional stereophotogrammetry as an objective assess-
ment tool for oral synkinesis in patients with peripheral facial palsy.
chapter 4 focuses on quality of life in patients with peripheral facial palsy. The first 
part, chapter 4.1, describes the health-related quality of life in 794 patients with pe-
ripheral facial palsy. Our goal was to describe the health-related quality of life of patients 
visiting a tertiary referral center for facial palsy, and to analyze possible factors associ-
ated with this health-related quality of life, using the FaCE Scale instrument.
In modern medicine more and more attention is paid to the health-related quality of 
life of a patient. This health-related quality of life can be measured using self-assessment 
questionnaires. General quality of life questionnaires exist, as well as disease-specific 
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questionnaires. Especially in facial palsy, patient reported outcome measures are very 
important for the reason that facial palsy has such a great impact on the psychosocial 
well-being of a patient. The face is even considered to be psychologically the most impor-
tant part of the human body.55 Few disease-specific self-assessment questionnaires exist 
for facial palsy. Ho et al. performed a systematic review to identify and critically appraise 
these instruments. Twenty-eight potentially relevant questionnaires were identified, 25 
of them were excluded because they were not developed/validated in patients with fa-
cial palsy, were ad hoc questionnaire, generic quality of life instruments, domain-specific 
questionnaires, or visual analogue scales.55 The only instruments that met all inclusion 
criteria were the Facial Disability Index56, the Facial Clinimetric Evaluation Scale57, and 
a questionnaire to evaluate synkinesis.58 This last mentioned questionnaire appeared 
not available after contacting the authors. The Facial Disability Index was developed by 
physical therapists at the University of Pittsburgh in the mid-ninety’s. The questionnaire 
covers two domains; physical function and social/well-being. The internal consistency of 
the questionnaire has been tested, but the test-retest reliability and content validity are 
not clear. Kahn et al. developed the Facial Clinimetric Scale at the end of the previous 
century.57 According to the systematic review this self-assessment questionnaire meets 
most of the validation criteria.55 In chapter 4.2 we developed a Dutch version of the 
FaCE Scale and tested its internal consistency, test-retest reliability, construct validity, 
and responsiveness for a valid use in the Dutch language and culture.
A synkinesis specific questionnaire has been developed as well: the Synkinesis As-
sessment Questionnaire.59 The translation and validation of the Dutch Synkinesis Assess-
ment Questionnaire can be found in chapter 4.3.
chapter 5 provides a summary, including a general discussion, presentation of future 
perspectives, and a final conclusion.
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AbstrAct
Importance: Recovery from facial nerve transection is typically poor, but daily mechani-
cal stimulation of the face in rats has been reported to remarkably enhance functional 
recovery after facial nerve transection and suture repair. This phenomenon needs ad-
ditional investigation because of its important clinical implications.
Objective: To determine whether automated mechanical stimulation of the whisker pad 
improves whisking recovery after facial nerve transection and repair in a rat model.
Design and Setting: Sixty-one rats underwent unilateral facial nerve transection and 
suture repair and were randomized into 8 groups. Six groups received daily automated 
whisker or whisker pad mechanical stimulation including 0.5-, 1.5-, and 8.0-Hz patterns. 
Two control groups received restraint without stimulation. Treatment started on post-
operative day 8,occurred 5 days per week, and lasted throughout 15 weeks of recovery. 
Whisking amplitude, velocity, and acceleration were quantified weekly for 15 weeks.
Interventions: Unilateral facial nerve transection, suture repair, and, for 6 groups, daily 
automated whisker or whisker pad mechanical stimulation.
Main Outcomes and Measures: Quantification of whisking amplitude, velocity, and ac-
celeration.
Results: Rats receiving the low frequencies of stimulation of the whiskers or whisker pad 
did not demonstrate enhanced whisking recovery, and rats receiving stimulation at 8.0 
Hz showed significantly worse whisking recovery compared with controls and previ-
ously published groups receiving lower dose manual stimulation.
Conclusions and Relevance: Although daily manual whisker pad stimulation has been 
shown to enhance whisking recovery, rats in this study did not demonstrate improved 
whisking recovery after automated mechanical stimulation across a wide range of 
driving frequencies. Moreover, faster stimulation (8.0 Hz) was actually detrimental to 
recovery. Further work is needed to understand the relationship between stimulation 
patterns and the physiologic mechanisms underlying improved or worsened functional 
outcomes after facial nerve transection and repair.
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introDuction
Facial paralysis is a disorder with profound consequences, both functional and psycho-
social. Causes of facial nerve paralysis are myriad, stemming from surgical, infectious, 
traumatic, congenital, and idiopathic factors. Among the various consequences, incom-
plete eye closure (leading to exposure keratopathy), external nasal valve obstruction, 
oral incompetence, speech and articulation problems, esthetic impairments, and the 
inability to express emotions through facial musculature are most clinically important. 
Treatment options comprise physical therapy, nerve transfers, muscle transfers, and 
static surgical techniques.1The results, even following aggressive treatment, remain 
variable and often disappointing. After nerve repair, the slow rate of nerve regeneration 
can lead to degeneration of the motor end organ and permanent loss of function. In 
addition, axonal misrouting can develop, leading to synkinesis.2
One driving question for facial nerve regeneration research groups is how to accelerate 
and improve facial nerve regeneration. The rat model is widely used to study interven-
tions that affect speed and completeness of facial nerve recovery. The rat facial nerve is 
anatomically comparable to the human facial nerve,3 and recovery is highly quantifiable 
by measurement of whisking kinematics.4 Research has focused on pharmacologic,5-8 
electrical,9,10 and mechanical11-14 interventions to accelerate and improve facial nerve 
regeneration; mechanical intervention has demonstrated the most promising results to 
date. The application of mechanical stimulation to the facial muscles during regenera-
tion of the facial nerve could be relatively easy to administer and would be of great value 
in clinical settings where recovery is expected. However, more thorough exploration of 
the therapeutic potential of this treatment option is required, and the underlying physi-
ologic mechanisms must be better understood before it can become part of routine 
clinical care of patients recovering from facial paralysis.
In previous studies from our laboratory10,11 and other laboratories,12-14 mechanical 
whisker and whisker pad stimulation has been delivered manually. Our laboratory re-
cently developed a whisk assist (WA) system for delivering controlled and quantifiable 
patterns of mechanically driven whisking after rat facial nerve injury.15 This WA appara-
tus drives or assists whisker movement on the horizontal (dominant) plane of natural 
whisking, and is well tolerated by head-fixed (restrained) animals. In the present study, 
we examined the effects of several preprogrammed WA patterns during recovery from 
facial nerve transection and suture repair. We studied larger groups of rats of previously 
promising conditions15 and piloted additional new conditions under the hypothesis 
that WA treatment would enhance the speed and/or completeness of whisking recovery 
compared with none in control (CNTR) animals.
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conditioning and head fixation
Sixty-one female Wistar-Hannover rats (Charles River Laboratorium) weighing 200 to 
250 g each were handled on a daily basis 5 days per week for 1 week to acclimate them 
to human handling. All rats then underwent implantation of a titanium head fixation de-
vice, as previously described.16 The device has 4 lateral extensions that provide points of 
attachment with an external framework for head fixation. Two weeks after implantation 
of the head fixation device, the rats were progressively conditioned to a body and head 
restraint apparatus 5 days per week.16 When the animals were sufficiently conditioned 
to undergo head and body restraint without struggling or other signs of stress (typically 
after 2 weeks), unilateral facial nerve cut and suture repair surgery was performed. All 
experimentation was conducted under protocols approved by the Massachusetts Eye 
and Ear Infirmary Animal Care and Use Committee.
facial nerve cut and suture repair surgery
Rats were anesthetized with an intramuscular injection of ketamine hydrochloride 
(50mg/kg) (Fort Dodge Animal Health) and dexmedetomidine hydrochloride (0.5mg/
kg) (Orion Corporation). The left facial nerve was exposed via a preauricular incision, and 
ipsilateral parotidectomy was performed. The main trunk and dominant branches of the 
facial nerve were identified. The main trunk of the nerve was sharply transected and mi-
crosurgically reconnected with two or three 10-0 epineural nylon sutures (Ethicon Inc). 
The wound was closed in a single layer with absorbable suture. All surgical procedures 
were performed by a single microsurgeon with substantial neurorrhaphy experience. 
The anesthetic was reversed with a subcutaneous injection of atipamezole hydrochlo-
ride (0.05mg/kg) (Orion Corporation). Postoperatively, the rats were monitored for signs 
of discomfort, weight maintenance, cage behavior, and wound issues.
mechanical stimulation With the WA system
The WA system has been previously described.15 Briefly, rats are placed in a body and 
head restraint half-pipe, which is then positioned in the apparatus. The WA system is 
designed to move the whiskers on one side of the face in the horizontal plane. The 
automated mechanical stimulation is delivered via a servomotor-controlled rod holding 
either a comb with 8 vertical tines that contact all of the prominent whiskers when the 
rod is moved horizontally or a brush that contacts the whisker pad for direct pad surface 
stimulation (Figure 1). The animals were randomized into 8 groups (Table 1). The most 
promising treatment patterns of Heaton et al15 were chosen to test in larger groups of 
rats; for 3 experimental groups, the mechanical stimulation treatment patterns moved 
the whiskers 60 to 70 degrees at a rate of 8.0 Hz, with these 3 groups differing in how 
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many treatment sessions were delivered per day or whether the stimulation was 
continuous or intermittent during the treatment sessions. Three additional treatment 
patterns of the same amplitude were tested: 1 was whisker movement at 1.5 Hz, and for 
the other 2 groups, the WA apparatus was altered to provide both whisker and whisker 
pad stimulation at 0.5 Hz via the head of a soft-bristled toothbrush in place of the comb 
(Figure 1). These latter 3 low-frequency conditions were chosen to better emulate the 
manual mechanical stimulation evaluated in prior studies.10-14 All treatment patterns 
started at postoperative day 8. Control animals were restrained for 20 minutes per day 
in an apparatus similar to the WA system, with the WA comb against the whisker pad, but 
without comb movement.
figure 1. Rat in the Whisk Assist apparatus. A. 
System overview. B. The comb in position to drive 
whisker movement. C. The bristle brush in position 
to mechanically stimulate the whisker pad.
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functional recovery testing
Whisking function was assessed weekly throughout the 15-week recovery period using 
our laboratory’s previously validated testing apparatus.17,18 Briefly, the rats were placed 
in head and body restraint and positioned in the testing apparatus for 5 minutes of con-
tinuous recording per recording session. Movement of lightweight markers threaded 
onto a representative prominent whisker (row C, whisker 1) on the right and left was 
tracked by laser micrometers (MetraLight) positioned adjacent to each whisker pad, and 
data on whisker movement were saved by custom data acquisition software.4,19,20
statistical Analysis
For each recording session, the 3 largest amplitude whisks on each side of the face were 
automatically identified and measured for amplitude, velocity, and acceleration using 
software adapted from Bermejo et al.4,19,20 Whisking function on the recovering side was 
analyzed in relationship to whisking on the healthy side to account for daily variation in 
whisking effort because whisking is typically symmetrical across both sides of the face.21 
The recovery variables of whisking amplitude, acceleration, and velocity were each aver-
aged by week across weeks 3 to 15 of recovery, and 1-way analysis of variance (ANOVA) was 
performed to test for overall treatment effects among the 8.0-Hz experimental and CNTR 
groups for each variable. Multiple post hoc Tukey tests were performed (as appropriate) af-
ter establishing main effects to determine which mechanical stimulation treatment groups 
differed from each other and from CNTR rats. These data were compared with previously 
published data,11 with 1-way ANOVA and Tukey post hoc tests. The small group sizes of the 
3 low frequency stimulation groups (Table) precluded meaningful statistical comparison, 
but data from these groups are presented descriptively with the other groups for compari-
son. Statistical testing was performed with SPSS software, version 16.0 (SPSS Inc).
table 1. Whisk Assist Treatment Programs
Group n WA Pattern Sessions/day Total Time in Apparatus, min/day
CNTR-A 8 no stimulation 1 20
CNTR-B 8 no stimulation 3 20
8.0 Hz-A 16 constant 1 20
8.0 Hz-B 8 constant 3 20
8.0 Hz-C 8 5 sec per 30 sec 3 20
1.5 Hz 3 constant 1 5
0.5 Hz-A* 5 constant 1 5
0.5 Hz-B* 5 constant 3 15
* These conditions included direct stimulation of the whisker pad surface; WA = whisk assist; CNTR = control 
group
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results
During the 15-week postoperative recovery period, 8 animals (13%) were excluded from 
the study because of head fixation device failure. This attrition rate was consistent with 
our laboratory’s prior findings using the head fixation device,10,11 and we have found this 
to be equal to or lower than attrition when simple head-mount screws are reinforced 
with adhesives over extended survival periods (eg, 15 weeks). The excluded animals 
were relatively equally spread across the groups (CNTR-A, 1 [2%]; CNTR-B, 2 [3%]; 8.0 
Hz–A, 2 [3%]; 8.0 Hz–B, 1 [2%]; 8.0 Hz–C, 1 [2%]; 1.5 Hz, 0;0.5Hz–A, 0; and0.5 Hz–B, 1 [2%]). 
There were no postsurgical wound infections after either the head fixation device im-
plantation or the facial nerve transaction and repair surgery, and all rats demonstrated 
normal feeding and social behavior.
Figure 2 shows the mean recovery of whisking amplitude across weeks 3 to 15 as a 
ratio of whisking amplitude for the nerve-repaired side divided by the healthy side. No 
trend of improvement was observed in animals undergoing these pilot WA conditions. 
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figure 2. Mean recovery of whisking amplitude across weeks 3 to 15 for experimental and control (CNTR) 
groups. Relative recovery determined as a ratio of whisking amplitude for the nerve-repaired side divided 
by the healthy side. The different groups are described in Table 1. Standard error bars are shown.
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Statistical analyses were performed with the 8.0-Hz experimental groups. Postoperative 
whisking amplitude data for the 8.0-Hz experimental and CNTR groups are shown in Fig-
ure 3. A 1-way ANOVA demonstrated an overall statistically significant difference among 
these 5 experimental groups in relative whisking amplitude across weeks 3 to 15 (P < 
.001). Tukey post hoc analysis found statistically significant differences between CNTR-A 
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figure 3. Recovery of amplitude for the 8.0-Hz experimental and control (CNTR) groups. A. Columns repre-
sent mean relative recovery of amplitude. Standard error bars are shown. B. Columns represent the mean 
recovery of amplitude across weeks 3 to 15 for the 8.0-Hz experimental groups. Standard error bars are 
shown. a P < .001, b P = .02, c P = .009.
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and 8.0 Hz–A (P = .02), between CNTR-A and 8.0 Hz–C (P < .001), and between CNTR-B 
and 8.0 Hz–C (P = .009) (Figure 3B), with the WA groups performing more poorly. Results 
of whisking velocity and acceleration recovery were qualitatively and quantitatively 
similar to whisking amplitude recovery (data not shown).
Because there were no statistically significant differences between the CNTR groups 
and among the 8.0-Hz treatment conditions in the present study, the CNTR-A and CNTR-
B groups were combined (all CNTR), as were the 8.0 Hz–A, Hz–B, and Hz–C groups (all 
8.0 Hz) for further comparison with manual mechanical stimulation (MMS) data from 
our laboratory’s prior report.11 The mean recovery of whisking amplitude across weeks 
3 to 15 in the MMS group was used for comparison. A statistically significant difference 
was found among these 3 groups (P < .001; 1-way ANOVA) (Figure 4), and Tukey post 
hoc analysis showed statistically significant differences between all 8.0 Hz and MMS (P 
= .004), and between all CNTR and all 8.0 Hz (P = .001), with CNTR animals and MMS 
animals performing better than WA animals. The mean recovery of whisking amplitude 
across weeks 3 to 15 for the MMS group from the prior report11 did not differ significantly 
from the all CNTR group of the present study (P > .05).
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figure 4. Mean recovery of whisking amplitude across weeks 3 to 15 of the present study (combined 
groups) and manual mechanical stimulation (MMS)11 All CNTR indicates combination of control A (CNTR-
A) and CNTR-B; all 8.0 Hz, combination of the three 8.0-Hz conditions (groups 8.0 Hz–A, Hz–B, and Hz–C). 
Standard error bars are shown. a P = .001. b P = .004.
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Discussion
Functional recovery from facial nerve transection and surgical repair is typically poor in 
rats and humans, providing an opportunity to test interventions intended to enhance 
facial nerve regeneration in rats that might ultimately translate to humans. Rat whisk-
ing movement begins to reappear approximately 3 weeks after unilateral facial nerve 
transaction and repair, improves steadily for several weeks, and generally plateaus by 
2 to 4 months at only approximately 25% of the whisking amplitude relative to the 
contralateral healthy side of the face.6,10-12,14 Previous studies10-14 have found enhanced 
functional recovery from brief, daily MMS of the whiskers and/or whisker pad delivered 
during recovery from unilateral facial nerve transection and repair. Such enhance-
ment has ranged from a modest 10% improvement in relative whisking amplitude 
reported by our laboratory10,11 to complete (symmetrical) whisking recovery observed 
by others.12-14
We sought to deliver multiple patterns of whisker and whisker pad mechanical stimu-
lation under greater experimental control than that in previous studies, with the goal of 
identifying optimal treatment patterns and potentially resolving discrepancies among 
prior outcomes. Based on pilot data,15 we anticipated that the 8.0-Hz stimulation patterns 
delivered in the present study would show greater enhancement of functional outcome 
compared with our prior moderate levels of stimulation.10,11,15 To the contrary, functional 
outcome after high-dose WA treatment was impaired relative to that in the CNTR ani-
mals, suggesting that high-dose WA treatment can cause deleterious overstimulation 
of the whisker pad. Moreover, lower-dose WA movement of the whiskers (1.5 Hz via 
comb interface) and/or whisker pad surface (0.5 Hz via brush interface) likewise failed to 
improve whisking recovery in the present study, drawing into question the cause of the 
complete recovery achieved after MMS performed in a different laboratory.12-14
One possible mechanism underlying the apparent deleterious effects of high-dose 
(8.0-Hz) stimulation is fatigue of the facial mechanoreceptors during prolonged ac-
tivation.22 The work of Pavlov et al13 indicated that intact sensory input is required for 
mechanical stimulation to provide a benefit and that mechanical stimulation delivered in 
the absence of normal whisker pad sensation (after infraorbital nerve cut) not only fails to 
enhance functional outcome but also worsens whisking recovery. Whisker pad sensation 
may have been diminished or interrupted during intensive mechanical stimulation in our 
study resulting from mechanoreceptor fatigue,22 thereby resembling the sensory nerve 
lesion effect reported by Pavlov et al13 and leading to reduced functional outcome. How-
ever, this does not explain why lower-frequency stimulation (0.5-1.5 Hz) failed to enhance 
whisking recovery and indicates that further experimentation is required to shed light 
on the interaction of sensory feedback and motor axon regeneration in the whisker pad.
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An additional explanation for the lack of benefit from the 8.0-Hz WA stimulation is that 
direct mechanical contact with the whisker pad may be required to evoke a beneficial 
regenerative effect. A denervated muscle undergoes various changes depending on the 
delay before reinnervation, including loss of muscle mass, diminished blood circulation, 
shrinking of connective tissue, and adhesion (fibrosis).23 Mechanical stimulation of 
the whisker pad itself (instead of just whisker movement) may help to minimize these 
sequelae of denervation by maintaining whisker pad health while the facial nerve is 
regenerating and perhaps provide an optimal interaction between trigeminal and facial 
brainstem nuclei, as noted in the previous paragraph. In the initial version of our WA 
system,13 the oscillating comb contacted whiskers close to their exit from the pad (Fig-
ure 1A), but the comb had little contact with the pad itself. Given that the prior studies 
that found the greatest enhancement of facial nerve regeneration involved stimulation 
of both the whiskers and the pad through fingertip stroking of the pad,10-14 we modified 
the WA hardware for groups 0.5 Hz–A and 0.5 Hz–B in the present study to provide direct 
pad contact via a soft bristle brush pressing against the pad surface to emulate fingertip 
pressure (Figure 1C). However, this pad-stimulating condition failed to enhance whisk-
ing recovery, leaving us at a loss for why relatively low-frequency stimulation did not 
enhance regeneration as had been seen with manual stimulation in prior reports.12-14
One potentially important difference between whisker pad stimulation delivered in 
the present study versus handheld delivery used in prior studies is the heightened stress 
that rats may have experienced under rigid restraint within the WA system. Rats were 
extensively conditioned to human handling and placement in restraint in the weeks 
before nerve injury and repair followed by WA treatment, and they did not exhibit signs 
of heightened stress under restraint (eg, vocalizing or struggling) while the WA system 
delivered stimulation compared with the stationary comb control condition. However, 
it is possible that WA treatment produced occult stress that offset potentially benefi-
cial effects of the treatment, explaining why whisking recovery that was similar to, or 
worse than, that of the restrained CNTR rats, as has been demonstrated in prior studies; 
van Meeteren et al.24 demonstrated that chronic intermittent stress impaired nerve 
regeneration in a sciatic nerve model. The nerve regeneration process is controlled by 
neuroendocrine, immunologic, and autonomic nervous system factors. Chronic stress 
deteriorates the efficiency of these processes; for example, activation of the autonomic 
nervous system causes epineural vasoconstriction and reduces endoneural nerve blood 
flow.24 Likewise, Amako and Nemoto25 found suppressed sciatic nerve recovery after 
water-immersion stress in rats.
Variability of the whisking amplitude within groups (Figure 3) and the fluctuation in 
mean whisking kinematics across all groups at most recovery time points is consistent 
with our prior observations and represents an inherent weakness in using this functional 
recovery measure. Because rats whisk with variable amplitude based both on muscle 
48 Chapter 2.1
strength and intactness of innervation, as well as on mood, state of curiosity, arousal, 
and interest in the surrounding environment, among other factors, the assay itself may 
be relatively insensitive to small but real influences and interventions.
Further investigations of mechanical stimulation effects on nerve regeneration will 
require exploring ways to mitigate the stress associated with restraint during treatment 
delivery, such as sedation or delivery of appetitive rewards.
The effects of mechanical stimulation have been studied in other animal models of 
peripheral nerve regeneration,26-31 sometimes with conflicting results. For example, van 
Meeteren et al.27 demonstrated that mild daily exercise (4 hours of hind paw stretching) 
augmented functional recovery in the early phase (persisting into the late phase) after 
sciatic nerve crush in the rats, whereas Herbison et al.32,33 showed that intense swimming 
did not enhance the repair of reinnervated muscle and that treadmill running led to a 
deleterious effect on muscle function recovery.
Potential explanations for these inconsistencies include variations in the type of nerve 
injury, whether or not the nerve contains sensory axons,30 the type of mechanical stimu-
lation delivered, and the duration and intensity of the stimulation.34 There are likewise 
conflicting results in the literature10-14 as described above with specific regard to the 
effect of mechanical stimulation on regeneration of the facial nerve. It is possible that, 
in our hands or apparatus, mechanical stimulation has not led to true enhancement in 
whisking recovery when the performance of CNTR and experimental groups is consid-
ered across our studies. The relative recovery of whisking amplitude for regenerated 
nerves versus the contralateral (healthy) side within rats has been approximately 10% 
better (on average, within studies) compared with that in simultaneous nerve repaired 
CNTRs10,15 or historical CNTRs.11 However, had the present nerve-repaired CNTR group 
served as the point of comparison in our laboratory’s prior studies, then none of the 
previous stimulated groups would have shown an enhancement. This is illustrated by 
comparing the greatest prior enhancement of MMS11 with the present all CNTR group 
(Figure 4), yielding similar whisking amplitude after 15 to 16 weeks of recovery. This 
suggests that either daily restraint for 20 minutes (with a stationary whisker comb)
provides the same degree of recovery enhancement as mechanical stimulation in all 
of the manual and automated forms our laboratory has tested to date,10,11,15 or that the 
effect of mechanical stimulation by our group has been negligible. Either way, we have 
repeatedly failed to replicate the complete symmetrical recovery caused by MMS of the 
whisker pad as previously reported.12-14 Differences in stimulation delivery techniques or 
whisking quantification methods across laboratories may contribute to these disparate 
findings,35 but our studies have shown that enhancing nerve regeneration through 
whisker pad manipulation is difficult to achieve at best and potentially detrimental at 
worst. Our failure to demonstrate recovery benefit despite our exhaustive use of myriad 
regimens of automated WA under systematic, highly controlled circumstances, with and 
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without direct whisker pad stimulation, leads us to conclude that the benefit originally 
proposed may not represent a true, reproducible phenomenon.
conclusions
Recovery of horizontal whisking was monitored for 15 weeks after unilateral facial nerve 
transection and repair in 61 rats, 45 of which received daily, automated WA mechani-
cal therapy and 16 of which served as sham-stimulated CNTRs. Automated mechanical 
stimulation failed to enhance whisking recovery for low-frequency stimulation (0.5 Hz 
or 1.5 Hz) resembling the manually delivered patterns used in prior reports, and higher-
frequency stimulation (8.0 Hz) resulted in worse recovery than that observed in CNTRs. 
Moreover, the CNTR group in the present study performed as well as the experimental 
groups in our laboratory’s prior reports, in which recovery was believed to have been 
enhanced by MMS (via whisker pad stroking with a fingertip10 or paintbrush11), drawing 
into question whether mechanical stimulation actually led to meaningful enhancement 
of whisking in those reports. The discrepancy between the modest or nonexistent 
whisking recovery enhancement caused by mechanical stimulation in some studies10,11,15 
compared with the complete recovery reported by other groups12-14 requires further 
clarification given the potential clinical importance of this physical therapy intervention.
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AbstrAct
Vibrissal whisking is often employed to track facial nerve regeneration in rats; however, 
we have observed similar degrees of whisking recovery after facial nerve transection 
with or without repair. We hypothesized that the source of non-facial nerve-mediated 
whisker movement after chronic denervation was from autonomic, cholinergic axons 
traveling within the infraorbital branch of the trigeminal nerve (ION). Rats underwent 
unilateral facial nerve transection with repair (N=7) or resection without repair (N=11). 
Post-operative whisking amplitude was measured weekly across 10weeks, and during 
intraoperative stimulation of the ION and facial nerves at ≥18weeks. Whisking was also 
measured after subsequent ION transection (N=6) or pharmacologic blocking of the 
autonomic ganglia using hexamethonium (N=3), and after snout cooling intended to 
elicit a vasodilation reflex (N=3). Whisking recovered more quickly and with greater am-
plitude in rats that underwent facial nerve repair compared to resection (P<0.05), but in-
dividual rats overlapped in whisking amplitude across both groups. In the resected rats, 
non-facial-nerve-mediated whisking was elicited by electrical stimulation of the ION, 
temporarily diminished following hexamethonium injection, abolished by transection 
of the ION, and rapidly and significantly (P<0.05) increased by snout cooling. Moreover, 
fibrillation-related whisker movements decreased in all rats during the initial recovery 
period (indicative of reinnervation), but re-appeared in the resected rats after undergo-
ing ION transection (indicative of motor denervation). Cholinergic, parasympathetic 
axons traveling within the ION innervate whisker pad vasculature, and immunohisto-
chemistry for vasoactive intestinal peptide revealed these axons branching extensively 
over whisker pad muscles and contacting neuromuscular junctions after facial nerve 
resection. This study provides the first behavioral and anatomical evidence of spontane-
ous autonomic innervation of skeletal muscle after motor nerve lesion, which not only 
has implications for interpreting facial nerve reinnervation results, but also calls into 
question whether autonomic-mediated innervation of striated muscle occurs naturally 
in other forms of neuropathy.
Evidence for autonomic contraction 55
2.2
introDuction
Facial paralysis is experienced by approximately 40,000 individuals in the United States 
each year1, and can lead to permanent disfigurement and functional loss despite ad-
vances in static and dynamic surgical intervention2. Efforts to improve management 
of facial nerve injury have turned to animal models for studying nerve coaptation 
techniques, grafting approaches, and interventions intended to enhance axonal regen-
eration. These interventions must be compared to appropriate controls, including the 
chronically denervated state, representing long-term failure for reinnervation to occur.
Our research team studies facial nerve recovery in the rat model, tracking whisking 
function over time after nerve injury and repair. Whisking is a highly quantifiable, dy-
namic behavior controlled primarily by the buccal and marginal mandibular branches 
of the facial nerve3-5. In the course of comparing facial nerve main trunk transection and 
suture repair to a chronically denervated state, we discovered that whisker movements 
would re-appear approximately 30 days after facial nerve resection, and grow stronger 
over the ensuing weeks. Although maximal whisking amplitude was generally greater in 
rats who had undergone facial nerve repair, there was nevertheless overlap in whisker 
movement amplitude for individual animals between repaired and resected groups. A 
deeper understanding of the source and mechanism of this non-facial nerve-mediated 
whisker pad motor innervation is imperative to the validity of vibrissal function as a 
metric for rat facial nerve recovery.
The rodent whisker pad receives a dense motor and sensory nerve supply from the 
facial and trigeminal nerves, respectively (Figure 1)3-5. Although the infraorbital division 
of the trigeminal nerve (ION) provides dense sensory innervation to the whisker pad, it 
is also known to contain postganglionic, parasympathetic, cholinergic axons3 that in-
nervate blood vessels of the whisker pad6. We hypothesized that these parasympathetic, 
cholinergic fibers were the source of motor innervation causing whisker movement in 
rats with chronic facial nerve discontinuity. We tested this hypothesis in rats at7 10 or 
more weeks after unilateral facial nerve resection by (1) electrically stimulating the 
ION intraoperatively and observing possible whisker movements, (2) transecting the 
ION and observing possible cessation of whisker movements, (3) administering the 
autonomic blocking drug hexamethonium to see if ION-based whisker movements 
were diminished, (4) cooling the snout to see if the vasodilation reflex would increase 
ION-based whisker movement, and (5) immunohistochemical identification of somatic 
and autonomic innervation of whisker pad intrinsic and extrinsic muscles.
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Animals and procedures
Eighteen female Wistar–Hannover rats (Charles River Laboratories, Wilmington, Mas-
sachusetts) weighing 250–300 g were obtained in accordance with Massachusetts Eye 
and Ear Infirmary guidelines for animal care under an approved protocol. For all surgical 
procedures, rats were anesthetized with an intramuscular injection of ketamine hydro-
chloride (50 mg/kg) (Fort Dodge Animal Health, Fort Dodge, Iowa) and medetomidine 
hydrochloride (0.5 mg/kg) (Orion Corp., Espoo, Finland). For assessment of fibrillation-
related whisker movements, rats were sedated with intramuscular injection of medeto-
midine hydrochloride (0.5 mg/kg), which was subsequently reversed with atipamezole 
hydrochloride (0.5 mg/kg) (Pfizer Inc., New York, NY). At the conclusion of the study, 
animals were euthanized according to NIH guidelines.
head restraint device implantation and restraint conditioning
Whisking assessment was performed under head and body restraint, requiring surgical 
implantation of a titanium head fixation device 5–6 weeks before testing (see reference 
8 for details). Prior to restraint device implantation, rats were handled daily for 2–3 days 
in order to acclimate them to handling. After device implantation, rats were handled 
daily for two weeks, and then gradually conditioned to restraint over an additional two-
week period (see reference 9 for a complete description of restraint training).
 
figure 1. Diagram of the rat facial nerve branches  beginning from the stylomastoid foramen, and infraor-
bital nerve (ION) beginning from the infraorbital fissure. Macro vibrissae follicles are represented by gray 
dots arranged in 5 major rows.
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facial nerve transection and repair or resection
All rats underwent left facial nerve (VII) transection at the main trunk distal to the sty-
lomastoid foramen. The main trunk was exposed by removal of the parotid gland and 
divided with microsurgical scissors under an operating microscope (Leica Wild M65m, 
Wetzlar, Germany). In 7 rats, the transected facial nerve was repaired with two or three 
interrupted 10-0 nylon epineurial sutures (VII Repaired group). In 11 rats, the incision 
exposing the facial nerve was extended to the lateral border of the whisker pad, permit-
ting extirpation of the buccal and marginal mandibular branches from the pes anserinus 
proximally to their distal convergence at the whisker pad (VII Resected group; see Figure 
2). The proximal and distal nerve stumps were then sutured into silicone tubes sealed 
with cyanoacrylate to prevent axons from exiting or entering the cut nerve ends, respec-
tively. Whisking assessment began one week after nerve manipulation and continued 
weekly for 10 weeks. The capped main trunk in rats undergoing nerve resection (VII 
Resected group; N = 11) was exposed through a small incision once per month during 
the recovery period, and a Montgomery bipolar nerve stimulator (Boston Medical Prod-
ucts, Inc., Westborough, MA) was used to stimulate around the capped nerve in order to 
confirm that axons had not escaped encapsulation and re-innervated the whisker pad.
figure 2. Diagram of the rat facial nerve showing where the nerve was unilaterally transected (X), and 
sutured into dead-end silicone tubes at the main trunk (right photo), as well as at the distal convergence of 
the buccal and marginal mandibular branches (left photo) for the VII Resected group (N=10). The region of 
nerve extirpated between the transection locations is shown as a lighter shade of blue.
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Rats from the VII Resected group underwent ION exposure at ≥16 weeks after their 
initial surgery (N = 11). The ION was transected just anterior to its exit point from the 
infraorbital fissure, and the distal fascicles were electrically stimulated while whisker 
movements were observed (N = 11). Five rats from the VII Resected group were eu-
thanized at the end of the ION transection surgery, and the remaining 6 were followed 
for an additional post-surgical period of at least one week to document spontaneous 
whisker movements.
Whisking assessment
Horizontal whisker movement was assessed bilaterally during weekly, 5-min recording 
sessions using non-contact laser micrometers (RX Series, MetraLight, Santa Mateo CA) 
while rats were under head and body restraint. The hardware and software used for 
monitoring whisker movement is described in detail by Heaton et al.9, and was adapted 
from the system employed by Bermejo and colleagues10, 11 through their generous as-
sistance.
Rats typically sweep their prominent whiskers (vibrissae) in unison on each side of 
the face, so whisking ability can be assessed by tracking the movement of single right 
and left pad whiskers. To do this we accentuated the visibility of the first whisker of the 
middle row (i.e. whisker C1) on each side by threading them into lightweight (3–4 mg) 
polyimide tubes (SWPT-045, Small Parts, Inc.) to make them selectively visible to the 
laser micrometers9-11. Rats often whisk spontaneously, even while restrained, but we also 
attempted to elicit vigorous whisking using computer-controlled air valves to deliver 
10-s scented air flows toward the snout at 3 random time points during each recording 
session (see method details in Heaton et al.9).
On any given post-operative week, rats were excluded from whisking assessment 
if they exhibited distress or discomfort when placed in restraint or during the 5-min 
whisking recording period. This led to the exclusion of 5 out of 160 recording ses-
sion data points during the 10 weeks of assessment (2 data points from rats in the VII 
Resected group and 3 from rats in the VII Repaired group). One rat in the VII Resected 
group experienced head implantation failure early in the postoperative period and was 
therefore excluded from quantitative whisking assessment, but was maintained for 
manipulations not requiring head restraint (i.e. fibrillation assessment, hexamethonium 
administration, snout cooling and intraoperative ION stimulation – see Sections Fibril-
lation assessment, Hexamethonium effect on whisker movement and Snout cooling 
effect on whisker movement), and another rat from the VII Resected group was used for 
immunohistochemical axon staining 19 weeks after resection but did not contribute to 
the whisker movement data because it was studied in a later cohort.
The average amplitude of the C1 whisker movements from onset (retraction) to peak 
protraction was calculated for the largest 3 whisks recorded during each recording ses-
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sion from each side of the face12. These maximal whisks were averaged within each rat, 
and compared for the left whisker pad across the recovery period using a mixed-factors 
analysis of variance (ANOVA) to evaluate the main effects of experimental group (VII Re-
paired versus VII Resected; between-subject factor), week of recovery (within-subjects 
factor), and a possible interaction (alpha of P < 0.05). Based on the outcome of omnibus 
(preliminary) main effects and interaction testing, post hoc pair-wise comparisons be-
tween treatment groups were performed using one-tailed t-tests for particular weeks 
of recovery. Post-hoc testing was restricted to a few particular time-points of interest 
in order to minimize the number of pair-wise comparisons. This included the first week 
of apparent whisker movement recovery from each treatment group (weeks 3 and 4), 
the middle of the recovery period (weeks 6 and 7), and the last measured time point 
(week 10). A starting alpha level of P < 0.05 was divided by the number of post hoc tests 
between treatment groups (as a family of tests) to mitigate alpha inflation (i.e. alpha of 
P < 0.05/5 = P < 0.01). Post-hoc tests were also performed between weeks 3 versus 4 
and weeks 4 versus 10 within the VII Resected group to determine whether the initial 
apparent recovery of whisker movement represented a true increase, and whether 
the initial whisker movement differed from the last time point in the tracked recovery 
(respectively), with an adjusted alpha level of P < 0.025 for this second family of tests.
fibrillation assessment
Fibrillation contractions, which provide a means of documenting whisker pad denerva-
tion and subsequent reinnervation13, 14, were visually assessed from video recordings 
taken from directly above the head of sedated animals13, 14. A 10-s video file was created 
for each rat in the VII Resected group (N = 10) every-other week from weeks 2 to 14 (or 
greater) of recovery, after sedating rats with medetomidine hydrochloride (0.5 mg/kg), 
using a digital video camera with a resolution of at least 720 × 480 pixels, with a data 
rate >1900 kbps (Optura PI or VIXIA HF R200, Canon USA, Inc., Lake Success, NY). Six rats 
were also video recorded one or two weeks after ION transection survival surgery (at 
≥17 weeks after facial nerve resection).
Video files were presented in random order to three observers (blinded to experi-
mental condition and naïve to the study hypotheses) via a custom-written graphic user 
interface (GUI) in Matlab software (The MathWorks Inc., Natick, MA). The software GUI 
provided instructions for how to rate fibrillation-related whisker movement, and pre-
sented three video clips representing none, moderate, and high amounts of movement 
(from rats selected from a different study), to familiarize raters with the range of motion 
they would observe in the rating task. The raters then judged the amount of fibrillation 
movement they observed in each randomly presented clip by sliding a marker on a 
linear continuum labeled “none” on the far left end, “moderate” in the middle, and “high” 
on the far right end, corresponding to a recorded value of 1–100 within the software. 
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Each video clip was viewed at least twice, using methods detailed previously14. The 
fibrillation-related movement rating for each clip was stored in computer memory after 
the clip’s first presentation, and the second time a given clip was viewed and rated (in 
random order), if the 2 ratings were within 20% of each other, the average value for the 2 
ratings was taken as the final score for that clip. If the second rating was not within 20% 
of the first rating, then the second value became the new point of comparison for that 
clip, and the process continued until all consecutive judgments had a minimum amount 
of variability (i.e. ≤20%). Ratings were then exported to a Microsoft Excel spreadsheet 
(Microsoft Corp., Redmond, WA) for compiling rater scores.
hexamethonium effect on whisker movement
To test the hypothesis that non-facial-nerve derived whisking is mediated by post-
ganglionic, parasympathetic axons (traveling within the ION), we injected 3 rats with the 
autonomic ganglia-blocking agent hexamethonium bromide15 (H0879, Sigma–Aldrich 
Co. LLC., St. Louis, MO) dissolved in sterile physiological saline (300 mg/ml) at a dose of 
7.4–30 mg/kg (IM) on two or more separate days. The head restraint implants of these 
rats would no longer reliably support rigid restraint at the time of hexamethonium 
injection, so rats were video recorded from a camera (VIXIA HF R200) positioned above 
their head while they were held in an experimenter’s hand resting on the surface of a 
laboratory table before and at multiple time points after drug injection. This enabled 
documentation of whisker movement bilaterally (with little head movement) for subse-
quent perceptual assessment by video clip observers. Ten second video segments were 
created for pre- and post-hexamethonium injection, and the clips were judged by four 
individuals blinded to experimental conditions, using the same methods as described 
previously for fibrillation assessment. The GUI for this task provided example video clips 
representing no movement, moderate movement and the strongest ION-mediated 
movement anticipated from the left whisker pad (from video segments not also appear-
ing in the test set).
All 3 rats were video recorded before injection and 20–30 min after injection of 30 
mg/kg hexamethonium bromide on two separate days. In addition, one rat was also 
video recorded 120 min after hexamethonium injection to demonstrate the return of 
ION-mediated movement. On a different day, one rat received a half dose (i.e. 15 mg/
kg) and another rat received a quarter dose (i.e. 7.5 mg/kg) ofhexamethonium; both rats 
were video recorded before and 20–30 min after injection for comparison with the full 
dose (30 mg/kg) condition.
snout cooling effect on whisker movement
To test the possibility that snout cooling would trigger a vasodilation reflex and thereby 
potentiate ION-mediated whisker movement due to increased acetylcholine (ACh) 
Evidence for autonomic contraction 61
2.2
release from parasympathetic axons, video recordings were obtained of whisker move-
ments (as described in the prior section) in 3 rats before and during or immediately after 
a piece of ice was held against the snout and upper lip. The relative change in whisker 
amplitude (in degrees) was measured for the 3 largest whisks in the 10 s prior to cooling 
and the three largest whisks in the 10 s during or immediately after cooling. This was 
done by capturing video still frames (1920 × 1080 pixels, 30 frames per second, using 
Corel Video Studio Pro X3, Corel Corp., Ottawa, Ontario), and measuring the angle of 
whisker movement from maximal retraction to maximal protraction of a prominent row 
C whisker using Adobe Photoshop (Version CS5, Adobe Systems, Inc., San Jose, CA).
immunohistochemical identification of somatic and autonomic axons
Axon staining was performed using antibodies for heavy weight neurofilament 
(anti-NF200) and basoactive intestinal peptide (anti-VIP). Heavy weight neurofilament 
is found only in motor axons and large, myelinated sensory axons but not autonomic 
axons. VIP is found in essentially all postganglionic, parasympathetic neurons within the 
pterygopalatine ganglia16-19 but not in motor axons or sensory fibers. These VIP-positive 
neurons are also believed to co-release ACh16-18, 20.
Whisker pad intrinsic and extrinsic muscles were harvested from the experimental 
(left) and control (right) sides of the face in one rat 19 weeks after facial nerve resection. 
Intrinsic muscle was represented by sling fibers obtained from the base of vibrissae 
along rows C and D (see reference 21), and extrinsic muscles were represented by the le-
vator labii superioris (LLS), and dilator naris muscles (DNM). Harvested muscles were im-
mediately placed into a solution of 2% paraformaldehyde (PFA; EMS) in 0.1 M phosphate 
buffer (PBS pH 7.4) for approximately 2 h, and the sling muscles (left and right pairs) 
were dissected free from the follicles and further post-fixed (2% PFA) for approximately 
2 additional hours. Samples were incubated overnight at 4 °C (on a shaker) in blocking 
solution (StartingBlock, ThermoScientific, Waltham, MA) containing Triton X-100 (0.1%, 
Sigma), sodium azide (0.1%, Sigma) in PBS 0.1 M pH 7.4. The primary antibodies: chicken 
anti-NF200 (Sigma) and rabbit anti-VIP (AB982; Millipore Corp., Billerica, MA) were pre-
pared in the blocking mixture, added to the sample, and incubated for 2 days at 1 °C on 
a shaker. After washing with PBS 0.1 M (3 times, each 15 min), samples were incubated 
overnight at 4 °C (on a shaker) with secondary antibodies (Alexa 488 goat anti-chicken, 
Alexa 594 goat anti-rabbit) and Alexa 647-conjugated with α-bungarotoxin prepared in 
the same blocking solution. After several washes in PBS, the samples were incubated 
overnight with SlowFade Gold (Invitrogen Corp., Carlsbad, CA).
Immunostained samples were mounted on standard microscope glass slides in 
SlowFade Gold and compressed slightly between magnets for approximately 24 h to 
enhance their optical accessibility. Samples were first screened for the location of neu-
romuscular junctions using a low power objective (10×, 0.45 NA) with a laser scanning 
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confocal microscope (Zeiss 780, Carl Zeiss AG, Oberkochen, Germany) by excitation of 
633 nm He-Ne laser. A 20x, 0.8 NA objective lens was then used to obtain confocal stacks 
in these regions. Alexa 488 (NF200), Alexa 594 (VIP), and Alexa 647 (α-bungarotoxin) 
labeling were then excited with 488, 594, and 647 nm wavelength lasers, respectively. 
Stacks were then processed with Zeiss ZEN software to created maximum projections.
results
electrical stimulation of the ion and facial nerves
Electrical stimulation of tissues surrounding the capped proximal trunk of the transected 
facial nerve for the VII Resected group rats did not cause whisker movement during the 
periodic post-surgical test points (at weeks 4 and 8), or during any subsequent surgical 
manipulations (≥16 weeks after initial VII resection). Likewise, electrical stimulation of 
tissues surrounding the distal capped nerve ends also failed to elicit whisker movements, 
strongly suggesting that facial nerve axons had not regrown into the whisker pad.
In contrast, electrical stimulation of the ION at ≥16 weeks after initial facial nerve 
resection caused immediate, conspicuous whisker protraction in all rats (N = 11) from 
the VII Resected group ipsilateral to their whisker pad denervation. Whisker protrac-
tion occurred roughly in rows, relating to the ION fascicular region being stimulated; 
stimulation of superomedial ION bundles resulted in upper whisker row protraction 
(rows A–C), while stimulation of inferolateral fascicles caused the lower rows to protract 
(rows D–E and labial follicles). This somatotopic relationship between stimulated fascicle 
location and corresponding row protraction was observed in all rats, and matches the 
general topography of whisker row sensory innervation by the ION3. Stimulation of the 
contralateral, healthy whisker pad did not cause visible whisker movement (N = 10). A 
video example of whisker movement during intraoperative ION stimulation on the VII 
Resected side is available as supplementary material through the publisher’s web site.
Whisking recovery
The average amplitude of the 3 largest whisks across weekly, 5-min recording sessions 
showed a different time course and magnitude of recovery for the two groups in this 
study (Figure 3). A mixed-factors ANOVA demonstrated a significant main effect for 
whisking amplitude, whereby the VII Repaired group recovered larger whisks than the 
VII Resected group (P < 0.05, N = 7 and 10, respectively), and a significant main effect for 
week of recovery, with earlier weeks showing lower amplitude whisks than later weeks 
(P < 0.05). There was also a significant interaction between experimental groups and 
week of recovery, where the VII Repaired group recovered whisks more rapidly than the 
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VII Resected group (P < 0.05). These significant omnibus main effects and interaction 
made it appropriate to conduct post hoc, pair-wise comparisons.
The VII Repaired group (N = 7) had larger average maximal whisking amplitude than 
the VII Resected group (N = 10) at the beginning of the whisking appearance (weeks 3 
and 4, P = 0.004 and P = 0.0082 respectively), in the middle of the recovery period at 
week 6 but not at week 7 (P = 0.0037 and P = 0.0478, respectively), and not at week 10 
(P = 0.0984). The lack of significant differences between the groups toward the second 
half of the recovery period (adjusted alpha of P < 0.01) is perhaps due to the apparent 
gradual increase in maximal whisking amplitude for the VII Resected group compared to 
a more steady amplitude for the VII Repaired group over those same weeks.
For the VII Resected group, whisking amplitude on week 4 of recovery was signifi-
cantly larger than for week 3 (P = 0.0045), consistent with the observation that recovery 
effectively began between those weeks for this group (Figure 3). However, week 4 was 
only borderline significantly different than week 10 for this group (P = 0.0291), suggest-
ing only a modest and/or inconsistent increase in ION-mediated whisker movement 
amplitude across the measured recovery period (adjusted alpha of P < 0.025).
Unilateral ION transection at ≥16 weeks after ipsilateral facial nerve resection resulted 
in a complete and immediate cessation of visible or measurable whisker movements (N 
= 6). Five of the six rats that were followed for a week or longer after ION transection had 
stable head implants, permitting rigid restraint for whisking quantification. These rats 
 
figure 3. Average whisking amplitude is shown for the 3 largest whisks across weeks 1-10 of recovery, 
ipsilateral to facial nerve transection and suture repair (VII Repaired group, open circles ; N=9) versus ipsi-
lateral to facial nerve resection (VII Resected group, open boxes , N=7). Group averages were statistically 
compared for weeks 3, 4, 6, 7, and 10, and significantly differed at weeks 3, 4, and 6, but not at weeks 7 and 
10. Error bars are ± 1 standard deviation.
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produced no measurable whisks (i.e. ≥3 degrees) on the combined ION and facial nerve 
lesioned side of the face.
fibrillation-related whisker movement
Visual assessment of fibrillation-related movements revealed persistent, random whisker 
movement in the first 4 weeks after facial nerve resection with rats under medetomidine 
sedation. The number of whiskers randomly moving and their relative fibrillation-related 
movement amplitude decreased steadily across the first 6 weeks, and remained weak 
or absent from week 8 onward across the recovery period (Figure 4). Within one or two 
weeks after unilateral ION transection (at ≥16 weeks after ipsilateral facial nerve resec-
tion; N = 6), there was obvious re-appearance of fibrillation-related movements, similar 
to or greater than the degree of movement seen after initial facial nerve resection, 
suggesting that ION transection (re)denervated whisker pad muscle cells. There was an 
average correlation of 0.802 for observed fibrillation movement ratings among the 3 
raters.
A video example of fibrillation-related whisker movements observed at one week 
after facial nerve resection, their disappearance by 20 weeks after facial nerve resection, 
and the re-appearance of fibrillation-related movements at 21 weeks (1 week after ION 
transection) is available as supplementary material to this article.
 
figure 4. Average fibrillation-related whisker movement ratings ipsilateral to facial nerve resection across 
the post-surgical period. Ratings were made on a continuous scale of whisker movement ranging from 
“none” (score 0), to “moderate” (score 50) to “high” (score 100). The visible appearance of fibrillation-related 
movements decreased over time (N=10), but increased again within one or two weeks after ION transec-
tion, as shown in the far right data point (N=6).
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hexamethonium injection effects on whisker movement
Visual assessment of whisker movements ≥16 weeks after facial nerve resection revealed 
consistent, low-amplitude, synchronous twitches (or whisks) of most macro vibrissae 
ipsilateral to facial nerve manipulation (N = 11). These movements were substantially 
or entirely eliminated within 20 min after 30 mg/kg IM injection of hexamethonium 
(N = 3) based on observer ratings of pre- versus post-injection video recordings using 
a visual analog scale ranging from “no movement” to “strong movement” (Figure 5). A 
recording made 120 min after drug injection (N = 1) revealed a return of movement, 
indicating that autonomic ganglia blocking of ION-mediated whisker movement lasts 
less than two hours for a 30 mg/kg dose in adult female rats. Moreover, suppression of 
ION-mediated movement 20 min after only 15 mg/kg (N = 1) suggests that this smaller 
dose may provide adequate autonomic suppression, but the persistence of very slight 
movement at 20 min after 7.5 mg/kg indicates that this lowest tested dose fails to block 
the pterygopalatine ganglion supplying autonomic axons to the whisker pad through 
the ION. Average correlation among the 4 visual raters of video recorded whisker move-
ment was 0.92. A video example of whisker movement at rest, 20 min after an intramus-
cular injection of 30 mg/kg hexamethonium, and 120 min after injection is available as 
supplementary material to this article.
 
figure 5. Average whisker movement ratings from video clips of rats before hexamethonium injection, 
20 minutes after injection of three different doses (30, 15, and 7.5 mg/kg), and 120 minutes after the larg-
est dose (30 mg/kg). Ratings were made on a continuous scale ranging from “no movement” (score 0), 
to “moderate movement” (score 50), to “strong movement” (score 100). Hexamethonium substantially re-
duced or completely blocked observable movement after the two larger doses, but incompletely blocked 
ION-mediated movement at the smallest dose. Movement began to return within 2 hours of drug delivery, 
as shown for the largest dose. The number of rats contributing to each data point is listed in the bar labels. 
Error bars are ± 1 standard deviation.
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snout cooling effects on whisker movement
Within only a few seconds of ice contact with the snout, an observable increase in 
ION-mediated whisker movement amplitude and frequency was appreciated. Average 
amplitude for the 3 largest whisker movements at ≥16 weeks after facial nerve resection 
in the 10 s prior to snout cooling compared to the 3 largest whisks in the 10 s dur-
ing or immediately after cooling (N = 3) showed an approximate doubling of whisking 
amplitude associated with cooling (Figure 6). A video example of ION-mediated whisker 
movement increasing in amplitude and frequency with brief ice cube contact with the 
snout is available as supplementary material to this article.
immunohistochemical identification of somatic and autonomic axons
Neuromuscular junctions were identifiable in muscles from both the experimental and 
control sides of the face by immunoreactivity to α-bungarotoxin (Figures 7, 8, and 9, in 
red). Endplates were normal in appearance on the control side (i.e. flattened, oblong 
regions), but were relatively swollen with somewhat fragmented staining on the facial 
nerve-resected side. Heavy weight neurofilament staining (using NF200 antibodies) 
revealed large caliber somatic motor fibers contacting endplates in the sling, LLS and 
DNM muscles on the control side, but there was a complete absence of these fibers at 19 
weeks after facial nerve resection in all three muscles on the experimental side (Figure 
7, 8, and 9, in yellow). Some thin NF200-positive sensory axons were found in both the 
experimental and control muscles in the vicinity of the neuromuscular junctions, but 
without a particular relationship with the endplates (Figure 7, 8 and 9, in yellow).
 
figure 6. Average whisking amplitude (in degrees) for the 3 largest whisks 10 seconds before versus 10 
seconds during or immediately after brief snout cooling with an ice cube (N=3). Error bars are ± 1 standard 
deviation.
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VIP-positive axons were observed on blood vessels in and around muscles on the 
control side of the face, but were not found near the neuromuscular junctions or con-
tacting the surface of muscle cells. In contrast, VIP-positive axons (Figure 7, 8, and 9, in 
cyan) were found to have extensively grown across the muscle surface on the facial-
nerve-resected side, with a greater apparent degree of surface contact in sling muscle 
(Figure 7) compared to the DNM (Figure 8) or LLS (Figure 9). Although there were some 
endplates in all three muscles without VIP-positive neural contact on the experimental 
side, many endplates did have VIP-positive axons in close proximity, suggesting that 
they were the source of parasympathetic input driving contraction.
 
figure 7. NF200-positive (yellow) and VIP-positive axons (cyan) in sling muscle. Neuromuscular junctions 
were labeled with α-bungarotoxin (red). In the control side, motor axons containing thick heavy weight 
neurofilament (NF200) bundles showed normal arborization patterns (A), with neurofilament staining of 
finer branches entering the neuromuscular junction (B, from bounded area in A). Occasionally, thin NF200-
positive sensory axons could be seen (A, arrow head). No VIP-positive parasympathetic axons were present 
near neuromuscular junctions. On the experimental side, no motor axons with thick neurofilament could 
be seen, while sensory axons with thin NF200 labeling and numerous VIP-positive branches were readily 
present (C). Many junctions were un-innervated after facial nerve resection. However, scattered neuromus-
cular junction showed strong co-localization with VIP-positive nerve terminals, suggesting innervation by 
parasympathetic axons (D, from bounded area in C). Scale bar: A, C: 50 μm. B, D: 5 μm.
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Discussion
Rat whisking is a dynamic and highly quantifiable behavior studied in many laboratories 
as a method of assessing facial nerve function. Whisking occurs primarily in an ante-
rior–posterior direction (i.e. horizontal plane), through the interaction of intrinsic and 
extrinsic whisker pad muscles21, 22. Protraction is achieved mostly through the contrac-
tion of small “sling” muscles wrapping around the base of each macro vibrissa follicle (i.e. 
like a sling), whereas retraction occurs through an interaction of passive tissue recoil and 
extrinsic whisker pad muscle contraction22, 23. The sling muscles are extremely small and 
difficult to study, prompting many groups to study the extrinsic pad muscles such as the 
LLS24, 25 and DNM26 in order to examine whisker pad innervation.
The sling muscles and DNM receive their motor supply from the buccal and marginal 
mandibular branches of the ipsilateral facial nerve3-5, and cutting these branches im-
 
figure 8. NF200-positive (yellow) and VIP-positive axons (cyan) in the dilator naris muscle (DNM). Neuro-
muscular junctions were labeled with α-bungarotoxin (red). In the control side, motor axons containing 
thick heavy weight neurofilament (NF200) bundles showed normal arborization patterns (A), with neuro-
filament staining of finer branches entering the neuromuscular junction (B, from bounded area in A). No 
VIP-positive parasympathetic axons were present. On the experimental side (C), no motor axons with thick 
neurofilament could be seen, while sensory axons with thin NF200 labeling and numerous VIP-positive 
branches were present. A significant number of the junctions were un-innervated after facial nerve resec-
tion. However, scattered neuromuscular junctions showed co-localization with VIP-positive nerve termi-
nals, suggesting innervation by parasympathetic axons (D, from bounded area in C). Scale bar: A, C: 50 μm. 
B, D: 5 μm.
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mediately eliminates whisker protraction4, 5. The return of whisker movement in the 
weeks and months after facial nerve injury has logically been attributed to facial nerve 
regeneration, but the present study demonstrates that whisker protraction can occur 
in the absence of facial nerve input, which must be considered when determining the 
neural source of low-amplitude whisking after facial nerve manipulation.
Skeletal muscle undergoes predictable changes in response to denervation, including 
(1) oscillation in sodium conductance leading to spontaneous contraction of individual 
muscle cells in a process known as fibrillation27, and (2) synthesis of ligand receptors 
along the muscle length, causing hypersensitivity to ACh28, 29 and broadening potential 
locations for neural contact beyond the original endplate region. Systemic delivery of 
ACh can reveal this hypersensitivity by causing a slow, sustained contraction of dener-
vated muscle29, 30. Slow contraction of denervated muscles can also be elicited by local 
release of ACh through stimulation of postganglionic, autonomic, cholinergic axons 
 
figure 9. NF200-positive (yellow) and VIP-positive axons (cyan) in the levator labii superioris muscle (LLS). 
Neuromuscular junctions were labeled with α-bungarotoxin (red). In the control side, motor axons con-
taining thick heavy weight neurofilament (NF200) bundles showed normal arborization patterns (A), with 
neurofilament staining of finer branches entering the neuromuscular junction (B, from bounded area in 
A). No VIP-positive parasympathetic axons were present. On the experimental side (C, D), no motor axons 
with thick neurofilament could be seen, while sensory axons with thin NF200 labeling and numerous VIP-
positive branches were present. A significant number of the junctions were un-innervated after facial nerve 
resection. However, scattered neuromuscular junctions showed co-localization with VIP-positive nerve ter-
minals, suggesting innervation by parasympathetic axons (D, from bounded area in C). Scale bar: A, C: 50 
μm. B, D: 5 μm.
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innervating denervated muscles’ blood vessels. Such contraction is known as the Phil-
ipeaux–Vulpian phenomenon (or the Vulpian–Heidenhain–Sherrington phenomenon), 
which was described over 150 years ago (Philipeaux & Vulpian, 1863 and Heidenhain, 
1883, as cited by Dale et al.31). For example, within a week or two after hypoglossal nerve 
transection, the denervated tongue of cat30-32, and dog31, 32 will begin slowly contract-
ing a few seconds after the initiation of repetitive lingual nerve stimulation, and begin 
relaxing on a similarly slow time-scale once stimulation ends. This has been attributed to 
stimulation of cholinergic, postganglionic axons traveling to the tongue vasculature via 
the lingual nerve, causing a local liberation of ACh (to which the hypersensitive muscle 
is responding) rather than direct synaptic contact between skeletal muscle cells and 
autonomic fibers33, 34.
In addition to the tongue, other muscles of the head are also known to contain 
vascular beds regulated in part by parasympathetic innervation, including those of the 
lips18, 35 and whisker pad6, 7. These postganglionic, parasympathetic axons are unmyelin-
ated, wrapping around vessels with a varicosed (beaded) appearance along their length, 
providing numerous en passant synapses36 for the diffuse release of nitric oxide, vasoac-
tive intestinal peptide and ACh onto vascular smooth muscle and endothelial cells37. 
Metabotropic reception of these transmitters causes vasodilation for thermoregulation6 
and blood flow control (see review by Campbell38).
The extensive innervation of whisker pad vasculature is completely eliminated by tran-
section of the IONs, but is not appreciably altered by loss of sympathetic supply through 
removal of the superior cervical ganglia6, 39, 40, indicating that vascular autonomic in-
nervation originates from parasympathetic neurons located within the pterygopalatine 
ganglia. Electrical stimulation of the cut distal portion of the ION (in an otherwise intact 
whisker pad) does not reliably cause whisker movement (present report and Mameli et 
al.41), and when it does occur, is likely due to current spread into adjacent facial nerve 
branches. However, in this study, we found that ION stimulation caused robust whisker 
protraction in all rats having undergone facial nerve resection 4 months previously. 
Given that sensory axons are incapable of functionally innervating muscle cells42, 43, we 
suggest that these contractions stem from autonomic innervation of denervated whis-
ker pad sling muscles. In addition, we suggest that parasympathetic axons formed direct 
(junctional) synaptic contacts with sling muscles in our rats rather than contractions 
stemming from hypersensitivity to locally liberated ACh from parasympathetic fibers 
(i.e. not the Philipeaux-Vulpian phenomenon) based on our immunohistochemical 
identification of VIP-positive (autonomic) axons on otherwise denervated sling muscle 
fibers, in addition to multiple functional observations discussed below.
The principal difference between the Philipeaux–Vulpian phenomenon and the con-
tractions we elicited by ION stimulation is the latency of motor response in relation to 
electrical stimulation. Hypersensitive muscle responds relatively slowly to rising (and 
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falling) ACh levels brought about by local, diffuse release and circulation of ACh from 
parasympathetic innervation of glands or vasculature. In sharp contrast, whiskers pro-
tracted immediately upon ION stimulation in our facial nerve resected rats, and likewise 
returned immediately to their resting position once stimulation ended. This pattern of 
movement was demonstrated repeatedly in each chronically denervated rat, and was 
visually indistinguishable from the timing of whisker movement we observe when 
stimulating the facial nerve in intact rats. This rapid response to ION stimulation implies 
direct, functional synaptic contact between autonomic fibers and skeletal muscle cells, 
which is not thought to occur (for review see reference 44) and has not been reported 
previously. This would be consistent with the close physical approximation we observed 
between VIP-positive axons and neuromuscular endplates on many muscle cells 19 
weeks after facial nerve resection.
Another indication that autonomic fibers of the ION directly innervated whisker sling 
muscle cells in our facial nerve resected rats was the post-surgical time-course of whis-
ker movement appearance, combined with the somewhat simultaneous disappearance 
of fibrillation-related movements. Muscle begins to fibrillate within a few days after 
denervation14 and likewise becomes hypersensitive to autonomic release of ACh with a 
week29, 30. However, clear whisker protraction did not appear until approximately 4 weeks 
after denervation, and grew stronger over time while fibrillation faded. This observation 
suggests that parasympathetic innervation of sling muscle vasculature sprouted in re-
sponse to sling fiber denervation over several weeks, and eventually formed junctional 
synaptic contacts with sling fibers that then generated periodic, twitch-like contrac-
tions when parasympathetic fibers released ACh, while at the same time reducing or 
eliminating extrajunctional receptors (that had previously produced fibrillation). The re-
appearance of fibrillation-related movement in whiskers within a week after transection 
of the ION (and parasympathetic supply) suggests that the resulting loss of junctional 
synapses caused the re-expression of extrajunctional receptors on sling muscle cells 
(or some other source of membrane instability), just as would be expected after loss of 
somatic motor innervation.
In addition to the facial nerve motor supply, extrinsic whisker pad muscles have also 
been reported to receive neural input from the mediodorsal part of the hypoglossal 
nucleus via the ION45. This input may be cholinergic, and has been suggested to serve a 
proprioceptive role41, 45, although through an unknown mechanism, given the absence 
of neuromuscular spindles in the whisker pad46, 47. It is possible that these hypoglossal 
fibers sprouted collateral branches from their extrinsic targets and grew into the sling 
muscles, generating whisker protraction and diminishing fibrillation in our facial nerve 
resected rats. However, that would not explain why ION-mediated whisker movements 
were greatly diminished (or eliminated) by the autonomic ganglion blocking drug 
hexamethonium. Moreover, our facial nerve-resected rats demonstrated significantly in-
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creased ION-mediated whisker movement from snout cooling, which is more consistent 
with an autonomic vasodilation reflex than with a hypoglossal proprioceptive input. 
Lastly, these hypoglossal fibers were not found in any of the 3 whisker pad muscles ex-
amined using immunohistochemical fiber staining 19 weeks after facial nerve resection.
Distal branches of the facial and trigeminal nerves are known to communicate (merge) 
in humans48-51 and other mammals52, raising the question of whether motor axons may 
have diverged from the facial nerve main trunk proximal to the point of transection and 
joined the ION to reach the whisker pad. These facial axons could then have sprouted 
after main trunk lesion, and have been the source of ION-mediated whisker movement 
found in this study. However, we find this possibility highly unlikely given that essentially 
all 25 macrovibrissae were observed to move both spontaneously and during electrical 
stimulation of the ION, which would require widespread sprouting throughout all of the 
whisker pad rows and columns by these ION-accompanying facial motor axons, yet none 
was observed in our immunohistochemical staining of pad muscle innervation. More-
over, retrograde axonal tracer applied to cut branches of the ION at the point where they 
enter vibrissae rows did not label neurons within the facial motor nuclei45. Additional 
retrograde pathway tracing studies are needed to rule-out potential sources of neural 
input (aside from the pterygopalatine ganglia) after chronic facial nerve discontinuity, 
but the present findings and prior pathway tracing45 indicate that facial motor neurons 
are not the source of whisker pad innervation after facial nerve resection.
A facilitating role for autonomic axons in motor recovery of regenerating nerves 
has been suggested by the mathematical modeling work of Medinaceli et al.53. They 
followed the conventional notion that axons of one genus (i.e. sensory, motor or auto-
nomic) could not form connections with neural targets normally innervated by another 
genus, so the potential role of autonomic input to skeletal muscle was perhaps under-
represented in their model. Reports have long shown that the central end of autonomic 
sensory neurons release ACh and are capable of innervating denervated skeletal muscle 
when experimentally directed to do so42, 54-58, as can the peripheral end of pregangli-
onic, parasympathetic efferent axons59. However, this is the first report of electrically 
stimulated twitch-like skeletal muscle contractions (and loss of muscle fibrillation) due 
to putative postganglionic autonomic synapse formation with skeletal muscle. Auto-
nomic endings have been shown (using electron microscopy) to form synapses with 
vacated neuromuscular junctions in chronically denervated cat laryngeal muscles after 
recurrent laryngeal nerve (RLN) injury60-62, but attempted electrical stimulation of these 
autonomic fibers was unable to produce laryngeal muscle contraction60. Investigators 
have suggested that spontaneous autonomic reinnervation of laryngeal muscles may 
explain why substantial atrophy does not always occur after long-term (i.e. >20 months) 
denervation in cat60-63 models. Autonomic synapse formation may also explain why 
many cases of vocal fold paralysis show a return of electromyographic activity and rest-
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ing tone months after RLN palsy, while still lacking meaningful vocal fold abduction or 
adduction (defined as laryngeal synkinetic reinnervation by some authors – for review 
see reference 64).
Autonomic reinnervation after various cranial nerve lesions may be naturally occur-
ring in an occult manner, but is revealed in the rat whisker pad due to the amplification 
of very small muscle forces at the follicle base (via sling muscles) into observable whis-
ker movements. Likewise, fibrillation-related fiber contraction, which occurs in a visually 
undetectable manner in most body locations, can be seen under certain circumstances 
such as through the thin mucosa of the tongue and when amplified by the whiskers14. 
Lastly, the possibility of autonomic reinnervation should be considered in instances 
when sensory neural input is implicated in preventing atrophy of a denervated muscle 
through a process called “sensory protection”65-69, since most, if not all, sensory nerves 
contain autonomic axons.
conclusion
We have demonstrated whisker movements in rats with chronic facial nerve discontinu-
ity, and provide functional and anatomical evidence that non-facial-nerve-mediated 
whisking stems from reinnervation of intrinsic whisker pad sling muscles by postgan-
glionic, parasympathetic axons traveling within the ION from the pterygopalatine 
ganglia. This conclusion is based upon the identified growth of VIP-positive axons into 
whisker pad muscles after facial nerve resection, and the effect of electrical stimulation 
and transection of the ION on non-facial nerve-mediated whisking, as well as selec-
tive pharmacologic blockage, and autonomic (vasodilation) reflex elicitation of such 
whisking. This represents the first reported instance of functional synapse formation of 
postganglionic, autonomic fibers with skeletal muscle. Our discovery has implications 
not only for interpreting facial muscle reinnervation results, but also raises the question 
of whether autonomic-mediated innervation of striated muscle occurs spontaneously in 
other forms of neuropathy, possibly underlying phenomena such as sensory protection 
of denervated muscle and contributing to some instances of synkinetic reinnervation of 
the face and larynx.
AcknoWleDGments
This work was supported by R01NS071067 to T. A. Hadlock and J. T. Heaton. The authors 
thank James B. Kobler PhD for his insightful suggestions regarding the methods used to 
demonstrate autonomic control.
74 Chapter 2.2
references
 1. Jackson CG, von Doersten PG. The Facial Nerve. Current Trends in Diagnosis, Treatment, and 
Rehabilitation. Med Clin North Am. 1999; 83: 179-95.
 2. Guntinas-Lichius O, Streppel M, Stennert E. Postoperative Functional Evaluation of Different 
Reanimation Techniques for Facial Nerve Repair. Am J Surg. 2006; 191: 61-7.
 3. Dorfl J. The Innervation of the Mystacial Region of the White Mouse: A Topographical Study. J 
Anat. 1985; 142: 173-84.
 4. Semba K, Egger MD. The Facial “Motor” Nerve of the Rat: Control of Vibrissal Movement and 
Examination of Motor and Sensory Components. J Comp Neurol. 1986; 247: 144-58.
 5. Henstrom D, Hadlock T, Lindsay R, Knox CJ, Malo J, Vakharia KT, Heaton JT. The Convergence of 
Facial Nerve Branches Providing Whisker Pad Motor Supply in Rats: Implications for Facial Reani-
mation Study. Muscle Nerve. 2012; 45: 692-7.
 6. Fundin BT, Pfaller K, Rice FL. Different Distributions of the Sensory and Autonomic Innervation 
among the Microvasculature of the Rat Mystacial Pad. J Comp Neurol. 1997; 389: 545-68.
 7. Wilke RA, Riley DA, Sanger JR. Histochemical Discrimination of Fibers in Regenerating Rat Infraor-
bital Nerve. Microsurgery. 1992; 13: 39-44.
 8. Hadlock T, Kowaleski J, Mackinnon S, Heaton JT. A Novel Method of Head Fixation for the Study of 
Rodent Facial Function. Exp Neurol. 2007; 205: 279-82.
 9. Heaton JT, Kowaleski JM, Bermejo R, Zeigler HP, Ahlgren DJ, Hadlock TA. A System for Studying 
Facial Nerve Function in Rats through Simultaneous Bilateral Monitoring of Eyelid and Whisker 
Movements. J Neurosci Methods. 2008; 171: 197-206.
 10. Bermejo R, Vyas A, Zeigler HP. Topography of Rodent Whisking--I. Two-Dimensional Monitoring of 
Whisker Movements. Somatosens Mot Res. 2002; 19: 341-6.
 11. Bermejo R, Houben D, Zeigler HP. Optoelectronic Monitoring of Individual Whisker Movements in 
Rats. J Neurosci Methods. 1998; 83: 89-96.
 12. Hadlock T, Lindsay R, Edwards C, Smitson C, Weinberg J, Knox C, Heaton JT. The Effect of Electrical 
and Mechanical Stimulation on the Regenerating Rodent Facial Nerve. Laryngoscope. 2010; 120: 
1094-102.
 13. Hadlock TA, Heaton J, Cheney M, Mackinnon SE. Functional Recovery after Facial and Sciatic 
Nerve Crush Injury in the Rat. Arch Facial Plast Surg. 2005; 7: 17-20.
 14. Heaton JT, Kobler JB. Use of Muscle Fibrillation for Tracking Nerve Regeneration. Muscle Nerve. 
2005; 31: 235-41.
 15. Paton WA, Zaimis EJ. Paralysis of Autonomic Ganglia by Methonium Salts. Br J Pharmacol Che-
mother. 1951; 6: 155-68.
 16. Lundberg JM, Anggard A, Fahrenkrug J, Hokfelt T, Mutt V. Vasoactive Intestinal Polypeptide in 
Cholinergic Neurons of Exocrine Glands: Functional Significance of Coexisting Transmitters for 
Vasodilation and Secretion. Proc Natl Acad Sci U S A. 1980; 77: 1651-5.
 17. Lundberg JM. Evidence for Coexistence of Vasoactive Intestinal Polypeptide (Vip) and Acetylcho-
line in Neurons of Cat Exocrine Glands. Morphological, Biochemical and Functional Studies. Acta 
Physiol Scand Suppl. 1981; 496: 1-57.
 18. Kaji A, Shigematsu H, Fujita K, Maeda T, Watanabe S. Parasympathetic Innervation of Cutaneous 
Blood Vessels by Vasoactive Intestinal Polypeptide-Immunoreactive and Acetylcholinesterase-
Positive Nerves: Histochemical and Experimental Study on Rat Lower Lip. Neuroscience. 1988; 25: 
353-62.
Evidence for autonomic contraction 75
2.2
 19. Kaji A, Maeda T, Watanabe S. Parasympathetic Innervation of Cutaneous Blood Vessels Examined 
by Retrograde Tracing in the Rat Lower Lip. J Auton Nerv Syst. 1991; 32: 153-8.
 20. Lundberg JM, Franco-Cereceda A, Lacroix JS, Pernow J. Release of Vasoactive Peptides from 
Autonomic and Sensory Nerves. Blood Vessels. 1991; 28: 27-34.
 21. Dorfl J. The Musculature of the Mystacial Vibrissae of the White Mouse. J Anat. 1982; 135: 147-54.
 22. Hill DN, Bermejo R, Zeigler HP, Kleinfeld D. Biomechanics of the Vibrissa Motor Plant in Rat: Rhyth-
mic Whisking Consists of Triphasic Neuromuscular Activity. J Neurosci. 2008; 28: 3438-55.
 23. Berg RW, Kleinfeld D. Rhythmic Whisking by Rat: Retraction as Well as Protraction of the Vibrissae 
Is under Active Muscular Control. J Neurophysiol. 2003; 89: 104-17.
 24. Guntinas-Lichius O, Irintchev A, Streppel M, Lenzen M, Grosheva M, Wewetzer K, Neiss WF, An-
gelov DN. Factors Limiting Motor Recovery after Facial Nerve Transection in the Rat: Combined 
Structural and Functional Analyses. Eur J Neurosci. 2005; 21: 391-402.
 25. Pavlov SP, Grosheva M, Streppel M, Guntinas-Lichius O, Irintchev A, Skouras E, Angelova K, Kue-
rten S, Sinis N, Dunlop SA, Angelov DN. Manually-Stimulated Recovery of Motor Function after 
Facial Nerve Injury Requires Intact Sensory Input. Exp Neurol. 2008; 211: 292-300.
 26. Jergovic D, Stal P, Lidman D, Lindvall B, Hildebrand C. Changes in a Rat Facial Muscle after Facial 
Nerve Injury and Repair. Muscle Nerve. 2001; 24: 1202-12.
 27. Purves D, Sakmann B. Membrane Properties Underlying Spontaneous Activity of Denervated 
Muscle Fibres. J Physiol. 1974; 239: 125-53.
 28. Axelsson J, Thesleff S. A Study of Supersensitivity in Denervated Mammalian Skeletal Muscle. J 
Physiol. 1959; 147: 178-93.
 29. Cangiano A. Denervation Supersensitivity as a Model for the Neural Control of Muscle. Neurosci-
ence. 1985; 14: 963-71.
 30. Radmanovic B, Torres SH. The Effect of Bradykinin on Denervated Tongue. Br J Pharmacol. 1972; 
46: 676-87.
 31. Dale HH, Gaddum JH. Reactions of Denervated Voluntary Muscle, and Their Bearing on the Mode 
of Action of Parasympathetic and Related Nerves. J Physiol. 1930; 70: 109-44.
 32. Bulbring E, Burn JH. The Sherrington Phenomenon. J Physiol. 1936; 86: 61-76.
 33. Hinsey JC. Some Observations on the Innervation of Skeletal Muscle of the Cat. J Comp Neurol. 
1927; 44: 87-195.
 34. Hinsey JC, Gasser HS. The Component of the Dorsal Root Mediating Vasodilatation and Sher-
rington Contracture. Am J Physiol. 1930; 92: 679-89.
 35. Euler US V, Gaddum JH. Pseudomotor Contractures after Degeneration of the Facial Nerve. J 
Physiol. 1931; 73: 54-66.
 36. Kilbinger, ‘The Autonomic Cholinergic Neuroeffector Junction’, in Handbook of Experimental 
Pharmacology, ed. by Whittaker (Berlin and Heidelberg, Springer Verlag, 1988), pp. 581-95.
 37. Lombard, Cowley. ‘Neural Control of Blood Vessels’, in Primer on the Autonomic Nervous System, ed. 
by Robertson (Boston, Academic Press, 2012), pp. 187-91.
 38. Campbell. ‘Autonomic Nervous Supply to Effector Tissues’, in Smooth Muscle, ed. by E. Bulbring 
(London, Edward Arnold, 1970), pp. 451-95.
 39. Rice FL, Kinnman E, Aldskogius H, Johansson O, Arvidsson J. The Innervation of the Mystacial Pad 
of the Rat as Revealed by Pgp 9.5 Immunofluorescence. J Comp Neurol. 1993; 337: 366-85.
 40. Waite PM, Li L. Unmyelinated Innervation of Sinus Hair Follicles in Rats. Anat Embryol (Berl). 1993; 
188: 457-65.
 41. Mameli O, Stanzani S, Russo A, Romeo R, Pellitteri R, Spatuzza M, Caria MA, De Riu PL. Hypoglossal 
Nuclei Participation in Rat Mystacial Pad Control. Pflugers Arch. 2008; 456: 1189-98.
76 Chapter 2.2
 42. Langley JN, Anderson HK. The Union of Different Kinds of Nerve Fibres. J Physiol. 1904; 31: 365-91.
 43. Gutmann E. The Reinnervation of Muscle by Sensory Nerve Fibres. J Anat. 1945; 79: 1-8 4.
 44. Buckley. ‘Transmission: Acetylcholine’, in Autonomic Neuroeffector Mechanisms, ed. by Burnstock 
(Philadelphia, Harwood Academic Publishers, 1992), pp. 257-322.
 45. Mameli O, Pellitteri R, Russo A, Stanzani S, Caria MA, De Riu PL. Role of the Trigeminal Nerve in 
Regrowth of Hypoglossal Motoneurons after Hypoglossal-Facial Anastomosis. Acta Otolaryngol. 
2006; 126: 1334-8.
 46. Bowden RE, Mahran ZY. The Functional Significance of the Pattern of Innervation of the Muscle 
Quadratus Labii Superioris of the Rabbit, Cat and Rat. J Anat. 1956; 90: 217-27.
 47. Rice FL, Munger BL. A Comparative Light Microscopic Analysis of the Sensory Innervation of the 
Mystacial Pad. Ii. The Common Fur between the Vibrissae. J Comp Neurol. 1986; 252: 186-205.
 48. Baumel JJ. Trigeminal-Facial Nerve Communications. Their Function in Facial Muscle Innervation 
and Reinnervation. Arch Otolaryngol. 1974; 99: 34-44.
 49. Tohma A, Mine K, Tamatsu Y, Shimada K. Communication between the Buccal Nerve (V) and Facial 
Nerve (Vii) in the Human Face. Ann Anat. 2004; 186: 173-8.
 50. Diamond M, Wartmann CT, Tubbs RS, Shoja MM, Cohen-Gadol AA, Loukas M. Peripheral Facial 
Nerve Communications and Their Clinical Implications. Clin Anat. 2011; 24: 10-8.
 51. Yang HM, Won SY, Kim HJ, Hu KS. Sihler Staining Study of Anastomosis between the Facial and 
Trigeminal Nerves in the Ocular Area and Its Clinical Implications. Muscle Nerve. 2013; 48: 545-50.
 52. Bowden RE, Mahran ZY. Experimental and Histological Studies of the Extrapetrous Portion of the 
Facial Nerve and Its Communications with the Trigeminal Nerve in the Rabbit. J Anat. 1960; 94: 
375-86.
 53. de Medinaceli L, Rawlings RR. Is It Possible to Predict the Outcome of Peripheral Nerve Injuries? A 
Probability Model Based on Prospects for Regenerating Neurites. Biosystems. 1987; 20: 243-58.
 54. Vera CL, Luco JV. Reinnervation of Smooth and Striated Muscle by Sensory Nerve Fibers. J Neuro-
physiol. 1967; 30: 620-7.
 55. Landmesser L. Contractile and Electrical Responses of Vagus-Innervated Frog Sartorius Muscles. J 
Physiol. 1971; 213: 707-25.
 56. Bennett MR, McLachlan EM, Taylor RS. The Formation of Synapses in Mammalian Striated Muscle 
Reinnervated with Autonomic Preganglionic Nerves. J Physiol. 1973; 233: 501-17.
 57. Coget J, Rousseau JP. Reinnervation of Striated Muscle by Peripheral Vagal Fibres Cut above or 
Below the Nodose Ganglion in the Cat and Rabbit. J Physiol. 1983; 335: 481-93.
 58. Delorme P, Rousseau A, Bernard J, Leek BF, Rousseau JP. Ultrastructural Changes in the Nerve Fiber 
Population of Anastomosed Vagal and Spinal Accessory Nerves in the Sheep. Anat Rec. 1997; 248: 
129-36.
 59. Flumerfelt BA, Kiernan JA, Krcek JP, Sholdice J. Reinnervation of Skeletal Muscle in the Tongue by 
Preganglionic Parasympathetic Vagal Neurons. J Anat. 1986; 146: 117-30.
 60. Nomoto M, Yoshihara T, Kanda T, Kaneko T. Synapse Formation by Autonomic Nerves in the Previ-
ously Denervated Neuromuscular Junctions of the Feline Intrinsic Laryngeal Muscles. Brain Res. 
1991; 539: 276-86.
 61. Nomoto M, Yoshihara T, Kanda T. Persistent Adrenergic Reinnervation of Previously Denervated 
Muscle in Cat. J Electron Microsc (Tokyo). 1993; 42: 236-9.
 62. Nomoto M, Yoshihara T, Kanda T, Konno A, Kaneko T. Misdirected Reinnervation in the Feline 
Intrinsic Laryngeal Muscles after Long-Term Denervation. Acta Otolaryngol Suppl. 1993; 506: 71-4.
 63. Miyamaru S, Kumai Y, Ito T, Yumoto E. Effects of Long-Term Denervation on the Rat Thyroarytenoid 
Muscle. Laryngoscope. 2008; 118: 1318-23.
Evidence for autonomic contraction 77
2.2
 64. Crumley RL. Laryngeal Synkinesis: Its Significance to the Laryngologist. Ann Otol Rhinol Laryngol. 
1989; 98: 87-92.
 65. Hynes NM, Bain JR, Thoma A, Veltri K, Maguire JA. Preservation of Denervated Muscle by Sensory 
Protection in Rats. J Reconstr Microsurg. 1997; 13: 337-43.
 66. Papakonstantinou KC, Kamin E, Terzis JK. Muscle Preservation by Prolonged Sensory Protection. J 
Reconstr Microsurg. 2002; 18: 173-82; discussion 83-4.
 67. Bain JR, Hason Y, Veltri K, Fahnestock M, Quartly C. Clinical Application of Sensory Protection of 
Denervated Muscle. J Neurosurg. 2008; 109: 955-61.
 68. Elsohemy A, Butler R, Bain JR, Fahnestock M. Sensory Protection of Rat Muscle Spindles Following 
Peripheral Nerve Injury and Reinnervation. Plast Reconstr Surg. 2009; 124: 1860-8.
 69. Zuijdendorp HM, Tra WM, van Neck JW, Mollis L, Coert JH. Delay of Denervation Atrophy by 
Sensory Protection in an End-to-Side Neurorrhaphy Model: A Pilot Study. J Plast Reconstr Aesthet 
Surg. 2010; 63: 1949-52.
1Department of Otolaryngology / Head and Neck Surgery, Massachusetts Eye and Ear 
Infirmary and Harvard Medical School, Boston, USA
2Department of Otorhinolaryngology / Head and Neck Surgery, Radboud university  
medical center, Nijmegen, The Netherlands
3Department of Surgery, Massachusetts General Hospital and Harvard Medical School, 
Boston, USA
Chapter 2.3
the Dilator Naris Muscle as a reporter of Facial 
Nerve regeneration in a rat Model
Julie S. Weinberg1, Ingrid J. Kleiss1,2, Christopher J. Knox1, James T. Heaton3, 
Tessa A. Hadlock, MD1.
Annals of Plastic Surgery. 2015 Jan 30 [Epub ahead of print].
80 Chapter 2.3
AbstrAct
Objective: Many investigators study facial nerve regeneration using the rat whisker pad 
model, though widely standardized outcomes measures of facial nerve regeneration 
in the rodent have not yet been developed. The intrinsic whisker pad “sling” muscles 
producing whisker protraction, situated at the base of each individual whisker, are ex-
tremely small and difficult to study en bloc. Here, we compare the functional innervation 
of two potential reporter muscles for whisker pad innervation: the dilator naris and the 
levator labii superioris, to characterize facial nerve regeneration.
Methods: Motor supply of the dilator naris and levator labii superioris was elucidated by 
measuring contraction force and compound muscle action potentials during stimula-
tion of individual facial nerve branches, and by measuring whisking amplitude before 
and after dilator naris distal tendon release.
Results: The pattern of dilator naris innervation matched that of the intrinsic whisker pad 
musculature (i.e. via the buccal and marginal mandibular branches of the facial nerve), 
whereas the levator labii superioris appeared to be innervated almost entirely by the 
zygomatic branch, whose primary target is the orbicularis oculi muscle.
Conclusion: Although the levator labii superioris has been commonly used as a reporter 
muscle of whisker pad innervation, the present data show that its innervation pattern 
does not overlap substantially with the muscles producing whisker protraction. The dila-
tor naris muscle may serve as a more appropriate reporter for whisker pad innervation 
because it is innervated by the same facial nerve branches as the intrinsic whisker pad 
musculature, making structure-function correlations more accurate, and more relevant 
to investigators studying facial nerve regeneration.
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introDuction
Facial paralysis is a debilitating condition that generates both physical and social impair-
ments1,2. Amongst the symptoms, the most clinically relevant include oral incompetence, 
incomplete eye closure, and difficulty smiling3. Research to develop strategies and ap-
proaches to improve functional outcome following nerve injury or sacrifice has been 
executed by many investigators4-6, and further development of facial nerve-specific 
models would substantially benefit afflicted patients.
Numerous animal models have been employed to study nerve recovery following 
nerve crush or transection injury, with significant gains in our understanding of the neu-
robiology of regeneration over the past several decades7-11. In rats, a highly quantifiable 
and commonly studied motor function of the facial nerve is movement of the vibrissal 
whiskers or “whisking”12-18. Rats whisk to explore their tactile environment through ac-
tive protraction and retraction of approximately 25 whiskers embedded in each whisker 
pad18 (Figure 1). Whisker protraction is achieved primarily through contraction of sling 
muscles located at the base of each individual whisker follicle (intrinsic pad muscles), 
and whisker retraction stems from elastic tissue recoil and from contraction of muscles 
attached to the skull posterior (caudal) to each pad19. These extrinsic whisker retract-
ing muscles include the levator labii superioris (LLS) and maxillolabialis (ML), which are 
enmeshed within the pad tissue between the rows of prominent whiskers. Although 
these extrinsic muscles play a relatively minor role in whisker movement, they are more 
frequently studied than the intrinsic sling muscles to represent whisker pad innervation 
due to the very small size and discontinuity of the individual sling muscles. For example, 
multiple studies have related immunohistochemical evidence of LLS reinnervation 
after facial nerve transection and repair rather than studying the whisker pad intrinsic 
muscles20,21. However, our previous anatomical examination of whisker pad innervation 
suggests that the LLS is innervated primarily by the zygomatic branch of the facial nerve 
rather than the buccal and marginal mandibular branches supplying the sling muscles22. 
Therefore, the LLS might not provide an optimal representation of whisking recovery 
after facial nerve manipulation, but may better relate to eye blink. Alternatively, the 
dilator naris muscle (DN) is immediately adjacent to the whisker pad and appears to 
receive its motor supply through the same facial nerve branches as the whisker pad 
intrinsic muscle, potentially making it a more appropriate reporter muscles for whisker 
pad function than the LLS.
In this study, we examined the basic electrophysiological and mechanical response of 
the LLS and DN muscles while electrically stimulating individual facial nerve branches 
with the goal of identifying their source(s) of innervation. Additionally, we examined the 
effect of disinsertion of the DN on whisking. Our hypothesis, based upon preliminary 
observations and dissections22, was that the DN receives its motor supply from the 
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same branches as those that innervate the whisker pad intrinsic, and thus may therefore 
represent a more appropriate reporter for studies of whisking recovery after facial nerve 
manipulation.
 
figure 1. A) Rat facial nerve anatomy, showing the arrays of whiskers, organized in five distinct rows (grey 
dots). B) In vivo CN VII exposure revealing the main trunk and zygomatic, buccal and marginal mandibular 
branches. C) Rat whisker pad extrinsic muscles, exposing the dilator naris muscle (DN): (1) levator labii supe-
rioris (LLS), (2) DN, (3) zygomatic arch, (4) mandibular branch of VII, (5) buccal branch of VII, (6) masseter, (7) 
zygomatic branch of VII, (8) temporal branch of VII. Drawing is from Muscle & Nerve 24:1202-1212,2001(Ref 
6). Photo insert shows DN under slight tension.
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methoDs
Eight female Wistar Hannover Rats (Charles River Laboratories, Wilmington, MA), 75 to 
90 days old weighing 200-250g, were employed for this study. Animals were treated 
following the Massachusetts Eye and Ear Infirmary guidelines for animal care and use; 
food and water were available ad libitum.
Dn and lls force tension and electromyography experiments
Four animals underwent very basic force tension and electromyography experiments 
to elucidate innervation patterns. Animals were anesthetized by an intramuscular 
injection of ketamine (50 mg/kg; Fort Dodge Animal Health, Fort Dodge, Iowa) and 
dexmedetomidine hydrochloride (0.5 mg/kg; Orion Corporation, Espoo, Finland). The 
right pre-auricular area and nasal trunk were shaved and aseptically prepared. The facial 
nerve main trunk was exposed via a pre-auricular incision followed by parotid gland 
removal. The main trunk was identified at its emergence deep to the posterior belly of 
the digastric muscle, and its three distal motor branches, buccal, marginal mandibular, 
and zygomatic, were identified and dissected. A 2-3mm segment of each branch was 
freed from the surrounding fascia, 10-15mm from the main trunk trifurcation, and a blue 
powder-free nitrile background was placed under each segment for electrical stimulator 
placement. A background was likewise placed under the main trunk of the facial nerve 
proximal to the trifurcation (Figure 1). Prior to nerve stimulation, mineral oil was placed 
on the nerve stimulator to electrically isolate the area. The exposed nerves and muscles 
were rinsed with saline throughout the experiments to prevent dehydration.
For LLS and DN muscle exposure, a midline incision was made along the nasal trunk, 
and a skin flap was elevated to the second whisker row, exposing the superficial and 
superior surfaces of the LLS. The DN distal tendon was identified immediately deep to 
the distal segment of the LLS along the nasal trunk, and dissected to its junction with the 
belly of the muscle. Dissection was then executed with meticulous attention to protect 
the neurovascular pedicle, and the distal tendon was transected and released (Figure 1).
Data were acquired using CyberAmp 380 (Molecular Devices, LLC, Sunnyvale, Califor-
nia) and a Digidata 1440a (Molecular Devices, LLC) acquisition system using pCLAMP 
10 software (Molecular Devices, LLC). Data were analyzed using Clampfit 10.2 software 
(Molecular Devices, LLC)
force tension experiment
For force tension experiments, a 6-0 braided undyed coated polyglactin 910 3/8 13mm 
suture (J492.P03 Ethicon, INC, Somerville, NJ) was secured between the DN tendon 
and a force transducer (FT03C, Grass Instruments Inc.). A second suture was secured 
superficially between the middle of the triangular muscular plane of the LLS and a micro 
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force transducer. The sutures were aligned in positions that paralleled normal muscle 
movement. Force of muscle contraction during facial nerve main trunk stimulation was 
first measured with muscles at approximately their resting length, and tension was 
adjusted until maximal contraction force was achieved. The subsequent testing proto-
col for each individual nerve stimulation location was as follows: 1st step: 0.1V, delta 
0.1V, pulse width: 0.4ms, duration 500ms, train rate: 100hz, sweep number: 20. Three 
iterations were conducted at each stimulation site (main trunk, buccal branch, marginal 
mandibular branch, and zygomatic branch), and the voltage delta was calculated for 
each stimulation (Figure 2), which was then calibrated to a series of known loads. Peak 
contractile forces (g) were averaged for the three stimulation repetitions performed at 
each nerve stimulation site for each muscle.
 
figure 2. A) Example of force tension in DN during facial nerve main trunk stimulation with a 100 Hz bipha-
sic pulse train. B) Example of CMAP in LLS during zygomatic branch stimulation of .40 ms biphasic pulses. 
Both techniques used increasing stimulation amplitudes until responses plateaued.
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electromyography experiment
For electromyographic experiments, a 25mm, 30ga electrode needle; (TECA elite dispos-
able concentric needle electrode; Carefusion, Middleton, WI) was placed superficially 
in both the DN and LLS, in the vector of physiologic muscle contraction. Three itera-
tions were conducted at each stimulation site exactly as conducted in the force tension 
experiments. The latency from onset of stimulus to first deviation in resting membrane 
potential was calculated post main trunk stimulation and compound muscle action 
potential (CMAP) amplitude data were analyzed using the greatest voltage delta from 
each action potential to compute average CMAP (Figure 2).
Dn Distal tendon release experiment
Four animals were head-fixed, and normal whisking function amplitude was recorded 
using previously described methods14. Animals were then anesthetized, as previously 
described, and a 2cm lower midline incision was made along the nasal trunk. The DN 
distal tendon was identified at its junction with the muscle belly and a 4mm segment 
was resected. The incision was closed with a 3-0 polyglactin suture, and postoperative 
whisking function was recorded one week later.
Data Analysis
For the force tension and electromyography experiments, each animal underwent three 
stimulations at each site, and data were analyzed to calculate an average excursion. 
These values from each animal were averaged to yield final measure, expressed as a 
percentage of the value achieved with main trunk stimulation, and are recorded as 
mean ± standard error. Data which were excessively noisy were omitted from analysis, 
and included a single set of CMAP data generated by the DN upon marginal mandibular 
and zygomatic branch stimulation. Additionally, there was a single channel malfunction 
during one of the experiments; these data were eliminated from analysis, and included 
CMAP data for the LLS in one experiment. For the distal tendon release, data were ana-
lyzed using whisking software developed by Bermejo et al17, which calculates amplitude 
data for vibrissae excursion over a 5 minute period. Amplitudes of the top three most 
vigorous whisks from each animal were averaged. A two sample Student’s t-test was 
used for statistical analysis. Significance was defined as p<0.05.
results
force tension Analysis
There was no statistical difference in contractile force generated upon main trunk 
stimulation in the LLS and DN (p=0.09). The DN generated a greater force than the LLS 
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upon marginal mandibular and buccal branch stimulation (p<0.05). The LLS generated 
a significantly greater force than the DN upon zygomatic branch stimulation (p<0.05).
There was no statistical difference in contractile force in the DN between main trunk 
and marginal mandibular branch stimulation (p=0.06); however the DN produced a sig-
nificantly greater force upon main trunk stimulation than buccal and zygomatic branch 
stimulation (p<0.05).
The contractile force generated by the LLS upon marginal mandibular and buccal 
branch stimulation was significantly less than the force generated upon main trunk 
stimulation (p<0.05). There was no difference in contractile force generated by the LLS 
upon main trunk and zygomatic branch stimulation (p=0.39) (Figure 3).
electromyography cmAp Analysis
Average CMAP latency, measured from stimulation onset to CMAP, demonstrated that 
the LLS (0.0030 ± 0.00019sec) responded significantly faster than the DN to stimulation 
of the facial nerve main trunk (0.0039 ± 0 .0002sec) (p<0.05)
There was no significant difference in CMAP voltage change in the DN compared to 
LLS upon main trunk stimulation (p=0.57). There was no significant difference in CMAP 
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figure 3. DN and LLS contraction force as a percentage of the force and CMAP generated during facial 
nerve main trunk stimulation (N=4). Bars are ± standard error.
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peak-to-peak average voltage change in the DN upon main trunk and the marginal 
mandibular (p=0.37) stimulation; however, the average voltage delta was significantly 
less upon both buccal and zygomatic branch stimulation (p<0.05) than main trunk 
stimulation in the DN.
The CMAP delta voltage was significantly lower in the LLS upon marginal mandibular 
and buccal branch stimulation, compared to main trunk stimulation (p<0.05). However, 
there was no significant difference in the CMAP action potential produced in the LLS 
upon main trunk and zygomatic stimulation (p=0.74) (Figure 4).
force tension and cmAp correlation
Force tension and CMAP peak-to-peak results at each stimulation site were correlated 
for both the DN and LLS (Figure 5) to account for variation among animals.
Dn Distal tendon release
Rat whisking amplitude measurements revealed that the DN distal tendon release did 
not affect whisking amplitude (p=0.26) (Figure 6).
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figure 4. DN and LLS CMAP peak-to-peak amplitude (B) as a percentage of the force and CMAP generated 
during facial nerve main trunk stimulation (N=4). Bars are ± standard error.
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Discussion
In this study, we investigated the role of different reporter muscles for studies of facial 
nerve regeneration, through clarifying the innervation patterns of the rodent LLS and 
DN using force tension and electrophysiological analysis, two commonly used methods 
to examine target muscle innervation23,24. Force tension recordings enabled maximum 
contractile force quantification and electrophysiological recordings quantified the 
latency and peak-to-peak times from each muscle’s compound muscle action potential 
(CMAP) upon nerve stimulation. The force tension and electrophysiological peak-to-
peak recordings demonstrate consistency, and together provide a plausible description 
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of the innervation patterns of the LLS and DN facial muscles despite variation among 
animals. While by no means a comprehensive description of the electrophysiologic 
characteristics of the muscles, these results provide important innervation information 
for investigators interested in studying facial nerve regeneration using the rat whisker 
pad model.
Average contractile force and CMAP amplitude data indicate that the LLS is inner-
vated primarily by the zygomatic branch of the facial nerve, with minor contributions 
from the marginal mandibular and buccal branches. We further observed that the DN is 
innervated primarily by the marginal mandibular and buccal branches, with little input 
from the zygomatic branch. Additionally, our CMAP and force tension cumulative aver-
ages at each stimulation site demonstrate a strong correlation in both the DN and LLS, 
which accounts for physiological variation observed among animals. .
The rhythmic pattern controlled by the intrinsic and extrinsic muscles of the rat 
whisker pad influence whisking and nostril movement through the facial nerve. Intrin-
sic muscles form a sling around each whisker follicle in the whisker pad, and control 
vibrissae protraction through the buccal and marginal mandibular branches of the 
facial nerve19,22,25,26. Our results show that the DN is innervated in large part by the same 
branches that control intrinsic whisking. The extrinsic muscles (LLS, m. maxillolabialis, m. 
transversus nasi, m. nasalis), have been associated with vibrissae retraction19,25,26 and our 
present results demonstrate that LLS retraction is primarily supplied by the zygomatic 
branch, unlike the intrinsic pad muscles. It is likely that previous investigators examined 
the LLS due to its convergence with the intrinsic whisker pad muscles, yet the two 
groups appear to receive their neural input through different pathways. Moreover, we 
observed that the LLS responded faster to stimulation of the main trunk compared to 
the DN, which further suggests an alternative pathway.
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figure 6. Whisking amplitude pre- and post- DN distal tendon release.
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Whisking function and whisker pad immunohistochemistry are common reporters of 
facial nerve regeneration12-18 following surgical manipulation. However, the orientation 
of the individual sling muscles makes them notoriously difficult to assess histologically 
since the muscle in its entirety cannot be sectioned based upon its oblique position 
around each follicle. Thus, it would be useful to identify a surrogate reporter facial muscle 
that displays a common innervation pattern, which would allow analysis of histological 
muscle changes along with functional whisking behavior. The DN is primarily involved in 
nostril dilation, in addition to nose deflection and reflection during sniffing27. Although 
we demonstrated that the DN distal tendon release did not change active whisking 
function, others have suggested that the DN is involved in vibrissae protraction during 
the first stage of the sniff cycle27. Our work herein demonstrates that the DN is mostly 
supplied by the buccal and marginal mandibular branches; thus, the muscle is likely to 
experience similar histological changes post- facial nerve manipulation as the whisker 
pad intrinsic musculature.
In addition to its motor supply, the DN possesses several advantages over the LLS as 
a reporter muscle. The DN can be harvested en bloc due to its ease of dissection from 
the surrounding soft tissues, and its long single nasal tendon. In contrast, the LLS fans 
out distally into multiple radians, converging with the whisker pad. The DN is composed 
of parallel muscle fibers (optimal for cross-sectional cryostat cuts), surrounded by a thin 
fascia layer. Additionally, using the LLS may introduce inaccuracies in experiments in 
which only the buccal and marginal mandibular branches are manipulated. We propose 
that the DN is the most suitable reporter for whisker pad innervation in rat model of 
facial nerve regeneration based upon its more closely matched innervation patterns to 
the whisker pad musculature, and have now integrated its histological analysis into our 
rodent facial recovery paradigms post-facial nerve manipulation.
In summary, facial nerve regeneration remains suboptimal following crush, transec-
tion and repair, and following cable grafting. Laboratory models to investigate manipu-
lations of the neuromuscular environment are of critical importance in identifying the 
utility of novel regeneration approaches. Tools such as DN re-innervation patterns will 
serve to further characterize any regenerative benefit derived by different experimental 
maneuvers.
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AbstrAct
Objective: To summarize and evaluate the quantitative assessment tools for facial func-
tion in peripheral facial palsy in the current literature.
Data Sources: A systematic review of the English literature through PubMed, EMBASE 
and the Cochrane Library.
Study Selection: All studies published between 1990 and August 2014 in the English 
language describing a quantitative assessment tool for facial function in patients with 
facial palsy were included. Studies on clinician-based grading scales, electrophysiologi-
cal studies, magnetic resonance imaging, tools for hemifacial spasm, and animal studies 
were excluded.
Data Extraction: A questionnaire was sent to professionals in the field of facial palsy to 
determine criteria used to evaluate the quantitative assessment tools.
Data Synthesis: No statistical analyses were used in this study.
Conclusions: Quantitative assessment of facial function in peripheral facial palsy is 
very complex. Of the studies assessed, three simple, static, linear, free available, two-
dimensional assessment tools are appropriate for implementation in clinical practice: 
Facial Analysis Computerized Evaluation software, Facial Assessment by Computer 
Evaluation software, and Glasgow Facial Palsy Scale software. A large prospective, mul-
ticenter comparative study is required to delineate one of them as a gold standard. Of 
the three-dimensional assessment tools, the drawbacks of complexity, time, cost and 
availability make it difficult to recommend any individual tool for widespread clinical 
implementation. Further development is needed to realize the goal of a widely accepted 
three-dimensional tool appropriate for universal facial palsy assessment. Few studies 
incorporated reporting of criteria deemed necessary and important for implementation 
into clinic practice, such as cost, time, required equipment, reliability, validation, and 
accuracy. For future tools, all of these criteria should be assessed and reported to allow 
transparent assessment by clinicians.
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introDuction
Patients with peripheral facial palsy experience myriad difficulties; for example incom-
plete eye closure (which may lead to exposure keratitis, and even blindness), inability 
to express emotions, eating and articulation problems, and social isolation. In manage-
ment of patients with facial palsy, assessment of facial function is critically important for 
several reasons: to evaluate the severity of the palsy, to follow the course of the disease, 
to judge treatment results, and to compare results between clinics. Traditionally, assess-
ment of facial function is performed by the clinician using a facial nerve grading system 
(i.e. House-Brackmann grading system1 or Sunnybrook facial grading system2). More 
recently, quantitative (automated) assessment tools have emerged. Various clinics have 
developed their own tools, and no gold standard has been determined yet.
In 1967 Jongkees stated: “In order to be able to evaluate the results of a certain treat-
ment, they must be comparable, i.e., we must use the same code. Only then can we 
compare. It seems important to come to universal standards of comparison”.3 In 2014 a 
group of authors performed a survey on behalf of the Sir Charles Bell Society (SCBS)* to 
investigate which methods of facial palsy documentation are used by members of the 
SCBS. This survey focused on clinician-based grading scales, patient reported outcome 
measures and documentation of photography and videography.4 The authors did not 
investigate how the photographic recordings were analyzed.
The goal of this systematic review is to summarize and evaluate quantitative assess-
ment tools for facial function in peripheral facial palsy described in the current literature, 
and to make a step forward in choosing a gold standard quantitative assessment tool for 
facial function in facial palsy.
methoDs
To appraise the various quantitative assessment tools for facial function in facial palsy, 
several criteria were established. To determine which criteria were relevant to facial 
nerve clinicians, a questionnaire was sent out to professionals in the field of facial palsy 
(members of the SCBS). These professionals were asked which aspects of a quantitative 
assessment tool are important in deciding quality and ability to be implemented into 
clinical practice (see Appendix I for this questionnaire). The criteria included for evalua-
tion of the assessment tools can be found in the tables (Table 1-5, Appendix III).
* The Sir Charles Bell Society (SCBS) is a non-profit multidisciplinary medical organization. The intent of 
the SCBS is to concentrate knowledge and to present a platform of exchange for all people and professions 
dealing with facial nerve problems. www.sircharlesbell.org
100 Chapter 3.1
A literature search was performed in PubMed, EMBASE and the Cochrane Database 
(see Appendix II for search entries). This search identified 1764 articles. A first, raw selec-
tion of potentially relevant articles (title and abstract) was undertaken by one of the 
authors (IJK) reducing the number of articles to 122. The first two authors (TJE and IJK) 
independently reviewed all 122 articles and included articles in the English language 
published in a peer reviewed journal after 1990 reporting on any quantitative assess-
ment tool for facial function in facial palsy. Clinician-based grading scales (i.e. House-
Brackmann, Sunnybrook), electrophysiological studies, studies employing magnetic 
resonance imaging, objective assessment tools for hemifacial spasm, and animal studies 
were excluded. Differences of opinion were discussed until a satisfactory agreement re-
garding inclusion was reached. The references of the articles were checked for possible 
missing articles.
Finally, 38 quantitative assessment tools were included. These tools were indepen-
dently criticized by the first two authors (TJE and IJK). They rated the previous determined 
criteria per tool. Differences of opinion were discussed until a satisfactory agreement 
regarding inclusion was reached.
results
results questionnaire
Twenty-five members of the SCBS completed our questionnaire (Appendix I). Nine of 
them (36%) were facial plastic surgeons, six (24%) ENT specialists, two (8%) neuro-otol-
ogists, six (24%) physical therapists, and three (12%) researchers. Fifty-two percent of 
respondents evaluate two to five patients with facial palsy per week, 24% see one or less 
patients per week, the other 24% more than five patients per week. The majority (87.5%) 
spend 20 minutes or more per patient per consultation. We asked the members of the 
SCBS how important an objective facial assessment tool would be for their practice. Fifty 
percent describe a quantitative assessment tool as ‘essential’ (Figure 1). Respondents 
had different opinions concerning a reasonable amount of time for the initial set up 
of a tool; 37.5% prefer less than one day to set up and no need for special training, 
45.8% consider one to three days and special training reasonable. The majority prefer 
a semi-automated tool (62.5%); 25% of them want the tool to be clinician guided, the 
other 37.5% nurse or assistant guided. Another third of the respondents (29.2%) prefer 
a fully manual input by the clinician. The amount of time SCBS members want to invest 
in assessment of each patient is one to eight minutes (83.3% of the respondents). Ap-
proximately half of respondents consider facial markers to be a barrier to using a tool in 
routine practice. Slightly less than half of the respondents (45.8%) demand a tool to be 
three-dimensional. The decision to use a certain tool is mainly influenced by published 
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data (45.8%) and international experts (33.3%). Fifty-eight percent want a quantitative 
tool to be +/- 1 millimeters accurate. Respondents want to be able to assess all zones 
of the face. Respondents of the SCBS are not willing to pay more than 5000 Euros or 
6600 US dollars for a quantitative assessment tool (Figure 2), though they are willing to 
buy additional equipment (83.3%). Quantitative assessment of synkinesis is essential for 
42% of the respondents, very important for 29%, and important for 17%. Assessment of 
symmetry is essential for 46%, very important for 33%, and important for 17%.
25% 
33% 
25% 
17% 
Financial investment 
0-200 euros / 0-250 US dollars (25%) 
200-500 euros / 250-650 US dollars (33%) 
500-1000 euros / 650-1300 US dollars (25%) 
1000-5000 euros / 1300-6600 US dollars (17%) 
> 5000 euros / > 6600 US dollars (0%) 
figure 2. Answer at the question ‘How much would you be willing to pay to implement an objective facial 
assessment tool into your practice?’ Answered by 24 members of the SCBS.
results of systematic review
Table 1 (Appendix III) presents five non-computerized tools. Unfortunately no informa-
tion is given about the time needed with the patient or the total time of analysis. Only 
the faciometer5 is known to take 20 minutes. Psychometric values (i.e. validity, reliability, 
sensitivity) of these tools are largely unknown.
12% 
38% 
50% 
Importance of a quantitative tool  
not important (0%) 
somewhat important (0%) 
important (12%) 
very important (38%) 
essential (50%) 
figure 1. Answer at the question ‘How important would an objective facial assessment tool be to your 
practice?’ Answered by 24 members of the SCBS.
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Table 2 (Appendix III) presents six tools for assessment of the ocular region. It is not 
clear if the Computer Assisted Design (CAD) software6 was tested in a facial palsy popu-
lation, though the other 5 were tested in this population. The methods described by 
Choi et al.7, Somia et al.8, and Miyazaki et al.9 assess the motion of the eyelid in terms of 
displacement, velocity, and/or acceleration. The methods presented by Borodic et al.10 
assesses palpebral fissure width, the method of Mabvuure et al.11 assesses eye surface 
area. CAD software evaluates both lagophthalmus and corneal exposure. For other 
characteristics of the tools see Table 2.
The other important zone of the face to assess is the smile. Assessment of the smile 
is very complex. This is expressed by the wide variety of assessment tools. We divided 
them into two-dimensional (2D) and three-dimensional (3D) tools. The 2D assessment 
tools we further divided into static and dynamic methods. Table 3 (Appendix III) presents 
all two-dimensional assessment tools that give static information and Table 4 (Appendix 
III) presents all two-dimensional tools that give dynamic information. In the columns on 
the right, assessment tools that were not tested in a facial palsy population.
Table 5 (Appendix III) presents all included three-dimensional measurement tools. 
Five of them were not tested in a facial palsy population. Little is known about duration 
of initial set-up, need for training, and duration of training. Neither about duration of 
testing with the patient and analyses afterwards.
Discussion
All articles describing a quantitative tool for facial function measurements begin with 
some comment that such a tool is mandatory in the evaluation of treatment results. Nev-
ertheless, there is no such tool adapted for widespread use because of the complexity of 
facial movement. Mitre et al. (2008) wrote: “The lack of a universally accepted peripheral 
facial palsy system is a widely recognized problem and subject of numerous discussions 
and studies despite almost 20 years of proposals and deliberations.”12 Kang et al. (2002) 
wrote: “The measurement of facial nerve function in a consistent, reliable manner is an 
important but elusive goal”.13 Croxson et al. (1990) wrote: “Many systems for reporting 
results of facial function tests have been proposed, but after five International Facial 
Nerve Symposia, a perfect system for reporting has yet to be developed.”14
Among the quantitative tools described in this review, there are six non-computerized 
tools (See Table 1, Appendix III). Their advantage is that they are not expensive, most 
of them just need a pen and a ruler. The time needed to perform the analysis is only 
described for the faciometer5 which takes 20 minutes, the other tools seem quite time 
consuming. Surveyed members of the SCBS prefer not to spend more than 8 minutes 
per patient using a quantitative tool. As Neely et al. said: ‘‘The big issue is that facial 
Quantitative assessment of facial function 103
3.1
motion analysis has not kept pace with the advancements in other areas, audiology for 
example. In that comparison, we are back with the tuning fork and whispered voice.’’15
At this stage, no gold standard can be applied to quantitative facial assessment tools. 
No one tool fulfills all criteria deemed necessary based on surveyed clinician opinion 
and each zone of the face requires its own approach. In the ocular zone a few aspects of 
facial palsy are important to measure. Most importantly, lagophthalmos (the inability to 
close the eyelids completely) resulting in corneal exposure. The degree of lagophthal-
mos can be expressed in palpebral fissure width or in corneal surface exposed. A second 
consequence of facial palsy in the ocular region is synkinesis which can be expressed in 
palpebral fissure width during smiling or puckering. Three dimensional measurements 
are not inevitably required in this zone. The methods described by Choi et al.7, Somia et 
al.8, and Miyazaki et al.9 assess motion of the upper eyelid in terms of displacement and 
velocity of the eyelid. We can extract information on incomplete eyelid closure from 
these data, but these tools are not suitable for corneal exposure or synkinesis assess-
ment. Information on movement of the eyelid can be useful in dynamic reconstructions 
of the ocular region. Computer assisted design (CAD) software was not clearly tested 
in a facial palsy population6, making it difficult to do a recommendation for this tool. 
ImageJ software used by Mabvuure et al.11 is favorable over the palpebral fissure width 
measurement by Borodic et al.10 because this latter tool requires markers on the patients 
face. (See Table 2, Appendix III.)
two-dimensional assessment tools
Most quantitative assessment tools described in the current literature are based on two 
dimensions of facial motion. These tools can be further divided in linear measurement 
tools (e.g. measurement of smile excursion and palpebral fissure width), tools that mea-
sure area changes using for example pixel changes, and tools that measure motion; ve-
locity and acceleration. The first two are mainly static and the latter dynamic. Particularly 
the linear, static, measurement tools are highly suited for routine, daily clinical practice. 
Facial symmetry can reliable be measured by simple, static, tools. However, for detailed 
evaluation of dynamic reconstructions evaluation of motion is preferred, or maybe even 
three-dimensional assessment.
Quantitative tools based on Photoshop software
Sargent et al.16 and Pourmomeny et al.17 used Photoshop software to quantify facial 
function. Advantages of this method are availability of the software, low cost, no need 
for special equipment, and ease of use. In our opinion, the need for markers is a disad-
vantage of this technique. Tomat et al.18 presented the Facial Reanimation Measurement 
System technique, which is Photoshop-based as well, and shows the same character-
istics as the two before mentioned methods. Hadlock et al. described a tool related to 
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the Photoshop software: Facial Assessment by Computer Evaluation (FACE) software.19 
FACE software is free available through the website of the SCBS. The advantage of this 
tool is that there is no need for facial markers. The software is not fully automated either, 
the physician or (trained) assistant has to mark the points of interest with a mouse click. 
FACE software has been tested in a facial palsy population and has proven to be reli-
able and sensitive. This tool can be used for assessment of ocular synkinesis as well by 
measuring palpebral fissure width.20 With this possibility it has the same characteristics 
as ImageJ software described before.11
Linear and symmetry assessment
Multipele tools are based on linear measurements between points, some use markers 
to track these anatomical landmarks, others select these anatomical landmarks on a 
photo- or videograph. Scaling can be done taping a ruler on the patients face or by 
using the iris of the patients eye. Wood et al.21 present a technique in which they use a 
video microscaler, a method in which they superimpose a computer-generated measur-
ing scale over a patients facial image.
O’Reilly et al.22 developed the Glasgow Facial Palsy Scale (GFPS), a fully automated tool 
that produces a facogram and a House-Brackman score (Figure 3). This method is proven 
to be reliable and sensitive, there is no need for facial markers, equipment consists of a 
simple video camera and computer with (free) GFPS software. Total duration of assess-
ment lies between 17 and 25 minutes. A disadvantage is that this tool cannot be used in 
bilateral facial palsy. Results, as shown in a facogram, are based on (a)symmetry. Kleiss et 
al. modified the GFPS to assess ocular synkinesis, but this appeared not to be reliable.20 
He et al.23 present a technique that is very technical. This technique is the basis of the 
GFPS, and the GFPS is more suited for clinical use.
Sawai et al.24 presented the OKAO Vision® facial image analysis software. Results are 
presented as a symmetry index, giving less specific information for example for dynamic 
reconstructions. A symmetry index is given by the method of Isono et al.25, distances 
between marked points on the face are measured and compared between both sides. 
Neely et al.15, 26-28 have been developing a quantitative tool since 1988: the Facial Analysis 
Computerized Evaluation system (FACE). In their 2010 article15 they suggest to free-
share their program with other investigators. Scriba et al.29, 30 have developed a very 
comparable quantitative method: objective scaling of facial nerve function based on 
area analysis (OSCAR). The fundamental drawback of all two-dimensional methods is 
their inability to assign accurate metric value for objective assessment of reconstructive 
interventions and subsequent inclusion in group data for technique comparison.
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Dynamic assessment tools
Dynamic reconstructions demand dynamic assessment. Three quantitative dynamic as-
sessment tools are included in this review (Table 4, Appendix III). One of them, described 
by Park et al., was not validated in a facial palsy cohort.31 The technique underlying this 
method is quite complicated, perhaps excessively complicated for clinical use. Linstrom 
et al.32-34 described the Peak Motus Motion Measurement System. A major disadvantages 
of this tool is the time needed; 20-25 minutes with the patient and 60-90 minutes for 
digitization of a test session. Automated Facial Image Analysis (AFA) presented by 
Wachtman et al. seems time consuming as well, although the exact duration has not 
been mentioned. However, 55 points have to be manually marked with a computer 
mouse.35, 36 One should realize that an accurate assessment of a complex motion can 
hardly be simple. A precise evaluation of smile will be more time consuming than a 
simple static symmetry analysis. Frey et al. stated in the early 1990s that it is “absolutely 
impossible to solve this complex problem with a simple grading system”.37
 
figure 3. Glasgow facogram of a patient with a left-sided facial palsy. From: G. Kecskes, J. Jori, B. F. O’Reilly, 
L. Viharos, and L. Rovo. Clinical Assessment of a New Computerised Objective Method of Measuring Facial 
Palsy. Clin Otolaryngol. 2011; 36: 313-9.
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three-dimensional assessment
Since facial movement occurs in three dimensions, 3D analysis of facial movement 
seems most accurate. Gross et al. compared 2D and 3D analyses of facial motions.38 They 
found that 2D and 3D motion amplitudes were highly correlated for all landmarks and 
motions, but that 2D amplitudes were significantly less, this difference was the most for 
smiling. Table 5 (Appendix III) presents 3D assessment tools. Tools that were not tested 
in a facial palsy population were excluded for further recommendation. Which is unfor-
tunate since the 3D stereophotogrammetry described by Sawyer et al.39 is a potentially 
useful tool, but they only tested the smiles of 71 healthy volunteers. Important aspects 
for clinicians, such as how much time and training is needed initially and how much time 
analysis takes (with the patient and afterwards), is not well described in the literature. 
Another important aspect for clinicians in deciding to use a certain tool is the cost of a 
tool, which is rarely well described in the literature. Most 3D methods require several 
pieces of equipment (most often three or more cameras to start with). Members of the 
SCBS mentioned this to be a disadvantage of a tool. Surface laser scanning (described 
by Okada et al.40) requires a laser light scanner and a computer and has no need for 
facial markers, and it takes only ten seconds to capture the shape of the entire face. 
Disadvantages of this tool include the way in which the results are presented (Figure 4). 
Moiré topography (described by Yuen et al.41) requires a moiré camera and a computer 
and neither has a need for facial markers. With this tool as well, presentation of results 
is not intuitive.
The assessment tools of Sforza et al. and Frey et al. have both been thoroughly tested 
in a facial palsy population. They both have proven to be reliable and sensitive. Draw-
backs are the amount of equipment needed, probably cost (although not described), 
and other characteristics of the tools that are not well described, including time needed 
for analysis and for initial training.
 
figure 4. Adapted from E. Okada. Three-Dimensional Facial Simulations and Measurements: Changes of 
Facial Contour and Units Associated with Facial Expression. J Craniofac Surg. 2001; 12: 167-74.
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synkinesis assessment
Looking at quantitative synkinesis assessment, measurement of ocular synkinesis is 
straightforward. Palpebral fissure width is a simple linear measurement. Assessment of 
oral synkinesis is more complex. Oral synkinesis does not exist of one simple vector. 
Area changes or 3D measurement are more suited. In the current literature no method 
to assess platysmal synkinesis exists, this is a field to further explore.
conclusions
One goal of this systematic review was to summarize and evaluate the various quantita-
tive assessment tools for facial function in peripheral facial palsy in the current literature. 
We did succeed in this goal; tables in Appendix III show an extensive evaluation of exist-
ing tools and the discussion of this article gives a thorough overview. The other goal was 
to make a step forward in choosing a gold standard quantitative assessment tool. We 
have concluded that it is not accurate to choose only one quantitative tool and nomi-
nate it to be the gold standard. For daily clinical use we recommend a two-dimensional, 
static, linear or (a)symmetry assessment tool. Thirteen possible tools are summarized in 
Table 3A and 3B (Appendix III). Based on proven validity in a facial palsy cohort, no need 
for markers, and free availability we selected the FACE software of Neely et al.15, 28, 42, the 
FACE software Hadlock et al.19, 20, 43, 44, and the GFPS of O’Reilly et al.22, 45, 46 as possible gold 
standard quantitative assessment tools. We suggest a (multicenter) prospective study in 
which these three tools are applied in the same patient group for a good comparison. 
In case OKAO Vision software24, FEMAS-1 software47, and OSCAR software29, 30 are free 
available they can be included in the study as well. Finally, we recommend to choose 
one of this tools as an international accepted and used gold standard tool, to be able 
to compare results between clinics. Journals in the field should request outcome results 
according to this gold standard.
Dynamic reconstructions, especially of the smile, require a more advanced assessment 
tool. Such a tool will be more time consuming than one of the above mentioned tools. 
They might be more expensive as well. We recommend a three-dimensional tool over a 
dynamic two-dimensional tool. Based on the information in the current literature on 3D 
assessment tools we are not able to recommend one specific tool to be eligible for gold 
standard. Cost and equipment are the major drawbacks for implementation of these 
tools in daily practice. As long as costs stay high and equipment plenty, we might have 
to be satisfied with one simple, 2D static assessment tool.
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AppenDix i
Questionnaire sent to members of the Sir Charles Bell Society
1. What is your profession?
2. How many patients with facial palsy do you see on average?
 (< 1 per week, 2-5 per week, 6-10 per week, 11-20 per week, > 20 per week)
3. How much time do you spend per patient per consultation?
 (+/- 5 minutes, +/- 10 minutes, +/- 15 minutes, +/- 20 minutes, +/- 30 minutes, > 30 minutes)
4. How important would an objective facial assessment tool be to your practice?
 (not important, somewhat important, important, very important, essential)
5. What would you consider to be a reasonable amount of time for the initial set up of an objective facial 
assessment system into your practice?
 (< 1 day to set up; no special training required, > 1 day to set up; no special training required, 1-3 days 
to set up; special training required, > 3 days to set up; special training required)
6. What would be your preference for how an objective facial assessment system would work?
 (fully automated; without supervision (patient directed), semi automated; nurse/assistant guided, semi 
automated; clinician guided, fully manual input; nurse present, fully manual input; clinician present)
7. What amount of your time would you be willing to invest in each patient to use an objective system 
routinely?
 ( < 1 minute, 1-3 minutes, 3-5 minutes, 5-8 minutes, > 8 minutes)
8. Would the application of facial markers be a barrier to your routine use of an objective facial assess-
ment tool in your practice?
 (yes, no)
9. Does an objective facial assessment tool need to be 3 dimensional?
 (yes, no)
10. Is your decision to implement an objective system into your practice influenced most by:
 (other clinicians in your area/department, other clinicians in your country, international experts, pub-
lished data, none of the above)
11. For you to consider an objective system reliable, the defined accuracy would need to be:
 (sub-millimetre, +/- 1mm, +/- 2mm, +/- 3mm, metric accuracy is not important)
12. The reporting of objective metric data for facial movements is important for:
 (all zones in all cases, some zones (eg mid face or brow) in all cases, some zones in some cases, all zones 
in some cases, metric data is not important for my practice)
13. How much would you be willing to pay to implement an objective facial assessment tool into your 
practice?
 (0-200 euro/0-250 US dollars, 200-500 euro/250-650 US dollars, 500-1000 euro/650-1300 US dollars, 
1000-5000 euro/1300-6600 US dollars, > 5000 euro/ > 6600 US dollars)
14. Would you be willing to purchase additional equipment to implement an objective facial assessment 
tool into your practice?
 (yes, no)
15. Is objective synkinesis assessment important?
 (not important, somewhat important, important, very important, essential)
16. Is symmetry assessment and reporting important?
 (not important, somewhat important, important, very important, essential)
17. What other factors would influence your decision to use an objective tool in your practice?
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AppenDix ii
PubMed Search
((“Facial Palsy”[Mesh] OR (Facial[tw] AND (Palsy[tw] OR Palsies[tw] OR Palsy[tw] OR 
Paralyses[tw] OR Paresis[tw])) OR “Facial Nerve Diseases”[Mesh] OR facial Nerve Disease[tw] 
OR Facial Nerve Diseases[tw] OR Cranial Nerve VII Disorders[tw] OR Seventh Cranial Nerve 
Diseases[tw] OR Cranial Nerve VII Diseases[tw] OR Facial Nerve Disorders[tw] OR Facial 
Nerve Disorder[tw] OR “Facial Nerve”[mesh] OR “Facial Nerve”[tw] OR “Facial Nerves”[tw] 
OR (Bell Palsies[tw] OR Bell Palsy[tw] OR Bell’s Palsy[tw] OR Bell’s Palsies[tw] OR Bells 
Palsy[tw] OR Facial Neuropathy[tw] OR “synkinesis”[MeSH Terms] OR “synkinesis”[tw]))) 
AND (((((((((((((((“Signal Processing, Computer-Assisted”[Mesh:noexp]) OR ((“Image Pro-
cessing, Computer-Assisted”[Mesh:noexp]) OR “Imaging, Three-Dimensional”[Mesh])) OR 
(Computer-Assisted Image Processing[tw] OR Computer Assisted Image Processing[tw] 
OR Computer-Assisted Image Analysis[tw] OR Computer Assisted Image Analysis[tw] 
OR Computer-Assisted Image Analyses[tw])) OR (Three-Dimensional Imaging[tw] 
OR Three-Dimensional Imagings[tw] OR 3-D Imaging[tw] OR 3 D Imaging[tw] OR 3-D 
Imagings[tw] OR 3-D Image[tw] OR 3 D Image[tw] OR 3-D Images[tw] OR Three-Dimen-
sional Image[tw] OR Three Dimensional Image[tw] OR Three-Dimensional Images[tw] 
OR Computer-Generated 3D Imaging[tw] OR Computer Generated 3D Imaging[tw] 
OR Computer-Generated 3D Imagings[tw] OR Computer-Assisted Three-Dimensional 
Imaging[tw] OR Computer Assisted Three Dimensional Imaging[tw] OR Computer-
Assisted Three-Dimensional Imagings[tw])) OR “Software”[Mesh:noexp]) OR “Video 
Recording”[Mesh:noexp]) OR “Photography”[Mesh:noexp]) OR “Photography”[tw]) 
OR video[tw]) OR software[tiab]) OR computeri*[tw]) OR automated[tw]) OR grading 
scale[tw]) OR ((Objective scaling[tw] OR objective scale[tw] OR objective scales[tw] OR 
objective assessment[tw] OR objective evaluation[tw] OR objective grading[tw] OR ob-
jective measurement[tw] OR objective analysis[tw] OR objective tool[tw] OR objective 
method[tw]))))
EMBASE Search
(exp facial palsy/ or exp facial nerve disease/ or exp Bell palsy/ or exp facial nerve injury/ 
or exp synkinesis/) AND (recording or automtion or clinical assessment or clinical as-
sessment tool or computer analysis or computer program or glasgow facial palsy scale 
or quantitative analysis or videorecording or image processing or photography or 
computer assisted diagnosis or image analysis or three dimensional imaging)
Cochrane Search
facial palsy AND (assessment OR evaluation OR objective OR tool OR software OR com-
puterised OR computerized OR automated)
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AbstrAct
Objective: To define an objective, easy to perform, rapid method for the assessment of 
ocular synkinesis, by employing both the Facial Assessment by Computer Evaluation 
software, and a modification of the Glasgow Facial Palsy Scale.
Study Design: Retrospective study.
Methods: 50 normal subjects and 50 patients with known ocular synkinesis were studied. 
Measurements of ocular synkinesis were made using the semi-automated Facial Assess-
ment by Computer Evaluation software, and a modification of the automated Glasgow 
Facial Palsy program.
Results: The mean resting vertical palpebral fissure width of a normal eye was 10.17 mm 
(SD 1.63 mm), and the degree of eye closure during smile was on average 21.56% (SD 
13.38%). Synkinetic eyes had a statistically significantly smaller resting palpebral fissure 
width on average (8.99 mm, SD 1.61 mm, P<0.001; t-test), and a statistically significantly 
greater degree of narrowing during smiling (32.65%, SD 13.68%, P<0.001; t-test). Using 
a modified, synkinesis-determining application of the Glasgow Facial Palsy Scale did not 
consistently correlate with the Facial Assessment by Computer Evaluation program, or 
clinical observations of eye closure during smiling (R=0.251; Pearson correlation) and 
puckering (R=0.253; Pearson correlation).
Conclusion: The Facial Assessment by Computer Evaluation program yields rapid, con-
sistent palpebral fissure width measurements, and when combined with a subjective 
self-assessment questionnaire, yields a comprehensive measure of ocular synkinesis. 
Our modified application of the Glasgow Facial Palsy Scale did not appear to be a reli-
able method for quantitative ocular synkinesis assessment.
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introDuction
Synkinesis is a major challenge for patients recovering from facial paralysis. The term 
refers to the involuntary contraction of certain muscles during voluntary movement 
of other muscles. For example, we often observe involuntary eye closure with smiling 
after facial nerve insult and recovery. This phenomenon is thought to arise from axonal 
misrouting during regeneration of the facial nerve.1 Treatment options consist of physi-
cal therapy2, 3, botulinum toxin injections4, and surgical interventions.5
An objective, reliable, and universally applicable method for the quantitative assess-
ment of synkinesis does not currently exist. There are myriad grading systems for the 
assessment of facial paralysis; the House-Brackmann grading system is the best known 
and most widely employed scale.6 Its major disadvantage is lack of consideration for 
segmental weakness or synkinesis, though it has been modified to address these short-
comings.7 Some grading systems do include assessment of synkinesis, for example the 
Sydney and Sunnybrook8 facial scales. However, they demonstrate low reliability for the 
evaluation of synkinesis.9 One validated and reliable synkinesis evaluation instrument 
is the Synkinesis Assessment Questionnaire; it is, however, a subjective self-assessment 
tool and does not provide objective clinical measurements.10 While there is still no gold 
standard method for synkinesis evaluation, there are automated tools for assessment 
of facial paralysis. The Massachusetts Eye and Ear Infirmary (MEEI) Facial Assessment by 
Computer Evaluation (FACE) program is a validated facial analysis system.11 Furthermore, 
the Glasgow Facial Palsy Scale (GFPS) is an automated program for objective and quanti-
tative assessment of zonal facial movement during different facial expressions.12 Herein, 
we sought to examine the accuracy of these two automated programs in reporting and 
quantifying ocular synkinesis in a paresis population. Since both programs have already 
been established as useful clinical tools, and can be easily employed in most clinical 
settings13, demonstrating that either program is sensitive to synkinesis would benefit 
clinicians caring for patients with the condition.
mAteriAls AnD methoDs
patients
Videographs of 50 patients with known ocular synkinesis seen at the Facial Nerve Center 
at MEEI between December 2011 and February 2012 were retrospectively reviewed. Pa-
tients were excluded for bilateral facial nerve disorders, ocular problems on the healthy 
side, incomplete eye closure on the injured side, presence of an eyelid weight, and facial 
trauma. Nearly all patients were receiving some form of treatment for ocular synkinesis 
(physical therapy or botulinum toxin treatment more than 3 months prior to this as-
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sessment). Fifty normal subjects were enrolled as controls. Massachusetts Eye and Ear 
Infirmary’s Institutional Review Board approval was obtained and all subjects consented 
to video analysis. Normal subjects were excluded for any history of facial paralysis or any 
pre-existing facial asymmetry.
facial Assessment by computer evaluation (fAce)
The FACE software has been described in detail previously.11 Briefly, the program mea-
sures the diameter of the iris after the limbus is outlined with 4 mouse clicks. The pho-
tograph is then scaled to the average human iris diameter (11.8 mm), and permitting 
calculation of distances between 2 points on the face .14, 15 Mouse clicks on the upper 
and lower eyelids allow the software to calculate the vertical palpebral fissure width 
(PFW) (Figure 1).
modified application of the Gfps
The GFPS, when used the way it was designed, permits automated, quantitative as-
sessment of zonal facial movement based upon pixel changes.12 Briefly, the software 
requires that a patient perform the following movements in order: raise eyebrows, 
close eyes gently, close eyes tightly, wrinkle nose, and smile. The software analyzes 
the forehead, ocular area, ocular area again, midface, and perioral area each in turn, to 
focus on the movement pertinent to each zone. We modified the sequence of recorded 
facial expressions, to “trick” the program into analyzing the synkinetic zones of the face 
rather than the areas being moved voluntarily. Patients were asked to perform mouth 
movements while the program was detecting ocular movement differences. Both full 
smile and puckering of the lips were chosen to elicit synkinetic ocular movement. The 
symmetry values for the eye region during mouth movements were extracted from the 
data for synkinesis determination.
 
figure 1. Example of PFW measurement by the FACE software. A mouse click on the upper and lower 
eyelids allows the software to calculate the PFW using the diameter of the iris as a scale. The MEEI FACE 
software can be downloaded from the website: www.sircharlesbell.org/blog/useful-downloads/
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recording
Patients were seated in front of a plain background, facing the camera. The distances 
among wall, chair, light source, and camera were kept constant. Symmetric lighting of 
the face was achieved with 2 light umbrellas at eye level. Patients wore a headband to 
keep hair off the face, and large earrings were removed before recording. The entire face 
was in the recording frame, along with a small amount of background. Recording began 
with the face in repose; patients were asked to smile and pucker serially; after each 
movement the face returned to repose, and the video ended in repose. Photographs for 
analysis with the FACE software were captured from screenshots during repose, maximal 
smile, and full puckering of the lips. The software was used to gather normative data on 
PFW and degree of eye closure during mouth movements in subjects with normal facial 
function.
Discrepancy analysis
When discrepancies were found between expected and measured outcomes, we re-
turned to the videographs to compare the results provided by the modified application 
of the GFPS with the physician’s subjective assessment.
Data analysis
Differences in PFW between healthy and synkinetic eyes in the same subject were 
analyzed using paired t-tests. Differences in PFW between groups were analyzed using 
a Student’s t-test. The difference in mean symmetry, as reported by the FACE program 
and the GFPS, between the normal subjects and the synkinesis patients was analyzed 
using a Student’s t-test. The relation between the measurements reported by the GFPS 
and FACE software was analyzed using Pearson correlations. A p-value smaller than 0.05 
was considered to be statistically significant. The statistical software SPSS 16.0 (SPSS Inc., 
Chicago, IL) was used for analysis.
results
fAce assessments
Normal eyes
In normal subjects, the difference between the mean PFW of the right and left eyes 
was 0.04 mm; not statistically significant (P=0.70; paired t-test). Normative data were 
collected from these 100 normal eyes; mean PFW was 10.17 mm (SD 1.63 mm), which 
is consistent with normative data in the literature.16, 17 The degree of eye closure during 
smiling was on average 21.56% (SD 13.38%) in normal subjects. During puckering of 
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the lips, normal eyes experienced trivial fluctuation of the PFW up or down, with an 
average of 0.09% (SD 8.44%); 53% of the eyes experienced some degree of eye opening 
during puckering with an average of 6.00% (SD 4.93%) and the other 47% of the eyes 
experienced some degree of eye opening during puckering with an average of 6.96% 
(SD 5.88%). Figure 2 shows PFW measurements in repose, and during expressions that 
in patients with aberrant regeneration would elicit synkinesis.
Synkinetic eyes
In synkinetic patients, the PFW of the healthy eye in repose (10.01 mm, SD 1.52 mm) was 
not statistically significantly different from eyes of normal subjects (P= 0.279; t-test). The 
PFW of the synkinetic eye in repose (8.99 mm, SD 1.61 mm) was statistically significantly 
reduced compared with normal subjects (P<0.001; t-test) and compared with the con-
tralateral healthy eye (P<0.001; paired t-test). The degree of eye closure of the healthy 
eye during smiling (12.03%, SD 13.66%) was significantly smaller than the degree of 
eye closure during smile in normal subjects (P < 0.001; t-test). The degree of eye clo-
sure of the synkinetic eye during smiling (32.65%, SD 13.68%) was significantly greater 
than the degree of eye closure during smiling in normal subjects (P<0.001; t-test) and 
greater than the degree of the contralateral healthy eyes (P<0.001; paired t-test). During 
puckering of the lips, 98% of the patients experienced eye closure in the synkinetic eye 
(27.64%, SD 20.33%). The degree of eye closure during puckering in the synkinetic eye 
was statistically significant greater than in normal subjects (P<0.001; t-test) and greater 
than in the contralateral healthy eyes (P<0.001; paired t-test).
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figure 2. Palpebral fissure width in 50 normal subjects (100 eyes) at rest, and while performing smile or 
pucker expressions.
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Symmetry
During smiling, the FACE software reported 91.9% (SD 6.0%) ocular symmetry in normal 
subjects and 69.5% (SD 16.8%) in synkinesis patients: this difference is statistically sig-
nificant (P<0.001; t-test). During puckering, the ocular symmetry was 95.0% (SD 4.3%) in 
normal subjects and 61.7% (SD 18.8%) in synkinesis patients; this difference is statisti-
cally significant (P<0.001; t-test).
modified application of the Gfps
During smiling, the GFPS reported 94.5% (SD 10.2%) ocular symmetry in normal subjects 
and 85.3% (SD 14.8%) in synkinesis patients: this difference is statistically significant 
(P<0.001; t-test). During puckering, the ocular symmetry was 94.4% (SD 8.4%) in normal 
subjects and significantly lower (82.2%, SD 15.5%) in synkinesis patients (P<0.001; t-test). 
There was a weak correlation between the degree of ocular synkinesis measured by the 
FACE software and the modified GFPS during either smiling (R=0.251; Pearson correla-
tion) (Figure 3) or puckering (R=0.253; Pearson correlation) in the synkinesis group, and 
reviewing the videographs revealed a significant incidence of missing synkinesis using 
our modification of the GFPS; 100% of synkinesis cases were identified by the FACE 
program, and only 46% by our GFPS modification.
clinical examples
Figure 4 demonstrates an example of ocular synkinesis detected by both programs in a 
particular patient, although less precisely by the modified GFPS. Figure 5 depicts a case 
in which synkinesis was picked up by the FACE program, but missed by the modified 
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figure 3. No correlation was demonstrated between the degree of ocular symmetry measured by the 
modified GFPS application and the FACE software during smiling.
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GFPS. Discrepancies between the 2 programs were found in the clinically less severe 
ocular synkinesis cases. No discrepancies between programs were found in normal 
subjects.
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figure 4. Ocular region of a patient in repose, smile and, pucker; the ocular synkinesis of the right eye 
during mouth movements was reported by the FACE software and the modified application of the GFPS, 
although not accurately by the second, as shown at right.
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figure 5. Ocular region of a patient in repose, smile, and pucker; ocular synkinesis of the left eye during 
mouth movements that is clear in the photographs and detected by the FACE program, was not detected 
by the modified application of the GFPS, as shown right.
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Discussion
In the current study, we report use of the FACE software in the assessment of ocular 
synkinesis, and demonstrate it to be a sensitive and accurate reporter. Our modified ap-
plication of the GFPS did not appear to be a reliable method to assess ocular synkinesis. 
Though the GFPS software is capable of distinguishing a group of normal subjects from 
patients with ocular synkinesis, the program was not found to be reliable for the quan-
titative assessment of the individual ocular synkinesis patient. In the literature, several 
automated facial measurement systems are described; none is universally accepted due 
to significant drawbacks associated with each. Some methods employ markers18-22 or 
reference scales taped to the face23; others are time consuming and complex21, 24, 25, or 
require head fixation26. With the lack of a gold standard assessment technique, mean-
ingful comparison of results among different institutions is not feasible. Focusing on the 
treatment of ocular synkinesis, an objective and widely accepted method would greatly 
facilitate assessment of results of treatment with botulinum toxin, physical therapy, and 
surgical interventions. The ideal assessment method for synkinesis should be objective, 
reliable, simple, rapid, inexpensive, and internationally applicable. The FACE software 
has previously been shown to be objective and reliable, easy to use, free, and interna-
tionally applicable.11, 15 The GFPS also possesses these characteristics for the assessment 
of facial paralysis, although in this study it was not found to consistently identify ocular 
synkinesis, using our modification. An important advantage of the GFPS over the FACE 
program is the completely automated process; there is no need for manual selection of 
measurement points. Though not reliable for synkinesis assessment in this study, it is pos-
sible that the GFPS software could be altered to address synkinesis specifically, thereby 
improving reliability and accuracy. The primary disadvantage of both approaches in this 
manuscript is that linear measurements on an image do not thoroughly characterize 
complex 3 dimensional facial movements, though they are sufficient for PFW calcula-
tions.27, 28 Herein, we have demonstrated that the FACE program is a sensitive reporter of 
ocular synkinesis. We found that there was a smaller degree of eye closure during smile 
in the healthy eye of synkinesis patients, compared to normal subjects. This is likely due 
to physical therapy, during which patients are taught to keep the synkinetic eye open 
during different facial movements, leading to an increased opening of the healthy eye 
during the same movements. Another explanation is that these patients have learned to 
smile with less force than normal subjects in order to avoid obvious synkinetic motion, 
and as a consequence have less eye closure during smiling.
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conclusion
The FACE program yields rapid results, correlates high with clinical observations, and 
when combined with a subjective self-assessment questionnaire, yields a compre-
hensive measure of ocular synkinesis. Our modified application of the GFPS appeared 
not to be reliable in the assessment of ocular synkinesis. Further development of 3D 
analysis may lead to a gold standard instrument for assessment of synkinesis and facial 
paralysis in general, though the FACE software is straightforward and already universally 
applicable.
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AbstrAct
Objective: To evaluate three-dimensional stereophotogrammetry as an objective assess-
ment tool for oral synkinesis in patients with peripheral facial palsy.
Methods: Participants were recruited at the Otorhinolaryngology outpatient clinic of 
the Radboud university medical center between March 2013 and July 2013. Inclusion 
criteria listed: age 18 years or older, a history of unilateral peripheral facial palsy, and the 
presence of oral synkinesis associated with eyelid closure. Control subjects were aged 
18 years or older, with a normal facial nerve function and no history of facial paralysis 
or perioral reconstructive surgery. In the control group both sides of the face were in-
cluded for analysis. Main outcome parameter was the mean absolute error of distances 
between corresponding surfaces of three-dimensional photographs in repose and dur-
ing gentle eyelid closure. This measure represented change in facial soft tissue surface 
of the perioral region during eyelid closure.
Results: 15 patients and 8 control subjects were included in this study. The mean abso-
lute error of distances was 0.413 mm (SD 0.116 mm) in the patient group and 0.302 mm 
(SD 0.051 mm) in the control group. Mean difference between patients and controls was 
0.112 mm (95% CI, 0.044 – 0.180 mm). This difference was statistically significant (p = 
0.003, t-test).
Conclusions: Three-dimensional stereophotogrammetry resembles an objective, simple, 
and non-invasive method for assessment of oral synkinesis. This assessment tool seems 
particularly suitable for use in research settings, for example to compare (treatment) 
outcomes in groups of patients, both within and among clinics.
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introDuction
Patients with facial palsy have to face myriad sequelae; esthetic disfigurement, oral 
incompetence, articulation problems, social isolation, exposure keratitis, and synkinesis. 
Synkinesis is defined as involuntary movement of certain muscles during voluntary 
movement of others, for example displacement of the corner of the mouth during 
eyelid closure. The most commonly held pathophysiologic theory behind synkinesis 
is misrouting of axons during the regeneration phase of the facial nerve after injury.1 
Treatment options for synkinesis exist of physical therapy,2, 3 botulinum toxin injections4 
and few surgical interventions.5, 6
Assessment of facial (dys)function is essential, starting at first presentation; initially 
to evaluate the severity of the paresis or synkinesis, and during follow-up to evaluate 
the natural improvement or effect of treatment options. Traditionally, assessment of the 
face is performed by a clinician, using different grading scales. Various grading systems 
exist to assess facial function; the House-Brackmann grading scale being the gold 
standard.7 Nowadays more attention is paid to the patient’s judgment as well, using self-
assessment questionnaires. For example, the FaCE Scale Instrument,8 and specifically for 
synkinesis the Synkinesis Assessment Questionnaire.9
These clinical grading scales and self-assessment questionnaires are all subjective 
measurements. Objective assessment is needed as well; to show evidence of treatment 
options and to be able to make fair comparison of outcomes among centers. The last 
three decades several computerized assessment programs have been developed, 
almost all using two-dimensional (2D) images of faces.10-18 Taking into account that our 
face moves in three directions, few three-dimensional (3D) systems have been studied 
as well.19-24 So far, none of these methods is universally accepted due to drawbacks as-
sociated with each.19, 25, 26
The aim of this study was to evaluate 3D stereophotogrammetry as an objective as-
sessment tool for oral synkinesis in patients with peripheral facial palsy.
methoDs
ethical considerations
The study protocol was assessed according to guidelines of the local committee on 
research involving human subjects; no formal ethical review was required. However, the 
study was conducted in accordance with principles of Good Clinical Practice. Informed 
consent was obtained before subjects were enrolled in the study.
The study was designed as a prospective, comparative analysis of the diagnostic 
value of 3D stereophotogrammetry in patients with oral synkinesis. Patients and control 
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subjects were recruited at the Otorhinolaryngology outpatient clinic of the Radboud 
university medical center, a tertiary referral center, from March 2013 to July 2013. Adult 
patients (aged 18 years or older) with a history of unilateral peripheral facial palsy, who 
presented with oral synkinesis associated with eyelid closure, were eligible for inclusion. 
Exclusion criteria were: treatment with botulinum toxin type A in the last four months 
and a history of dynamic or static reconstructive surgery influencing the perioral region. 
Facial hair in the region around the mouth (i.e., beard, moustache, or both) limits the 
assessment of perioral surface with 3D stereophotogrammetry27 and was therefore 
considered to be an exclusion criterion for both the patient and control group. Inclusion 
criteria for control subjects were: age 18 years or older with a normal facial nerve func-
tion and no history of facial palsy or perioral reconstructive surgery. It was ensured that 
subjects in the control group matched the patient group, taking gender and age into 
account. Patient characteristics were derived from medical charts; date of birth, gender, 
and start date, side and etiology of the facial palsy, as well as previous treatments. Al-
though synkinesis may occur in different zones of the face, this study was specifically 
designed to assess oral synkinesis to start with, mainly because this region causes the 
least artifact with 3D stereophotogrammetrical analysis.27
objective assessment
Acquisition of 3D photographs of the facial soft tissue surface was performed using a 
2-point 3D stereophotogrammetrical camera setup and the software program Modular 
System (3dMDFace™System, 3dMD LLC, Atlanta, USA). The 3D photographs were cap-
tured in natural head position28; one photograph during repose and another during 
gentle eyelid closure. During acquisition, study subjects were asked to swallow and 
relax their lips subsequently to guarantee that the basic position of the mouth was 
comparable in both images. Surface-based registration of 3D photographs was per-
formed using Maxilim™ software (version 2.3.0.3, Medicim NV., Mechelen, Belgium).29 
First, error regions of the photograph (hair and clothing) were excluded manually. In 
both photographs three points (lateral corner of the eye, tip of the nose and the lowest 
point of cupid bow of the upper lip) were marked for a first rough matching of the two 
photographs. The Maxilim™ software uses an adapted version of the iterative closest 
point algorithm to perform surface-based registration: a way to find the closest point 
on the to be matched photograph to a given point on the reference photograph, ap-
proximately 30,000 points are used.30, 31 The 3D photograph in repose was used as a 
reference, on which the 3D photograph with gentle eyelid closure was superimposed. 
This is schematically illustrated in Figure 1.The accuracy of this method to evaluate facial 
changes has been demonstrated by Maal et al.29 The perioral region was isolated using 
a limited cephalometric analysis, as shown in Figure 2. The upper part of the alar lobule 
and the labiomental fold used as reference points in constructing the superior and infe-
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rior border of the perioral region were validated in our pilot study (unpublished data). In 
this pilot study, intra-observer reliability was determined by identifying reference points 
twice with a time interval of two weeks, to prevent memory effects. Intra-observer 
variation was 0.04 mm, which fell within acceptable margins as defined in previous 
studies.32, 33 Other reference points used in isolating the perioral region had already 
been validated by Van Loon et al.34 Acquisition and analysis of 3D photographs were 
performed by the same researcher (MvE), preventing inter-observer bias. After isolating 
   
figure 1. Schematic illustration of surface-based registration of 3D photographs. Panel a. 3D photograph 
in repose. Panel b. 3D photograph with gentle eyelid closure. Panel c. Combining both 3D photographs us-
ing surface-based registration; showing a distance map in which differences in corresponding surfaces are 
highlighted in red and green. Since 3D photographs of a healthy control subject are shown, no change in 
the perioral region can be observed, only eyelid closure is represented in green.
 
figure 2. Isolation of the perioral region using four planes. The transverse plane through the exocanthion 
of both eyes (A) was used as a reference, parallel to which planes B and C were constructed. Superiorly, the 
perioral region was bounded by a transverse plane through the upper part of the alar lobule (B). The inferior 
border was constructed using a transverse plane through the most posterior part of the chin, located in the 
labiomental fold (C). Medially, the perioral region was bounded by a sagittal plane running through the 
midline of the face (D). The lateral border matched the outline of the mandible.
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the perioral region, the difference between corresponding surfaces could be computed. 
These calculations were performed using Matlab® (7.4.0 (R2007b) Mathworks, Natick, 
MA, USA). The mean absolute error, 50th and 95th percentile of distances between 
corresponding surfaces of 3D photographs in repose and during gentle eyelid closure 
were calculated. Main outcome parameter was the mean absolute error of distances, 
representing change in facial soft tissue of the perioral region during eyelid closure.
subjective assessment
In the patient group, the degree of facial palsy and facial synkinesis were subjectively 
evaluated using the House-Brackmann Grading Scale7 and the Sunnybrook Facial Grad-
ing System.35 To avoid inter-observer bias, all patients were subjectively assessed by the 
same clinician (CB) with extensive experience in this field.
statistical analyses
Sample size calculation was performed using data of our pilot study in 9 patients and 5 
control subjects. This pilot study showed that the mean absolute error of distances in the 
patient group (0.554 mm) was higher than in the control group (0.209 mm) (unpublished 
data). We performed a sample size calculation using the difference of 0.345 mm and a 
standard deviation of 0.194 mm. With an α of 0.05 and a power of 90% (1-β), the sample 
size needed to be at least 14 patients to demonstrate a statistically significant difference 
between the patient and control group. In the unaffected face both sides could be used 
for analysis. Therefore a minimum of 7 control subjects was required. Data of the current 
study were analyzed using a two-tailed independent samples t-test to compute the 
difference between patients and controls. A two-tailed Pearson correlation coefficient 
was calculated to measure the relationship between outcomes of objective assessment 
of oral synkinesis and subjective scores derived from the Sunnybrook Facial Grading 
System. For all statistical testing, significance level was set at p<0.05. Data collection 
and statistical testing was performed using IBM SPSS Statistics 20.0 software (IBM Inc, 
Armonk, NY, USA).
results
participants’ characteristics
A total of 15 patients and 8 control subjects were included between March 2013 and July 
2013. All participants gave their informed consent. Table 1 shows the characteristics of 
both patients and control subjects. Facial palsy was right sided in 9 cases (60.0%) and left 
sided in 6 cases (40.0%). Most patients suffered from synkinesis after Bell’s palsy (46.7%) 
or Ramsay Hunt syndrome (40.0%), the other two patients had Lyme disease and iatro-
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genic facial palsy. Mean time that had elapsed since onset of facial palsy counted 1 year 
and 10 months (ranging from 6 months up to 6 years). No data were available concern-
ing the first development of synkinesis. All patients had already undergone treatment 
for facial palsy, facial synkinesis, or both; including, but not exclusive to: prednisone, 
antiviral drugs, mime therapy, and botulinum toxin.
objective assessment
Acquisition of 3D photographes took approximately 5 minutes per study subject, most 
of the time being spent on instructing and positioning the subject. Processing of 3D 
photographes was performed in about 15 minutes per subject, by an experienced user 
of the software.
In the patient group, mean absolute error of distances in the perioral region of the 
affected side of the face was 0.413 mm (SD 0.116 mm). In the control group, mean abso-
lute error of distances was 0.302 mm (SD 0.051 mm). Mean difference between patients 
and controls was 0.112 mm (95% CI, 0.044 – 0.180 mm). This difference was statistically 
significant (p=0.003, t-test, unequal variances). An overview of outcomes of objective 
assessment in patients and controls is given in Table 2.
subjective assessment
Twelve patients (80.0%) scored 3 on House-Brackmann Grading Scale for peripheral fa-
cial palsy; two patients (13.3%) scored 2 and one patient (6.7%) scored 4. An overview of 
patients’ scores on Sunnybrook Facial Grading System is given in Table 3. To measure the 
relationship between outcomes of objective and subjective assessment, a two-tailed 
Pearson correlation coefficient was calculated. A low correlation was found between 
table 1. Participants’ characteristics
Patients Controls
Number 15 8
Mean age [range] (years) 49 [31-72] 45 [38-55]
Gender
 Female (%) 12 (80.0) 5 (62.5)
 Male (%) 3 (20.0) 3 (37.5)
table 2. Overview of outcomes of objective assessment
Patients Controls
Mean absolute error of distances (mm) 0.413 0.302
Standard deviation (mm) 0.116 0.051
Mean 50th percentile (mm) 0.328 0.254
Mean 95th percentile (mm) 1.084 0.735
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mean absolute error of distances and total scores on Sunnybrook Facial Grading System 
(R = 0.294, Pearson correlation). A similar result was found when comparing mean abso-
lute error of distances with synkinesis score (R = 0.290, Pearson correlation). When only 
scores on gentle eyelid closure were taken into account, a slightly higher correlation was 
found (R = 0.475, Pearson correlation), meaning that a higher Sunnybrook synkinesis 
score on eyelid closure tends to correlate with a higher mean absolute error of distances, 
both indicating a more severe form of oral synkinesis.
Discussion
synopsis of key findings
The aim of this study was to evaluate 3D stereophotogrammetry as an objective as-
sessment tool for oral synkinesis in patients with peripheral facial palsy. We examined 
whether the change in facial soft tissue of the perioral region due to oral synkinesis 
table 3. Overview of scores on Sunnybrook Facial Grading System
Mean SD Range
Total Score 46 15 20-65
Synkinesis Score 8 2 5-12
Synkinesis Score on gentle eyelid closure 1 1 1-3
SD = standard deviation.
 
 
figure 3. Distance map of a healthy control subject (a) versus a patient with oral synkinesis (b). Differences 
in corresponding surfaces between the 3D photograph in repose and the 3D photograph with gentle eye-
lid closure are highlighted in red and green. In Panel b the change in facial soft tissue surface of the perioral 
region due to oral synkinesis is clearly visualised, whereas in Panel a no differences in de perioral region 
can be observed.
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could be quantified using 3D stereophotogrammetry. It was shown that the mean ab-
solute error of distances between 3D photographs in repose and during gentle eyelid 
closure was statistically significantly higher in patients than in controls. This indicates 
that patients experienced a larger change in perioral soft tissue during eyelid closure, 
compared to healthy control subjects. To the best of our knowledge this is the first study 
to describe 3D stereophotogrammetry for the assessment of oral synkinesis.
comparison with other studies
In the past, significant efforts have been made to develop objective assessment tools 
for facial palsy and facial synkinesis. Although several objective evaluation methods 
are described in the literature, each of them is associated with drawbacks that hamper 
implementation in clinical practice.19, 25, 26 Reducing the amount of time needed for 
analysis poses one major challenge. For example, the Peak Motus Motion Measurement 
System36 requires approximately 1.5 to 2 hours per patient. Tzou et al. updated their 3D 
video system for facial motion analysis in 2005, but still a considerable 3 to 4 hours time 
was needed for the complete analysis procedure in one patient.25 In the current study, 
the complete procedure took approximately 20 minutes per study subject, during which 
presence of the subject was required for only 5 minutes, with image capturing taking 
only 2 milliseconds.
Another drawback being mentioned repeatedly is the need of markers10, 13, 17, 22, 37 or 
reference scales18 on the patient’s face. 3D stereophotogrammetry does not require any 
of these, making it a relatively simple and non-invasive assessment tool. However, some 
experience with the software is required to analyze 3D photographs in the time frame 
stated above.
Although analyses in this study were performed by the same researcher to eliminate 
any potential inter-observer bias, previous studies have shown that 3D stereophoto-
grammetry is a reliable method for soft tissue analysis, with an acceptable intra-observer 
and inter-observer variability.19, 30, 32-34 This suggests that the number of observers does 
not have to be limited to one for the use of 3D stereophotogrammetry in daily practice.
The cost of 3D imaging systems are currently the biggest deterrent, limiting the avail-
ability of this technique in clinical settings, with costs ranging from $50,000 to $70,000 
dollar (not including software).38 When our 3D lab was setup in 2005, the sole hardware 
cost around €50,000 (approximately $66,000).
In 2000, Coulson et al. showed that in the healthy face significantly more anterior-
posterior than horizontal displacement arises during facial expression (the most dis-
placement occurring in the vertical plane).20 Sawyer et al. have shown similar results in 
their 3D analysis of the healthy smile.19 These results emphasize the importance of using 
3D imaging techniques in the assessment of facial function, since anterior-posterior 
displacement cannot be evaluated using 2D photographs.
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In this study we have shown the change in facial soft tissue in the perioral region dur-
ing eyelid closure, which resembles oral synkinesis. We have not shown the direction or 
vector of the movement. However, in treating synkinesis the direction of the movement 
is of minor importance, since the final goal of treatment lies in the elimination of muscle 
contraction, thereby eliminating the vector as well. In contrast to facial palsy treatment, 
where restoring facial movement is the goal. In those cases a vector is essential for 
evaluation of treatment effects.
It was not possible to compare 3D stereophotogrammetry with an objective measure-
ment tool that is universally accepted, since a gold standard method for synkinesis 
evaluation is lacking. However, when comparing patients to healthy control subjects 
a statistically significant difference was found in mean absolute error of distances. 
This supports the mean absolute error of distances being regarded as a proxy for oral 
synkinesis. Although only a low correlation was found between outcomes of objective 
and subjective assessment methods, this is probably due to the insufficient sample 
size to study this correlation (the current study was not designed to investigate this 
correlation). We estimated that a sample size of about 50 patients is needed to detect 
a moderate relationship (defined as Pearson correlation coefficient 0.5 – 0.7) between 
outcomes of 3D stereophotogrammetry and Sunnybrook scores with 90% power.
clinical applicability of the study
The mean absolute error of distances in our control group coincides the variation within 
a healthy face in rest position demonstrated by Maal et al. in 2010.39 Although the mean 
difference between patients and controls was statistically significant, the absolute value 
was only 0.112 mm. Considering the clinical applicability of this study, the question is 
whether this rather small difference can be of any meaning in the individual patient. 
It appears as though 3D stereophotogrammetry might be more suitable for research 
purposes than for use in clinical practice. However, 12 out of 15 patients scored 1 (slight 
synkinesis) on the Sunnybrook synkinesis score on eyelid closure, whereas the one 
patient with a score of 3 (disfiguring synkinesis) had a mean absolute error of distances 
of 0.647 mm, resembling double the amount of controls. The latter suggests that 3D 
stereophotogrammetry might be more sensitive in severe synkinesis.
We found that 3D stereophotogrammetry was of educational value for patients, since 
differences between patients and healthy controls were clearly visualised in the distance 
map, as shown in Figure 3. This contributed in great extent to patients’ understanding 
of oral synkinesis.
Further research is needed to assess other zones of the face and the responsiveness 
of 3D stereophotogrammetry in the evaluation of treatment effects. Currently we are 
studying the use of 3D stereophotogrammetry to evaluate botulinum toxin treatment 
effects. Another topic of interest is the use of four-dimensional (4D) techniques in 
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analysis of facial movement, thereby including changes over time.40, 41 We expect this 
technique to become increasingly important in the development of objective assess-
ment tools in the future.
Nevertheless, as Frey et al. already stated in 1994, when introducing the International 
Registry for Neuromuscular Reconstruction in the Face42; the assessment of the face 
should comprise three components: (1) clinical grading by the clinician, (2) patient’s 
self-assessment, and (3) objective analysis. We suggest that 3D analysis is superior to 
2D analysis in the assessment of facial function, and that 3D stereophotogrammetry is a 
rapid, simple, and non-invasive tool compared to other techniques.
conclusion
For the assessment of oral synkinesis in patients with peripheral facial palsy, 3D ste-
reophotogrammetry resembles an objective, simple, and non-invasive method. This 
assessment tool seems particularly suitable for use in research settings, for example to 
compare (treatment) outcomes in groups of patients, both within and among clinics. 
In the current age of evidence based medicine and cost-effective therapy decisions, 
objective assessment of treatment effects becomes increasingly important. We can see 
a place for 3D stereophotogrammetry in this field, but future research is needed.
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AbstrAct
Objectives: to describe the health-related quality of life of patients visiting a tertiary re-
ferral center for facial palsy, and to analyze factors associated with health-related quality 
of life, using the FaCE Scale instrument.
Design: retrospective cohort study.
Setting: the Facial Nerve Center at the Massachusetts Eye and Ear Infirmary, a tertiary 
referral center.
Participants: patients with a peripheral facial palsy visiting the center for an initial con-
sultation between August 2007 and June 2012.
Main outcome measures: the total FaCE score and the FaCE social function sub domain. 
Multiple regression models were developed to identify factors associated with the total 
FaCE score and FaCE social function score.
Results: 794 patients with a mean age of 47.0 ± 16.0 years were analyzed in this study, 
of which 59.9% were female. The mean House-Brackmann, Sunnybrook, total FaCE 
and FaCE social function scores were 3.6 ± 1.5, 48.2 ± 21.2, 47.3 ± 19.3, and 55.5 ± 19.2, 
respectively. Increasing age (r = -0.229, p < 0.001) was associated with a lower total FaCE 
score. Female gender (r = -4.422, p = 0.033) and increased duration of palsy (r = -0.018, p 
=0.041) were associated with lower FaCE social function scores.
Conclusions: While counseling patients on what to expect during the recovery process 
after facial paralysis is an important part of any clinical visit, FaCE score correlations sug-
gest that female patients with chronic facial palsy and increased age constitute a patient 
category that may require additional time and attention in order to prevent or mitigate 
psychosocial dysfunction.
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introDuction
The consequences of facial palsy (FP) are both functional and psychosocial, making 
assessment of both aspects essential to comprehensive care of the FP patient. Patients 
require objective examination of facial movement, and subjective evaluation of the 
influence of FP on quality of life. In the current literature, attention is paid primarily 
to clinical grading scales1-3 and objective assessment tools;4-8 few instruments address 
these patients’ psychological and social issues,9-12 even though facial disfigurement as-
sociated with various clinical entities is known to affect psychosocial function.13-15
In 2001, Kahn et al. presented a validated patient-graded instrument for facial 
palsy; the Facial Clinimetric Evaluation (FaCE) Scale. This instrument covers 6 different 
domains; facial movement, facial comfort, oral function, eye comfort, lacrimal control, 
and social function.10 Since its introduction, the FaCE Scale instrument has been used 
to demonstrate the effect of different treatment modalities on health-related quality of 
life (HRQoL); FaCE scores improved statistically significantly after botulinum toxin injec-
tions16, surgical treatment of the periocular complex17, free gracilis transfer in children18, 
and platysmectomy.19 Ng et al. performed a follow-up study on Bell’s palsy patients 
using the FaCE Scale20, and Saito et al. compared FaCE scores in two groups of patients: 
Bell’s palsy and post-operative vestibular schwannoma patients.21 The FaCE Scale has 
been translated and validated into Swedish22, Chinese23 and Dutch24.
The general HRQoL of patients with peripheral FP and its possible contributing factors 
are not well described in the current literature. Most attention to HRQoL is paid to the 
subgroup of patients with cerebellopontine angle pathology with FP.25-27 The objective 
of this study was to describe the HRQoL of patients initially visiting a tertiary referral 
center for facial movement disorders, and to analyze possible predictors of the HRQoL, 
using the FaCE Scale instrument. Insight into possible factors associated with HRQoL 
may inform psychological counseling of these patients as part of comprehensive multi-
disciplinary management.
methoDs
The records of all peripheral FP patients who visited the Facial Nerve Center at the 
Massachusetts Eye and Ear Infirmary (MEEI) for an initial consultation between August 
2007 and June 2012, and who completed the FaCE questionnaire, were retrospectively 
reviewed. Patients younger than 14 years of age or with segmental FP were excluded 
because the FaCE Scale has not been validated in pediatric patients and because seg-
mental paralysis does not lend itself to quantification using widely-utilized facial palsy 
scales, such as the House-Brackmann scale. Age, gender, side of palsy, duration of palsy, 
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etiology, previous treatment, House-Brackmann score, Sunnybrook score, and FaCE 
scores were extracted from their medical records.
ethical considerations
This study was conducted with approval from the MEEI institutional review board (pro-
tocol number 12-072H).
face scale
The FaCE Scale is a validated, disease-specific quality of life instrument including 15 
items, each to be answered using a 5-point Likert scale, with 1 indicating the lowest 
possible score and 5 the highest. The instrument consists of 6 sub domains: facial move-
ment, facial comfort, oral function, eye comfort, lacrimal control, and social function. The 
total score ranges from 0 (worst score) to 100 (best score). The instrument was validated 
by Kahn et al. in 2001.10
statistical Analysis
Over the course of the study, patient data were iteratively entered into a statistical da-
tabase (SPSS 20.0, © IBM Inc, Armonk, NY, USA). Descriptive statistics were computed to 
provide a general overview of the sample population. Bivariate statistics were computed 
to identify significant associations between the predictor variables and measures of 
quality of life. Age and duration of palsy were analyzed by Pearson correlation. Gender, 
laterality (uni- or bilateral), and prior treatment were analyzed using a t-test, since these 
variables are dichotomous. Side of palsy and etiology were analyzed using an analysis of 
variance test, since these variables are ordinal. Associations in analyses with p ≤ 0.15, as 
well as biologically relevant measures (age and gender) were used to construct regres-
sion models, which were used to compute adjusted associations between the predictors 
and FaCE scores. Two different multiple regression models were developed, since we 
were interested in factors associated with the total FaCE score as well as the social func-
tion sub domain. Correlations between clinical grading scales and the FaCE score were 
assessed using a Spearman correlation coefficient (House-Brackmann), and a Pearson 
correlation coefficient (Sunnybrook). A p-value <0.05 was considered to be statistically 
significant.
results
Between August 2007 and June 2012, 794 patients visited the MEEI Facial Nerve Center 
with a weakness or palsy in all divisions of the face, unilateral or bilateral, and completed 
the FaCE questionnaire. Patient characteristics are presented in Table 1. The most com-
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mon etiology was Bell’s palsy (44.4%), followed by acoustic neuroma surgery (12.5%), 
other etiologies included Ramsay-Hunt syndrome, Lyme disease, facial nerve tumors, 
malignant head and neck tumors, brain tumors, trauma, congenital and iatrogenic 
causes. Seventy-two percent of the patients had received no form of treatment prior to 
presentation to our center (excluding steroids and antivirals); the other 28% had under-
gone treatments including, but not limited to: acupuncture, physical therapy, botulinum 
toxin chemodenervation, electrical stimulation, nerve grafting, static periocular reani-
mation, and muscle transfer.
table 1. Patient characteristics
N 794
Gender
 female 59.9%
 male 40.1%
Age (years)
 mean (SD) 47.0 (16.0)
 range 14-89
Side
 right 50.7%
 left 44.5%
 bilateral 4.8%
Time since onset
 25% percentile (months) 3
 50% percentile (months) 12
 75% percentile (months) 48
 range (years) 0-72
House-Brackmann score
 mean (SD) 3.6 (1.5)
 I 3%
 II 27%
 III 26%
 IV 14%
 V 12%
 VI 18%
Sunnybrook score (n=188)
 mean (SD) 48.2 (21.2)
 range 9-98
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face score
Total FaCE score and sub domain scores are presented in Table 2. Facial Movement was 
associated with the lowest mean score (33.0) and Social Function the highest (55.5).
multivariate regression models
Table 3 demonstrates the associations between the predictor variables and total FaCE 
score. A multiple linear regression model was built using the dependent variables age, 
gender, duration of palsy, and etiology. The model correlation coefficient (R2) was 0.038 
(p < 0.001). In this model, age (p < 0.001, R = -0.229) was associated with total FaCE score; 
a higher age was associated with a lower FaCE score (Figure 1).
social function
Table 3 also presents the individual analyses of each possible predictor variable for FaCE 
social function score. A multiple linear regression model was constructed to include the 
dependent variables age, gender, duration of palsy, and etiology. The regression correla-
table 2. FaCE score sub domains
mean (SD)
Facial Movement 33.0 (25.6)
Facial Comfort 49.6 (30.3)
Oral Function 50.7 (32.1)
Eye Comfort 44.8 (31.7)
Lacrimal Control 51.2 (33.4)
Social Function 55.5 (27.9)
Total Score 47.3 (19.2)
table 3. Possible predictors of FaCE score and social function sub domain
Possible predictor (x) FaCE social function
coefficient p-value coefficient p-value
Age -0.229 < 0.001* -0.085 0.327*
Gender -1.312 0.514* -4.422 0.034*
Side of palsy n/a 0.777 n/a 0.529
Uni- or bilateral palsy n/a 0.523 n/a 0.616
Duration of palsy 0.007 0.150* -0.018 0.097*
Etiology 0.171 0.000* 0.468 0.002*
Prior treatment n/a 0.364 n/a 0.934
* Possible predictors included in the multivariate regression model (p ≤0.15 or biologically relevant). FaCE 
= total FaCE score, social function = FaCE social function score, n/a = not applicable
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tion coefficient (R2) was 0.016 (p = 0.016). Gender (p = 0.033, R = -4.422) and duration of 
palsy (p = 0.041, R = -0.018) were found to be associated with FaCE social function. With 
a longer duration, the FaCE social function score was worse. Female patients had a lower 
FaCE social function score (53.5) than men (57.8) (Figure 2).
correlations
A correlation of -0.373 was found between the FaCE score and the House-Brackmann 
score (p < 0.001, Spearman correlation). A higher correlation was found between the 
House-Brackmann and the Facial Movement sub domain of the FaCE score; R = -0.569 
(Spearman correlation). These correlations are negative because of the arrangement 
of the House- Brackmann grading system; where 1 represents normal function and 6 
complete palsy. A correlation of R = 0.488 was found between the FaCE score and the 
Sunnybrook score (p < 0.001, Pearson correlation) (Figure 3).
Discussion
synopsis of key findings
To the best of our knowledge, this is the largest series to describe FaCE scores in patients 
with peripheral FP; providing a baseline of HRQoL at initial consultation at a tertiary 
facial nerve referral center. In the current literature, there is no consensus on possible 
predictors of HRQoL in facial palsy. In this study, we found that age was inversely as-
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figure 1. Correlation between age and total FaCE score. R = -0.229, p < 0.001.
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sociated with the total FaCE score, and gender and duration of palsy were associated 
with the FaCE social function score. Lee et al. found that age, gender, and severity of 
FP were not statistically significant factors predicting the FaCE social function score in 
their group of 28 patients.25 Ryzenman et al. studied a large cohort of patients with FP 
after acoustic neuroma surgery (1,595 patients), they found that females and younger 
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figure 2. Female patients have a statistically significantly worse FaCE social function score than male pa-
tients (p = .033).
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figure 3. Correlation between FaCE score and Sunnybrook score. R = 0.488 p < 0.001 (Pearson correlation).
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patients felt more affected by FP or eye problems and were less satisfied with their ap-
pearances.27 In a study by Fu et al, females had significantly higher levels of anxiety when 
compared with males, but similar levels of depression; no significant associations were 
found between clinical severity of the FP and levels of distress.28
Patient characteristics that did not appear to be associated with FaCE scores in this 
study were the side of the palsy, if the palsy was uni- or bilateral, the etiology, and if 
the patient had received prior treatment. Pouwels et al. investigated whether patients 
prefer their true or mirror image when having a right- or left-sided palsy. They found that 
patients with a right-sided palsy choose their true image in 70% of the cases compared 
to 10% of the patients with a left-sided palsy.29 Borod et al. reviewed the literature on 
facial asymmetry during emotional expression; the majority of studies found more 
profound emotional expression in the left hemiface.30 Based on these results it could be 
hypothesized that patients with a left sided palsy have a lower total FaCE score, and/or 
FaCE social function score. In this study no statistically significant differences were found 
among right-sided, left-sided, or bilateral palsies.
In this study, only 4.8% of the patients (n = 38) suffered bilateral FP, making comparison 
between uni- and bilateral palsy statistically insignificant. Moebius syndrome patients 
constitute a well-studied group of patients with bilateral FP; however, a comparison 
between patients with unilateral FP and Moebius patients would be skewed due to the 
fact that Moebius patients have congenital FP, while the vast majority of unilateral FP 
patients have acquired palsy. Bogart et al. suggest that patients who have been living 
with FP their whole lives may be better adjusted than people with acquired conditions.29
Etiology was not correlated with FaCE scores in this study. As mentioned above, the 
current literature addresses quality of life in the specific subgroup of cerebellopontine 
angle pathology, but not specifically in other conditions. When compared to the mean 
total FaCE score in our group we do not find significant differences with this specific 
etiology.24
As expected, we found a high correlation between the Sunnybrook score and the FaCE 
score (Figure 3, R = 0.488, P < 0.001). The House-Brackmann score had a statistically 
significant correlation with the FaCE score as well (R = -0.373, P < 0.001). These correla-
tions mean that patients that are assessed by a clinician to have a worse facial function, 
are likely to have more psychosocial problems. Underlining this fact was however not 
the purpose of this study.
strengths of the study
To date, this is the largest series describing FaCE scores in patients with peripheral FP, 
offering valuable information on health-related quality of life in this entity. The large 
amount of patients provides us a reliable insight in quality of life in FP, and the various 
factors analyzed give us a tool for psychological counseling. While the current study did 
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not focus on the effect of management and treatment options, the effect of different 
treatment options on HRQoL is an extremely important topic in modern medicine; not 
only do clinicians apply this information when formulating management strategies and 
when discussing prognosis with patients, but third party payers consider these data 
when deciding on reimbursement criteria.30 Several studies on treatment effects using 
the FaCE Scale have been performed.16-19
limitations of the study
Not all patients, who visited our facial nerve center between August 2007 and June 2012 
and matched the inclusion criteria, completed the questionnaire. Patients who did not 
complete the questionnaire visited our center before we had a systematic way of col-
lecting the scores, or during a period where office staff was turning over so there was 
inconsistency in data collection, or when people were seen and operated upon on the 
same day. In the last case they did not present through the normal avenues and by the 
time they came again, they were already a follow-up patient, and thus did not get the 
initial survey. Missing data because of the first two reasons are very random, and we do 
not expect that much bias because of this. Patients operated on the same day are mainly 
emergency patients, in which we do not expect a change in quality of life because of the 
facial palsy yet.
clinical applicability of the study
Management of patients with peripheral FP is ideally performed in a multidisciplinary 
fashion, with otolaryngologists, facial and plastic surgeons, ophthalmologists, physical 
therapists, speech therapists, and specialized chemodenervation nurses involved.31 A 
psychologist, specialized in the psychosocial consequences of FP, may further complete 
the multidisciplinary team. We recommend psychological counseling for all patients 
suffering FP in order to ameliorate potential psychosocial dysfunction, and the current 
analysis demonstrates that female patients with more chronic FP and increased age are 
more at risk, based upon their lower FaCE scores.
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AbstrAct
Objective: To validate an existing health-related quality of life questionnaire for patients 
with facial palsy for implementation in the Dutch language and culture.
Methods: The Facial Clinimetric Evaluation Scale was translated into the Dutch language 
using a forward-backward translation method. A pilot test with the translated question-
naire was performed in 10 patients with facial palsy and 10 normal subjects. Finally, 
cross-cultural adaption was accomplished at our outpatient clinic for facial palsy. Analy-
ses for internal consistency, test-retest reliability, construct validity and responsiveness 
were performed.
Results: Ninety-three patients completed the Dutch Facial Clinimetric Evaluation Scale, 
the Dutch Facial Disability Index, and the Dutch Short Form (36) Health Survey. Cron-
bach’s α, representing internal consistency, was 0.800. Test-retest reliability was shown 
by a intraclass correlation coefficient of 0.737. Correlations with the House-Brackmann 
score, Sunnybrook score, Facial Disability Index physical function and social/well-being 
function were r=-0.292, r=0.570, r=0.713, and r=0.575 respectively. The SF-36 domains 
correlate best with the FaCE social function domain, with the strongest correlation 
between the both social function domains (r=0.576). The FaCE score did statistically 
significantly increase in 35 patients receiving botulinum toxin type A (P=0.042, Student 
t-test). The domains ‘facial comfort’ and ‘social function’ improved statistically significant 
as well (p=0.022 and p=0.046 respectively, Student t-test).
Conclusions: The Dutch Facial Clinimetric Evaluation Scale shows good psychometric 
values and can be implemented in the management of Dutch-speaking patients with 
facial palsy in the Netherlands. Translation of the instrument into other languages may 
lead to widespread use, making evaluation and comparison possible among different 
providers.
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introDuction
Patients experiencing peripheral facial palsy experience both functional and psychoso-
cial consequences. The evaluation of both aspects is fundamental in the management 
of facial palsy. Among the consequences of peripheral facial palsy are brow ptosis, 
incomplete eye closure (leading to exposure keratopathy), external nasal valve collaps, 
oral incompetence, speech and articulation problems, synkinesis (involuntary move-
ment during voluntary movement), esthetic impairments, and the inability to express 
emotions, sometimes leading to social isolation.
Assessment of facial function in peripheral facial palsy comprises different perspec-
tives; evaluation by a physician using grading scales1, 2, objective (sometimes automated) 
measurement methods3-5, and patient self-assessment using questionnaires. In an era 
of rapid developments in computerized, automated measurement tools, the influence 
of the disease on the patient’s quality of life must not be overlooked, and should be 
considered an essential feature of clinical assessment, and remains important during 
first consultation, during follow-up, and after treatment.
The self-assessment of patients using questionnaires gives an impression of the influ-
ence of disease on quality of life. For this purpose, non-disease specific questionnaires 
exist6, 7, as well as disease-specific questionnaires, though very few of them are adapted 
in regular clinical practice. Kahn et al. developed an instrument which covers both the 
functional and psychosocial aspect of facial nerve palsy, the Facial Clinimetric Evalua-
tion Scale (FaCE Scale).8 This questionnaire consists of 15 questions with a 5-point Likert 
scale. The FaCE Scale comprises six domains; facial movement, facial comfort, oral func-
tion, eye comfort, lacrimal control and social function. Total and domain scores range 
from 0 (worst) to 100 (best).
The FaCE Scale is a valid, reliable, and easily administered instrument.8 Since its original 
description, this questionnaire has been used in several studies showing patient satis-
faction following treatment.9-12 We wanted to implement this instrument in the Dutch 
speaking population in the Netherlands, both because we want to use an instrument 
that covers both functional and psychosocial domains, and also so that we may compare 
our treatment and recovery results with international results.
In the current literature there is no consensus on ‘gold standard’ guidelines for trans-
lating quality of life questionnaires. Two methods are described; the forward-backward 
translation13-15 and the dual panel translation.16 Dual panel translation compromises the 
translation by a team of translators working together and assessment of the transla-
tion by a lay panel.17 The forward-backward translation seems to be the most accepted 
method; although there is no evidence to support this view. Acquadro et al. performed a 
literature review in 2008; they did not find evidence in favor of one method, but strongly 
advised researchers to adopt a multistep approach.17 When using a questionnaire in 
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another country and another language, translation of the items alone is not enough. 
The items must be adapted to the new culture to maintain the content validity of the 
instrument: cross-cultural adaption is required.18, 19
The aim of this study was to create a Dutch version of the FaCE Scale and to test its 
internal consistency, test-retest reliability, construct validity, and responsiveness for a 
valid use in the Dutch language and culture.
mAteriAls AnD methoDs
translation
The study protocol was assessed according to guidelines of the local committee on 
research involving human subjects; no formal ethical review was required.
We approached the developers of the FaCE Scale and obtained permission to use the 
instrument for translation and validation.8 A forward-backward translation approach 
was used in this study (Figure 1). Considerations and difficulties of each step were docu-
mented. Choice of wording and phraseology had to be compatible with a reading level 
of age 14.13 The pilot test was performed in a group of ten patients with a facial palsy and 
ten persons without history of facial disease. Respondents completed the questionnaire 
and were asked about difficulties with answering and understanding the items. After 
this pilot test, final adjustments were made and documented.
Validation
Validation of the Dutch FaCE Scale was performed at our university medical center 
between December 2012 and August 2014. Dutch speaking adult (18 years or older) 
patients with a facial palsy were included. Patients completed three different question-
naires: (1) the Dutch FaCE Scale, and to test construct validity (2) the Dutch Facial Dis-
ability Index (FDI), (3) and the Dutch Short Form (36) Health Survey (SF-36). All responses 
were entered in IBM SPSS Statistics 20 (IBM Corp. Armonk, NY) according to the principle 
of double data entry. In addition, gender, age, etiology, side and duration of the palsy, 
House-Brackmann (HB) scores, and Sunnybrook (SB) scores were collected in the data-
base. This information was retrieved from the medical charts retrospectively, so missing 
data could occur. Patients not receiving any form of treatment were sent the Dutch 
FaCE Scale again after two weeks for test-retest reliability. At the end of the study, to 
increase the response rate for test-retest, patients were send the Dutch FaCE Scale (plus 
FDI and SF-36) two weeks before visiting our clinic and the test-retest was performed 
during their visit, independent in the waiting room. Patients receiving treatment with 
botulinum toxin type A for synkinesis were sent the Dutch FaCE Scale four weeks after 
injection to test the responsiveness of the questionnaire.
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Facial Disability Index
The FDI is a disease-specific quality of life questionnaire for patients with facial palsy, de-
veloped in at the Facial Nerve Center in Pittsburg around 1996 by VanSwearingen et al.20 
The FDI has two domains; physical function and social/well-being function. The physical 
function scores range from -25 (worst) to 100 (best), and the social/well-being function 
scores range from 0 (worst) to 100 (best). This questionnaire has been translated into 
Dutch according to a forward-backward method previously (not published), but has not 
officially been validated for use in the Dutch culture.
The Short Form (36) Health Survey
The SF-36 is a general health-related quality of life questionnaire, consisting of 36 
questions. All questions save one (item 2), are converted in eight domains; physical 
functioning (PF), role limitations due to physical health problems (RP), bodily pain (BP), 
general health perceptions (GH), vitality (VT), social functioning (SF), role limitations due 
to emotional problems (RE), and mental health (MH). The scores range from 0 (worst) to 
 FaCE Scale(Kahn et al. 2001) 
Translation 
into Dutch (1)* 
Translation 
into Dutch (2)* 
Merging to one translation 
by committee# 
Back translation 1  ^ Back translation 2  ^ 
Creation of pilot version after comparison of 
original and back translations by committee# 
Pilot test 
Revision if necessary 
Dutch FaCE Scale  
figure 1. Method of translation in this study. * two in-
dependent translators, both native Dutch with Amer-
ican-English as their second fluent language; one of 
them was a medical doctor. # committee consisting 
of the authors of this manuscript. ^ two independent 
translators; both American from origin with Dutch as 
a second language and blinded for the original ques-
tionnaire; one of them had a medical background.
172 Chapter 4.2
100 (best). This self-report health status questionnaire is the most widely used instru-
ment, and has been translated for use in more than 40 countries (including Dutch).6, 21
Statistical analysis
IBM SPSS Statistics 20 (IBM Corp. Armonk, NY) was used for data collection and statisti-
cal analysis. First, descriptive analyses were performed to show patient characteristics. 
Cronbach’s α coefficient was calculated to test the internal consistency of the Dutch 
FaCE Scale. Intra-class correlation was calculated to analyze test-retest reliability. Cor-
relations between the Dutch FaCE Scale and the HB score, SB score, FDI, and SF-36 were 
calculated using Spearman’s rank correlation coefficient to show construct validity. To 
test responsiveness, a paired samples t-test was performed.22
results
pilot testing
Ten normal subjects, without history of facial disease, completed the pilot version of 
the Dutch FaCE Scale, they all had a FaCE score of 100 (best score). Ten patients with pe-
ripheral facial palsy completed the pilot version of the translated questionnaire as well. 
Subjects did not document any difficulties in understanding or answering the items, and 
no further changes were made in the Dutch FaCE Scale.
Validation
Between December 2012 and September 2014 93 patients completed the Dutch FaCE 
Scale, FDI and SF-36. Patient characteristics are shown in Table 1. The category “other 
etiologies” comprised Lyme disease, congenital facial palsy, traumatic cases, parotid 
malignancies, cholesteatoma, and benign facial nerve tumors. FaCE scores are shown 
in Table 2.
The internal consistency of the Dutch FaCE Scale was tested by Cronbach’s α, which 
showed a value of 0.80. A Cronbach’s α > 0.7 is generally considered acceptable, and α 
> 0.8 as good.22 The Cronbach’s α scores ranged from 0.57 to 0.84 for the FaCE Scale sub 
domains (Table 3). Test-retest reliability was calculated with the intra-class correlation 
coefficient (ICC). Fourty patients met the criteria for test-retest reliability analysis, but only 
21 patients (53%) completed the questionnaires at both time points. Results are shown in 
Table 3. Test-retest reliability was demonstrated with ICC’s ranging from 0.65 – 0.80.
Correlations between the FaCE scores and the FDI, SF-36, HB and SB scores are shown 
in Tables 4 and 5. Correlation with the HB score is negative because of the design of 
the HB (1 is no palsy, 6 is complete flaccid palsy). A Spearman’s correlation coefficient 
of 0.570 for the SB score indicates good construct validity of the Dutch FaCE Scale. As 
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expected, the HB and SB scores show the best correlations with the facial movement 
domain of the Dutch FaCE Scale (r=-0.410 and r=0.603 respectively). The total FaCE score 
correlates well with the FDI physical function and FDI social/well-being function scores; 
r=0.713 and r=0.575 respectively. The FDI social/well-being function has the highest cor-
relation with the FaCE social function domain (r=0.729). The FDI physical function has 
the highest correlation with the FaCE oral function domain (r=0.661). The SF-36 domains 
correlate best with the FaCE social function domain, with the strongest correlation be-
tween the both social function domains (r=0.576). FaCE domain facial movement shows 
the weakest correlations with the SF-36. Since the SF-36 is a general health-related 
questionnaire, strong correlations were not expected.
table 1. Patient characteristics
n % mean SD median range
Gender
 female 61 66
 male 32 34
Age (years) 55.1 13.8 55 20-89
Side
 left 43 46
 right 47 51
 bilateral 3 3
Time since onset (months) 45 52 29 4-298
Etiology
 Bell’s Palsy 48 52
 Ramsay Hunt 16 17
 iatrogenic 7 8
 acoustic neuroma 6 7
 other 16 16
House-Brackmann 3.3 1.2 3.0 1-6
Sunnybrook 45.9 20.4 49.0 0-83
table 2. FaCE Scores (total and domains)
mean SD median range n
Total Score 44.6 16.4 46.7 3-87 83
Facial Movement Score 33.0 22.3 33.3 0-83 81
Facial Comfort Score 32.2 25.6 25 0-100 83
Oral Function Score 45.6 27.1 50 0-100 83
Eye Comfort Score 41.8 33.6 43.8 0-100 82
Lacrimal Control Score 47.4 28.7 50 0-100 78
Social Function Score 62.3 26.1 62.5 0-100 83
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Responsiveness
Thirty-five patients received treatment for synkinesis with botulinum toxin A. Nineteen 
of them (54%) had received botulinum toxin previously, and the other 46% were new 
to this treatment. Total FaCE score before treatment was 44.7 (SD 15.0) and about four 
weeks after treatment 48.5 (SD 15.2). This difference is statistically significant (P = 0.042, 
Student t-test). The domains ‘facial comfort’ and ‘social function’ improved statistically 
significantly as well (p=0.022 and p=0.046 respectively, Student t-test).
table 3. Internal consistency reliability and test-retest reliability
Internal consistency Test-retest
Cronbach’s α ICC 95% CI
test retest
Total Score 0.80 0.81 0.737 0.463-0.883
Facial Movement Score 0.64 0.54 0.653 0.322-0.843
Facial Comfort Score 0.84 0.77 0.802 0.564-0.917
Oral Function Score 0.79 0.90 0.700 0.341-0.872
Eye Comfort Score 0.57 0.43 0.747 0.472-0.891
Lacrimal Control Score # # 0.741 0.427-0.895
Social Function Score 0.75 0.85 0.674 0.350-0.854
ICC = intraclass correlation coefficient, CI = confidence interval, # this sub domain has only one item, for 
internal consistency n= 93, for test-retest reliabilty n = 21.
table 4. Correlation between FaCE scores with House-Brackmann scores, Sunnybrook scores, and Facial 
Disability Index (Spearman’s correlation coefficient)
House-Brackmann Sunnybrook FDI physical 
function
FDI social/well-being 
function
FaCE scores n=62 n=54 n=92 n=92
Total -0.292* 0.570** 0.713** 0.575**
Facial movement -0.410** 0.603** 0.310** 0.062
Facial comfort 0.134 0.086 0.443** 0.318**
Oral function -0.222 0.385** 0.661** 0.365**
Eye comfort -0.226 0.475** 0.367** 0.108
Lacrimal control 0.006 0.128 0.247* 0.180
Social function -0.119 0.323* 0.477** 0.729**
** P < 0.01, * P < 0.05
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Discussion
In this study, the FaCE Scale has been translated and validated for use in the Netherlands. 
Good psychometric values for the Dutch version of the self-assessment questionnaire 
are shown. The internal consistency of the Dutch FaCE Scale is reflected by a Cronbach’s 
α of 0.80. The internal consistency of the Swedish and German translations show a 
Cronbach’s α of 0.92 and 0.91 respectively.23, 24 A possible explanation for this difference 
might be a different patient population used in the different studies. We compared our 
patient characteristics with the Swedish and German study, and they match highly. 
Other methodological differences between studies can explain different outcomes as 
well, for example if questionnaires were completed individually or in company of a phy-
sician. We consider our internal consistency as good, as well as the test-retest reliability, 
and construct validity.
strength of this study
Translation of the FaCE Scale into the Dutch language, and validation for use in the 
Dutch culture were performed according to the highest standards for translation of self-
assessment questionnaires.14, 19, 25
limitations of this study
Translators (forward and backward) were not professional translators, nor experienced 
in questionnaire translation, nor familiar with the questionnaire. During both stages, a 
translator with a medical background and a layperson were chosen; the idea was to pro-
duce one translation that would reflect the concepts of the original questionnaire and 
the other translation would reflect the language used by a layperson. In the literature 
there is no consensus on the choice of translators.17
table 5. Correlation between FaCE scores with SF-36 (Spearman’s correlation coefficient)
FaCE scores
Physical 
function
Physical 
role
Bodily 
pain
General 
health
Vitality Social 
function
Emotional 
health
Mental 
health
Total 0.394** 0.389** 0.270** 0.276** 0.447** 0.555** 0.382** 0.416**
Facial movement 0.163 -0.046 -0.062 -0.110 -0.010 0.227* 0.140 0.072
Facial comfort 0.153 0.269* 0.291** 0.164 0.302** 0.283** 0.248* 0.310**
Oral function 0.280** 0.310* 0.084 0.118 0.341** 0.336* 0.254* 0.207*
Eye comfort 0.115 0.138 0.136 0.121 0.062 0.127 0.005 0.055
Lacrimal control 0.141 0.169 0.167 0.157 0.180 0.134 0.045 0.133
Social function 0.391** 0.376** 0.274** 0.346** 0.519** 0.576** 0.432** 0.499**
** P < 0.01, * P < 0.05, n=86
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The FDI we used in this study has not been translated and validated for use in Dutch 
according to the current standards. We could have done this together with the trans-
lation and validation of the FaCE Scale, however we have chosen to validate just one 
questionnaire. Assessment of the health-related quality of life by the use of two self-
assessment questionnaires seems unnecessary. The FaCE Scale is the instrument of our 
choice, based on the study of Kahn et al. and Ho et al.8, 26 Kahn et al. showed that the 
mean difference in FDI social/well-being function scores between subjects with facial 
palsy and control subjects was relatively small, indicating that the FDI instrument does 
not discriminate as well as the FaCE Scale between normal and disease states.8 Ho et al. 
performed a systematic review of patient-reported outcome measures in facial palsy. 
Three self-assessment questionnaires met their inclusion and exclusion criteria: the FaCE 
Scale, the FDI, and a questionnaire developed by Borodic et al.9 The FaCE Scale met the 
most psychometric standards.26
One of the domains of the Dutch FaCE Score (eye comfort) shows a poor internal con-
sistency (α = 0.57), in the validation study of Kahn et al, this domain has the lowest score 
as well (0.72). A possible explanation for our low α might be the sample in which the 
questionnaire was applied; reliability is a characteristic of the test scores, not of the test 
itself; our group might be more heterogeneous in terms of co morbidity for example .27
The response rate for test-retest reliability was quite low in this study; 40 patients met 
the criteria for test-retest reliability analysis; which meant they did not receive any form 
of treatment during their visit and received a second Dutch FaCE Scale per mail after 
two weeks. Only 21 of them (53%) completed the questionnaires. We likely could have 
increased this response rate if we had been more persistent in pursuing a response.
comparison with grading systems
Many different facial grading systems have been developed, almost all focusing on the 
physiological and anatomical abnormalities in the face.28, 29 The effect of the disability 
on the patient’s quality of life is not covered by these systems, while reduced social 
functioning after facial palsy is described in the literature.30 The extent of physiological 
impairment is not by definition correlated with impact on patient quality of life. For 
example, a patient with a HB 5 can have very little influence of the palsy on his/her 
quality of life, where as a patient with HB 2 can be completely socially isolated. Kahn 
et al. found that the correlations between the FaCE Scale and physician-graded scales 
were not always as expected; for example, the eye comfort domain of the FaCE Scale did 
not strongly correlate with the physician’s assessment regarding eye closure, suggesting 
that the degree of eye closure does not predict the problems the patient experiences.8
Validation of the Dutch FaCE Scale 177
4.2
conclusion
The Dutch FaCE Scale is a valid, reliable and easy to perform instrument for the assess-
ment of the influence of facial palsy on the patient’s quality of life. The use of the Dutch 
FaCE Scale can now be implemented in the management of patients with facial palsy in 
our clinic. With comparable studies in Sweden, China and Germany, this self-assessment 
questionnaire for patients with facial palsy is now available in 5 languages.8, 23, 24, 31 This is 
a great step forward in the implementation of a widely used instrument.
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AbstrAct
Objective: To validate an existing health-related quality of life questionnaire for patients 
with synkinesis in facial palsy for implementation in the Dutch language and culture.
Methods: The Synkinesis Assessment Questionnaire was translated into the Dutch lan-
guage using a forward-backward translation method. A pilot test with the translated 
questionnaire was performed in 10 patients with facial palsy and 10 normal subjects. 
Finally, cross-cultural adaption was accomplished at our outpatient clinic for facial palsy. 
Analyses for internal consistency, test-retest reliability, construct validity and respon-
siveness were performed.
Results: Sixty-six patients completed the Dutch Synkinesis Assessment Questionnaire 
and the Dutch Facial Disability Index. Cronbach’s α, representing internal consistency, 
was 0.80. Test-retest reliability was 0.53 (Spearman’s correlation coefficient, P < 0.01). 
Correlations with the House-Brackmann score, Sunnybrook score, Facial Disability In-
dex physical function and social/well-being function were -0.29, 0.20, -0.29, and -0.32 
respectively. Correlation with the Sunnybrook synkinesis subscore was 0.50 (Spearman’s 
correlation coefficient).
Conclusions: The Dutch Synkinesis Assessment Questionnaire shows good psychometric 
values and can be implemented in the management of Dutch-speaking patients with 
facial palsy and synkinesis in the Netherlands. Translation of the instrument into other 
languages may lead to widespread use, making evaluation and comparison possible 
among different providers.
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introDuction
Patients with facial palsy experience several problems; brow ptosis, incomplete eye 
closure (leading to exposure keratopathy), nasal valve collapse, oral incompetence, 
articulation difficulties, overall facial asymmetry, and psychosocial problems. Facial 
nerve injury and recovery is often accompanied with secondary effects; crocodile tears, 
eye dryness, taste disturbances, and synkinesis. Synkinesis is the phenomenon of in-
voluntary movement in one (or more) area(s) of the ipsilateral face during voluntary 
movement in another area of the face. For example, eye closure during speaking or eat-
ing. Three possible mechanisms for the development of synkinesis are described. The 
first, and most widely accepted, proposed mechanism is that of aberrant regeneration. 
During regeneration axons might regrow in endoneural tubes other than their original 
ones, innervating different muscle groups. A second mechanism is the stimulation of 
neighbor axons due to loss of myelin. A last possibility is hyper excitability of the facial 
nucleus itself.1
Patient reported outcome measures and disease specific quality of life have become 
more and more important, leading to the development of self-assessment question-
naires. Many grading scales for facial function have been developed, only a few includ-
ing the assessment of synkinesis, for example the Sunnybrook facial grading system.2 
Assessment can be performed by the physician using clinician based grading scales, but 
quantitative (sometimes automated) tools have been developed as well. The Synkinesis 
Assessment Questionnaire (SAQ) is a valid, reliable, and easily administered instrument 
for the self-assessment of synkinesis in patients with facial palsy.3 This instrument was 
developed and validated in the Facial Nerve Center at the Massachusetts Eye and Ear 
Infirmary (Boston, USA) in 2007. The questionnaire consists of nine items. Total scores 
range from 0 (no synkinesis) to 100 (severe synkinesis, all the time). In our clinic there 
was need for a synkinesis self-assessment tool and we wanted to be able to compare our 
results with other clinics
The aim of this study was to create a Dutch version of the Synkinesis Assessment 
Questionnaire and to test its internal consistency, test-retest reliability, construct valid-
ity, and responsiveness for a valid use in the Dutch language and culture.
methoDs
translation
We approached the developers of the SAQ and obtained permission to use the instru-
ment for translation and validation.3 In the current literature there is no consensus on 
‘gold standard’ guidelines for translating quality of life questionnaires. Two methods 
184 Chapter 4.3
are described; the forward-backward translation4-6 and the dual panel translation.7 Dual 
panel translation compromises the translation by a team of translators working together 
and assessment of the translation by a lay panel.8 The forward-backward translation 
seems to be the most accepted method; although there is no evidence to support this 
view. Acquadro et al. performed a literature review in 2008; they did not find evidence in 
favor of one method, but strongly advised researchers to adopt a multistep approach.8 
A forward-backward translation approach was used in this study (Figure 1). Consider-
ations and difficulties of each step were documented. Choice of wording and phraseol-
ogy had to be compatible with a reading level of age 14.4 The pilot test was performed 
in a group of ten patients with a facial palsy and ten persons without history of facial 
disease. Respondents completed the questionnaire and were asked about difficulties 
with answering and understanding the items. After this pilot test, final adjustments were 
made and documented.
 
Synkinesis Assessment 
Questionnaire(Mehta et al. 2007) 
Translation 
into Dutch (1)* 
Translation 
into Dutch (2)* 
Merging to one translation 
by committee# 
Back translation 1  ^ Back translation 2  ^ 
Creation of pilot version after comparison of 
original and back translations by committee# 
Pilot test 
Revision if necessary 
Dutch Synkinesis Assessment 
Questionnaire  
figure 1. Method translation in this study. * two in-
dependent translators; both native Dutch with Amer-
ican-English as their second, fluent, language; one of 
them was a medical doctor. # committee consisting 
of the authors of this manuscript. ^ two independent 
translators; both American from origin with Dutch as 
a second language and blinded for the original ques-
tionnaire; one of them had a medical background.
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Validation
When using a questionnaire in another country and another language, translation of the 
items alone is not enough. The items must be adapted to the new culture to maintain 
the content validity of the instrument: cross-cultural adaption is required.9, 10 Validation 
of the Dutch SAQ was performed at our university medical center between December 
2012 and August 2014. The study protocol was assessed according to guidelines of the 
local committee on research involving human subjects; no formal ethical review was 
required. Dutch speaking adult (18 years or older) patients with a facial palsy were in-
cluded. Patients completed two different questionnaires: the Dutch SAQ and the Dutch 
Facial Disability Index (FDI). In addition, gender, age, etiology, side and duration of the 
palsy, House-Brackmann (HB) scores, and Sunnybrook (SB) scores were collected in the 
database. This information was retrieved from the medical charts retrospectively.
To assess test-retest reliability, patients not receiving any form of treatment were sent 
the Dutch SAQ again after two weeks. At the end of the study, to increase the response 
rate for test-retest, patients were sent the SAQ (plus FDI) two weeks before visiting our 
clinic and the retest assessment was performed independently just before their visit 
while sitting in the waiting room. To test construct validity the HB, SB, and FDI were used. 
To assess responsiveness patients receiving treatment with botulinum toxin type A for 
synkinesis were sent the Dutch SAQ four weeks after injection.
Facial Disability Index
The FDI is a disease-specific quality of life questionnaire for patients with facial palsy, 
developed in at the Facial Nerve Center in Pittsburg around 1996 by VanSwearingen 
et al.11 The FDI has two domains; physical function and social/well-being function. The 
physical function scores range from -25 (worst) to 100 (best), and the social/well-being 
function scores range from 0 (worst) to 100 (best). The questionnaire does not have a 
synkinesis specific sub domain. This questionnaire has been translated into Dutch ac-
cording to a forward-backward method previously (not published), but has not officially 
been validated for use in the Dutch culture.
Statistical analysis
IBM SPSS Statistics 20 (IBM Corp. Armonk, NY) was used for data collection and statisti-
cal analysis. All questionnaire items were entered according to the principle of double 
data entry. First, descriptive analyses were performed to show patient characteristics. 
Cronbach’s α coefficient was calculated to test the internal consistency of the SAQ. 
Spearman’s correlation coefficient was calculated to analyze test-retest reliability. Cor-
relations between the Dutch SAQ and the HB score, SB score, and FDI were calculated 
using Spearman’s correlation coefficient to show construct validity. To test responsive-
ness, a paired samples t-test was performed.12
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results
pilot test
Ten normal subjects, without history of facial disease, completed the pilot version of 
the Dutch SAQ, they all had a SAQ score of 0 (best score). Ten patients with peripheral 
facial palsy completed the pilot version of the translated questionnaire as well. Subjects 
did not document any difficulties in understanding or answering the items, one minor 
adjustment was made in the Dutch SAQ.
Validation
Between December 2012 and September 2014 66 patients completed the Dutch SAQ 
and FDI . Patient characteristics are shown in Table 1.
The internal consistency of the Dutch SAQ was assessed using Cronbach’s α, which 
showed a value of 0.80. A Cronbach’s α > 0.7 is generally considered acceptable, and 
α > 0.8 as good.[22] Test-retest reliability was moderate (0.53, Spearman’s correlation 
coefficient, n=46, P < 0.01). Table 2 shows the individual item and total correlation coef-
ficients. Correlations between the SAQ score and the HB, SB, and FDI scores are shown in 
Tables 3 and 4. Correlation with the HB score is negative because of the design of the HB 
(1 is no palsy, 6 is complete flaccid palsy).
Responsiveness
Twenty-two patients received treatment for synkinesis with botulinum toxin A. Ten 
of them (46%) had received botulinum toxin previously, and the other 54% were new 
to this treatment. Total SAQ score before treatment was 55.8 (SD 21.8) and about four 
weeks after treatment 53.4 (SD 17.2). This difference is not statistically significant (P = 
0.50, Student t-test).
Discussion
In this study, the Synkinesis Assessment Questionnaire has been translated and vali-
dated for use in the Netherlands. Cronbach’s α, representing internal consistency, was 
good (0.80). Test-retest reliability was moderate (0.53). Correlation with the Sunnybrook 
synkinesis sub score was moderate as well (0.50). Translation of the SAQ into the Dutch 
language, and validation for use in the Dutch culture were performed according to the 
highest standards for translation of self-assessment questionnaires.5, 10, 13
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comparison with original questionnaire
Patient characteristics of this validation study are comparable with the original valida-
tion of the Synkinesis Assessment Questionnaire. Although, patients were on average 
about ten years older. Bell’s palsy was the diagnosis in the majority of patients in both 
studies.3 Internal consistency, reflected by Cronbach’s alpha coefficient, was 0.80 for 
the Dutch Synkinesis Assessment Questionnaire, in comparison to 0.86 for the original 
instrument. Test-retest reliability for the Dutch SAQ was moderate (0.53) in comparison 
to good (0.88) in the original validation study. Nevertheless, test-retest reliability was 
statistically significant for all items individually and for the total score in the current 
validation study (Table 2), overall with lower correlations than Mehta et al.3
comparison with other grading systems
The patient reported SAQ scores showed low correlations with the clinician-based grad-
ing scales (HB and SB, -0.29 and 0.20 respectively). One reason for a low association with 
table 1. Patient characteristics
n % mean SD median range
Gender
 female 45 68
 male 21 32
Age (years) 55.8 13.4 57.5 25-89
Side
 left 27 41
 right 37 56
 bilateral 2 3
Time since onset (months) 40 50 26 5-300
Etiology
 Bell’s Palsy 36 55
 Ramsay Hunt 15 23
 iatrogenic 3 5
 traumatic 3 5
 acoustic neuroma 3 5
 other# 6 9
House-Brackmann 3.0 0.9 3.0 1-5
Sunnybrook 47.9 17.7 49.5 11-83
FDI physical function 55.0 17.4 55.0 25-100
FDI social/well-being function 70.1 18.0 72.0 30-100
SAQ total score 47.6 18.0 44.4 18-93
# other etiologies comprised Lyme disease, cholesteatoma, multiple sclerosis, and benign facial nerve tu-
mors.
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the HB is that the HB facial grading system does not take into account synkinesis. For 
instance, one patient in this study had a House-Brackmann score of 1, which represents 
normal facial function, while he did experience synkinesis. A higher correlation was 
demonstrated between the (clinician-based) Sunnybrook synkinesis sub score and the 
SAQ, r=0.50. However, Mehta et al. found an even higher correlation between the SAQ 
and the Sunnybrook synkinesis sub scores (0.77). We sought for an explanation for this 
difference, but unsuccessfully. In any case, the SAQ is a patient reported measure, while 
the HB and SB are physician reported measures. Therefore a high correlation between 
these two types of measures is not expected. For this reason, both types of measures 
should be used in the assessment of synkinesis.
responsiveness
In this study, total SAQ scores did not improve reliably after treatment of synkinesis 
with botulinum toxin. This raises the question whether the Dutch SAQ is insensitive or 
whether botulinum toxin was not effective in this group of patients. Mehta et al. showed 
a reliable improvement of the SAQ in their original validation study, from 43.6 before 
treatment with botulinum toxin and 25.7 after treatment (P < 0.001).3 They assessed 
patients two weeks after botulinum toxin injection. In contrast, we evaluated after four 
weeks, although this does not explain the difference in patient reported outcome as the 
effect of botulinum toxin is reversible and temporary, but will last up to three months 
minimum.1
To further explore this issue, we analyzed available FaCE scores pre- and post-bototu-
linum toxin in this cohort. We found that, just like the SAQ score, the FaCE score did not 
improve either (from 46.9 to 49.5, P = 0.288). However, in the validation study of the 
Dutch FaCE Scale, in a comparable but larger cohort, we showed in that cohort a statisti-
table 2. Individual item and total test-retest correlation coefficient (Spearman)
Item Correlation
1 0.448
2 0.596
3 0.677
4 0.606
5 0.518
6 0.364*
7 0.447
8 0.522
9 0.396
Total 0.534
* significant at the 0.05 level, all other items and total score significant at the 0.01 level
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cally significant improvement of the FaCE score after treatment with botulinum toxin 
(from 44.7 to 48.5, P = 0.042).14 We did not have a House-Brackmann or Sunnybrook 
score post-treatment to test if clinicians reported an effect of the treatment. Based on 
these considerations, we assume that the sample size of the current study is too small to 
find a statistically significant effect of the botulinum toxin. In future studies we should 
evaluate the outcomes after botulinum toxin for synkinesis using a clinician based 
grading scale (Sunnybrook), the SAQ, and a quantitative, computerized tool. A study 
using all types of assessment will give us more insight in the effectiveness of synkinesis 
treatment.
conclusion
The Synkinesis Assessment Questionnaire is a simple instrument for use in daily clinic. 
This subjective instrument should be combined with a quantitative instrument and 
clinician-based grading for a complete assessment of synkinesis. The use of the Dutch 
SAQ can now be implemented in the management of patients with facial palsy in the 
Netherlands. Implementation worldwide would facilitate comparison between clinics.
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table 3. Correlation between SAQ and House-Brackmann and Sunnybrook scores (Spearman’s correlation 
coefficient)
House-Brackmann Sunnybrook Sunnybrook synkinesis score
Total score -0.288 0.203 0.496*
*P<0.01
table 4. Correlation between SAQ score and Facial Disability Index (Spearman’s correlation coefficient)
FDI physical function FDI social/well-being function
Total score -0.290* -0.320*
FDI = facial disability index, * P < 0.05
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Assessment of facial function in rats
In the rat, muscles producing whisker movement are innervated by branches of the 
facial nerve. Whisker movement is a commonly used outcome measure of facial nerve 
regeneration in rats. Whiskers are arranged in rows and columns in the whisker pad. 
Studies by Angelov et al.1-3 have shown enhanced whisking recovery after daily manual 
mechanical stimulation of the whisker pad. Our goal was to study whether automated 
mechanical stimulation of the whiskers improved whisking recovery after facial nerve 
transection and repair. We used the Whisk Assist (WA) apparatus to deliver mechanical 
stimulation under greater experimental control (than manual stimulation) to identify 
optimal treatment patterns.
Unfortunately, we did not find improved recovery after automated mechanical 
stimulation in the WA apparatus, whereas another laboratory found some cases of 
complete (symmetrical) whisking recovery after manual mechanical stimulation.1-3 Our 
findings actually suggested impaired functional outcome after automated mechanical 
stimulation, compared to our control group. One possible explanation for this apparent 
deleterious effect might be fatigue of the facial mechanoreceptors during prolonged ac-
tivation. However, we piloted some lower-frequency stimulations (0.5-1.5 Hz), and these 
failed to enhance whisking recovery as well. Another possibility for impaired recovery 
following whisk-assistance is that direct mechanical contact with the whisker pad, like 
manual stimulation, is required. Thus, the comb of the WA apparatus was adjusted with 
a soft bristle brush to simulate manual stimulation, though this intervention likewise 
failed to enhance regeneration. Another important difference between manual and au-
tomated mechanical stimulation might be that rats may experience higher stress levels 
with automated whisk-assistance. Animals undergoing manual stimulation while being 
handheld probably experience less stress than rats being fixated in our WA. However, 
our control group was restrained for 20 minutes per day as well, with the WA comb 
against the whiskers, without comb movement. The group of rats receiving automated 
mechanical stimulation (8.0 Hz) did statistically significant worse than rats in the control 
group. Remarkably, there was no statistically significant difference in recovery between 
the current control animals and our previously manual stimulated animals (figure 4, 
chapter 2.1), rejecting the hypothesis of stress-inhibition of recovery. We currently have 
no solid explanation for why our interventions did not enhance regeneration, as had 
been seen with manual stimulation in prior studies.1-3
Our research group elected to establish new control groups for further experiments; 
one control group with facial nerve transection and repair, the other control group with 
complete permanent denervation. In this latter group, the facial nerve was transected 
at the main trunk and the buccal and marginal mandibular branch were resected for 
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several centimeters. Both stumps were sutured into silicone tubes sealed with cyano-
acrylate to prevent axon regrowth into the distal stump. To our surprise, we discovered 
whisker movements in these denervated rats approximately 30 days later, which grow 
stronger over the ensuing weeks (figure 3, chapter 2.2). Further research was needed 
to understand the source and mechanism of this non-facial nerve-mediated whisking. 
So we developed a hypothesis that parasympathic fibers of the infraorbital division 
of the trigeminal nerve were the source of motor innervation causing whisker move-
ment in our denervated rats. We provided functional and anatomical evidence that 
non-facial-nerve-mediated whisking stems from reinnervation to intrinsic whisker pad 
sling muscles by parasympathetic axons traveling with the infraoribital nerve. Whisking 
was elicited by electrical stimulation of the infraorbital nerve, temporarily diminished 
following hexamethonium (autonomic ganglia-blocking agent) injection, eliminated by 
transection of the infraorbital nerve, and rapidly and significantly increased by snout 
cooling (vasodilatation reflex increasing acetylcholine release). Immunohistochemistry 
for vasoactive intestinal peptide (VIP) revealed axons travelling within the infraorbital 
nerve branching extensively over whisker pad muscles and contacting neuromuscular 
junctions after facial nerve resection. These findings have implications for the interpre-
tation of whisking recovery results after facial nerve manipulation. Return of whisking 
function after facial manipulation is now thought not to be only the result of facial nerve 
regeneration, but also may be caused by innervation through parasympathic fibers of 
the infraorbital nerve. The discovery of whisker pad innervation by parasympathic nerve 
fibers also leads to possibilities to prevent muscle atrophy. Denervation of muscles 
results in atrophy, innervation of muscles by parasympathic fibers might prevent this 
process. The mechanism of reinnervation of a muscle, other than by motor axons, is 
called sensory protection (or babysitting). There are studies showing more favorable 
and better preserved muscle properties after sensory protection.4, 5
Aside from whisking function, whisker pad immunohistochemistry is another common 
reporter of facial nerve regeneration after surgical manipulation. Contraction of sling 
muscles located at the base of each individual whisker follicle (intrinsic pad muscles) 
results in whisker protraction.6, 7 These sling muscles are extremely small and difficult to 
study based upon their oblique position around each follicle. Thus, it would be useful to 
identify a surrogate reporter facial muscle that displays a common innervations pattern, 
which would allow analysis of histological muscle changes along with functional whisk-
ing behavior. We examined the basic electrophysiological and mechanical response of 
the levator labii superioris muscle (LLS) and dilator naris muscle (DN) while electrically 
stimulating individual facial nerve branches with the goal of identifying their source(s) 
of innervations. Our results indicate that the LLS is innervated primarily through the zy-
gomatic branch of the facial nerve, with minor contributions of the marginal mandibular 
and buccal branches. The DN is innervated primarily by the marginal mandibular and 
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buccal branches, the same branches that control intrinsic whisking, with little input of 
the zygomatic branch. We demonstrated that the DN is not involved in whisking function 
by cutting the DN tendon which did not change active whisking function. Nevertheless, 
the DN is likely to experience similar histological changes after facial nerve manipula-
tion as the whisker pad intrinsic musculature because of the similar innervation pattern. 
Furthermore, the DN is easier to harvest than the LLS, and the parallel muscle fibers are 
optimal for cross-sectional cryostat cuts. We concluded that the DN is the most suitable 
reporter for whisker pad reinnervation in the rat model of facial nerve regeneration. 
Our research group integrated histological analysis of the DN into the rat facial recovery 
paradigms after facial nerve manipulation.
Assessment of facial function in humans
Quantitative assessment of facial function in humans after facial palsy is thought to 
be controversial in daily practice. We therefore systematically reviewed the current 
literature on quantitative assessment tools for facial function. Our initial goal was to be 
able to advice professionals in the field of facial palsy on which quantitative tool to use 
in daily practice. We ultimately concluded that it was not possible to select only one 
tool. Different zones of the face require different methods and evaluation of results after 
dynamic reconstructions requires more comprehensive tools. For routine (daily) clinical 
practice we recommend a simple, two-dimensional, static tool that gives information 
on linear distances and/or (a)symmetry. We recommend a prospective (multicenter) 
comparative study with the Facial Analysis Computerized Evaluation software of Neely 
et al.8, Facial Assessment by Computer Evaluation (FACE) software of Hadlock at al.9, 
and Glasgow Facial Palsy Scale (GFPS) software of O’Reilly et al.10 These three tools are 
proven to be valid in a facial palsy population, and are available free. After the proposed 
comparative study, a single tool should be chosen as a gold standard, to be able to com-
pare results between clinics. Journals should request outcome data using these tools in 
effectiveness studies. Dynamic reconstructions, especially of the smile, require a more 
advanced assessment tool. Such a tool will be more time consuming than one of the 
above mentioned tools and perhaps more expensive as well. We recommend a three-
dimensional tool over a dynamic two-dimensional tool. Based on the information in the 
current literature on 3D assessment tools, we are not able to recommend one specific 
tool to be eligible for gold standard. Cost and equipment are the major drawbacks for 
implementation of these tools in daily practice.
Prior to the systematic review (presented in Chapter 3.1) we had tried to define an 
objective, easy to perform, rapid method for the assessment of ocular synkinesis by 
employing both FACE9 and a modification of the GFPS10. The FACE software was shown 
to be a sensitive and accurate reporter of ocular synkinesis. Our modified application of 
the GFPS did not appear to be a reliable method to assess ocular synkinesis. The GFPS 
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should be used the way it was originally designed; for the assessment of facial motion 
(a)symmetry.10 FACE software is a really easy, rapid and sensitive method for measure-
ment of palpebral fissure width and with that for ocular synkinesis. FACE software is not 
applicable for synkinesis in other zones of the face, since these zones do not have linear 
synkinesis vectors.
We also, prior to the systematic review, evaluated 3D stereophotogrammetry as a 
quantitative assessment tool for oral synkinesis in patients with peripheral facial palsy. 
This study (Chapter 3.3) was specifically designed to assess oral synkinesis, mainly be-
cause this region causes the least artifact with 3D stereophotogrammetrical analysis.11 
We examined whether the change in facial soft tissue of the perioral region due to oral 
synkinesis could be quantified using 3D stereophotogrammetry. It was shown that 
the mean absolute error of distances between 3D photographs in repose and during 
gentle eyelid closure was statistically significantly higher in patients than in controls. 
This finding indicates that patients experienced a larger change in perioral soft tissue 
during eyelid closure, compared to healthy control subjects. Although the mean dif-
ference between patients and controls was statistically significant, the absolute value 
was only 0.112 mm. Considering the clinical applicability of this study, the question is 
whether this rather small difference can be of any meaning in the individual patient. 
It appears as though 3D stereophotogrammetry might be more suitable for research 
purposes than for use in clinical practice. One could argue that the sample size appears 
to be rather small. However, the sample size was based upon a power calculation in 
which results of a previously conducted pilot study were taken into account. As shown, 
our study had sufficient power to detect a statistically significant outcome. Obviously, 
this does not guarantee a clinically relevant result. Despite statistical significance, we 
believe that the difference between patients and controls is too small for 3D stereo-
photogrammetry to be of true additional value in diagnosing oral synkinesis in daily 
clinical practice. Nonetheless, further research might prove 3D stereophotogrammetry 
to be useful in evaluating treatment effects, with a high ability to detect even small 
changes in individual patients. This study addresses the change in facial soft tissue in 
the perioral region during eyelid closure, which resembles oral synkinesis. Assessment 
of facial motion by 3D stereophotogrammetry should be further examined. Further 
research is needed as well to assess other zones of the face and the responsiveness of 
3D stereophotogrammetry in the evaluation of synkinesis treatment effects. The results 
of this study have not been published yet, as still other options remain to be explored 
in which 3D stereophotogrammetry could contribute quantitative assessment of facial 
function.
Quality of life and patient reported outcome measures (PROMs) are becoming increas-
ingly more important, and seem to reflect closely the results of patient care. Fattah et 
al. surveyed members of the Sir Charles Bell Society in 2014, asking if they use a patient 
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reported outcome measure and if yes, which one. Forty-two percent of the eighty-three 
respondents did not use any self-assessment questionnaire. Thirty-one percent use the 
FaCE Scale. Twelve percent use the Facial Disability Index, and fifteen percent use other 
assessments. The large number of clinicians not using a PROM should be decreased in 
the upcoming years.12
We studied health-related quality of life of patients visiting a tertiary referral center 
for facial palsy, and analyzed possible factors associated with this health-related quality 
of life, using the FaCE Scale. In this study, we found age to be associated with total FaCE 
score, and gender and duration of palsy are likewise associated with FaCE social function 
score. To date, this is the largest series describing FaCE scores in patients with peripheral 
facial palsy, offering valuable information on health-related quality of life in this popula-
tion. The large number of patients provides us a reliable insight into quality of life in 
facial palsy, and the associated factors provide a tool for psychological counseling.
In larger and in specialized clinics, management of patients with peripheral facial 
palsy is ideally performed in a multidisciplinary fashion, with otolaryngologists, facial 
plastic surgeons, ophthalmologists, physical therapists, and speech therapists involved. 
A psychologist, specialized in the psychosocial consequences of facial palsy, may further 
complete the multidisciplinary team. We strongly recommend psychological counseling 
for all patients suffering long-lasting facial palsy in order to ameliorate potential psy-
chosocial dysfunction. Our study demonstrates that female patients with more chronic 
facial palsy and increased age are more at risk for poor quality of life, based upon their 
lower FaCE scores.
We also translated and validated the FaCE Scale for implementation in the Dutch lan-
guage and culture (Chapter 4.2). The Dutch FaCE Scale shows good psychometric values 
(internal consistency, test-retest reliability, construct validity, and responsiveness) and 
can be implemented in the management of Dutch-speaking patients with facial palsy in 
the Netherlands. Translation of the instrument into other languages may lead to wide-
spread use, making evaluation and comparison possible among different providers. The 
FaCE Scale is now available in five languages.13-16 This availability in multiple languages 
is a great step forward in the implementation of a widely used instrument.
In Chapter 4.3 the translation and validation of the Synkinesis Assessment Question-
naire (SAQ) for implementation in the Dutch language and culture is presented. The 
SAQ is a simple instrument for use in daily clinic. This subjective instrument should be 
combined with a quantitative instrument and clinician-based grading for a complete 
assessment of synkinesis. The Dutch SAQ shows good psychometric values (internal 
consistency, test-retest reliability, construct validity, and responsiveness) and can be 
implemented in the management of Dutch-speaking patients with facial palsy and 
synkinesis in the Netherlands. Implementation worldwide would make comparison 
between clinics possible.
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conclusions
In conclusion, the rat model provides two ways to assess facial nerve regeneration. First, 
whisking function has been evaluated after various interventions that were supposed 
to accelerate and improve facial nerve regeneration. We found evidence of spontane-
ous autonomic innervation of facial muscles after motor nerve lesion. This finding has 
implications for interpreting facial nerve regeneration results; return of whisking after 
facial nerve manipulation can not only be assigned to reinnervation by the facial nerve 
branches. The parasympathic fibers of the infraorbital nerve are responsible for return 
of whisking as well. In addition, we failed to demonstrate enhanced recovery despite 
our exhaustive use of myriad regimens of automated WA under systematic, highly con-
trolled circumstances, with and without direct whisker pad stimulation. We concluded 
that the benefit from mechanical stimulation may not represent a true, reproducible 
phenomenon. Secondly, whisker pad histology is the other reporter of facial nerve regen-
eration. We recommend to harvest the dilator naris muscle since its innervation is most 
comparable with innervation of the whisker pad intrinsic musculature.
Future studies in the field of facial nerve regeneration improvement and acceleration 
should focus on interventions other than mechanical stimulation. In the field of periph-
eral nerve regeneration there is a lot of interest in ways to accelerate nerve regenera-
tion, for example through the use of immunosuppression and/or neurotrophic factors. 
Several authors have demonstrated that FK506 (a drug used for immunosuppression 
after solid organ transplantation) increases the rate of axonal regeneration.17 Some 
other agents with promising positive effects are hepatocyte growth factor, adrenocor-
ticotropic hormone, vascular endothelial growth factor, celecoxib, dexamethasone, and 
insulin-like growth factor.17 Another field to further explore is the sensory protection of 
facial muscles.
Based on our findings, we advise research groups working with the rat model in the 
field of facial palsy to be critical in interpreting recovery of whisking function after facial 
nerve manipulation; it is not only the facial nerve that drives whisker movement. We 
found evidence for innervation of whisking musculature by parasympathetic fibers. We 
also doubt the benefit of mechanical stimulation to enhance facial nerve regeneration, 
though further research is needed in approach to accelerating nerve regeneration. Fi-
nally, we recommend that research groups implement histological analysis of the dilator 
naris muscle as a reporter of facial nerve regeneration.
Many centers have developed tools for quantitative assessment of facial function in 
peripheral facial palsy. The majority of these tools have important drawbacks, includ-
ing our 3D stereophotogrammetry. For detailed assessment of smile and evaluation of 
dynamic reconstruction results we recommend 3D analysis, but as long as costs stay 
high and equipment plenty, we might have to be satisfied with one simple, 2D static 
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assessment tool. We selected three simple, 2D, static tools as a potential gold standard 
and we recommend a prospective, comparative study: FACE software (twice) and GFPS 
software are proven to be valid in a facial palsy population and free available.
Assessment of facial function using solely a quantitative tool will not be sufficient. It 
can occur that two patients with exact the same quantitative outcome do experience 
a different health-related quality of life, making a self-assessment questionnaire a 
necessary addition. Moreover, patient satisfaction should be a major goal of treatment. 
Based on our findings we recommend special attention for the psychosocial status of 
female patients with chronic facial palsy and increased age. We advise professionals in 
the field of facial palsy to assess facial function in three ways: (1) assessment using the 
clinician-based grading systems (House-Brackmann and Sunnybrook), (2) quantitative 
assessment using FACE software8, 9 or GFPS software10 (until a gold standard is assigned), 
and (3) self-assessment using the (Dutch) FaCE Scale and the (Dutch) SAQ. The disadvan-
tages of one entity, would be mostly covered by another entity. Professionals in the field 
of facial palsy should make a step forward during the next International Facial Nerve 
Symposium (California, 2017) in presenting and discussing suggested gold standards.
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A
i. Dutch summAry (neDerlAnDse sAmenVAttinG)
Uitval van de aangezichtszenuw (nervus facialis), met een aangezichtsverlamming 
als gevolg, is ingrijpend voor patiënten. Zij kunnen last hebben van zowel functio-
nele verschijnselen als psychosociale gevolgen. Een aantal voorbeelden van functio-
nele verschijnselen zijn het niet kunnen sluiten van een oog, het achterblijven van de 
mondhoek bij glimlachen en het niet goed kunnen articuleren. Patiënten ondervinden 
psychosociale hinder van hun aandoening doordat emotionele expressies in het gezicht 
verstoord zijn en door schaamte voor hun uiterlijk. Momenteel zijn er diverse mogelijk-
heden voor het behandelen van een aangezichtsverlamming. Ondanks behandeling is 
het herstel van de aangezichtszenuw vaak traag, onvolledig of met restverschijnselen. 
Eén van deze restverschijnselen is het voorkomen van synkinesen. Synkinesen zijn on-
willekeurige bewegingen die optreden bij het maken van een willekeurige beweging, 
bijvoorbeeld het onbedoeld sluiten van een oog tijdens het praten of eten.
Er wordt momenteel veel onderzoek verricht naar nieuwe behandelingen voor uitval 
van de aangezichtszenuw ten behoeve van een sneller herstel met minder restverschijn-
selen. Dit proefschrift beschrijft onderzoek naar de verbetering van de behandeling 
en naar de mogelijkheden om de resultaten van deze behandelingen te evalueren. Er 
bestaan verschillende mogelijkheden om de effectiviteit van een behandeling van de 
aangezichtszenuw te beoordelen, maar helaas ontbreekt een gouden standaard. Een 
deel van het onderzoek berust op dierexperimenten, waarvoor de rat als model is ge-
bruikt. De anatomie van de aangezichtszenuw van de rat is vergelijkbaar met die van de 
mens, en daarom een representatief diermodel. Bij ratten stuurt de aangezichtszenuw de 
spieren aan die zorgen voor de beweging van de snorharen. De mate van beweging van 
de snorharen wordt daarom veelal gebruikt als uitkomstmaat bij onderzoek naar herstel 
van de aangezichtszenuw. Een onderzoeksgroep uit Duitsland1 heeft aangetoond dat 
dagelijkse manuele mechanische stimulatie van de snorharen leidt tot verbeterd herstel 
van snorhaarbewegingen na schade aan de aangezichtszenuw. Het doel van onze studie 
(hoofdstuk 2.1) was om te bepalen of geautomatiseerde mechanische stimulatie van 
de snorharen ook zou leiden tot een verbeterde snorhaarbeweging na schade aan de 
aangezichtszenuw. Met geautomatiseerde stimulatie zou kunnen worden vastgesteld 
welke mate van stimulatie het meest effectief is. Hiervoor gebruikten wij een apparaat 
waarin de snorharen van de rat automatisch voor- en achterwaarts kunnen worden 
bewogen: de Whisk Assist (WA). Dit experiment werd zowel in een testgroep als in een 
controlegroep uitgevoerd. De controlegroep onderging nagenoeg dezelfde behande-
ling, waaronder plaatsing in de WA, alleen werden de snorharen (en dus de aange-
zichtszenuw) niet gestimuleerd. Helaas verbeterde de beweging van de snorharen niet 
na automatische mechanische stimulatie. Bij de ratten in de testgroep herstelden de 
snorhaarbewegingen zelfs minder dan in de controlegroep. Een mogelijke verklaring 
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hiervoor is het ontbreken van direct (druk-)contact met de spieren, zoals bij manuele 
stimulatie, of een te hoge frequentie van de stimulatie. Om dit te onderzoeken werden 
lagere frequenties van stimulatie getest en werd de WA aangepast door toevoeging 
van een tandenborstel die direct contact maakte met de spieren in de wang van de rat. 
Deze beide aanpassingen resulteerden niet in beter herstel van snorhaarbeweging ten 
opzichte van de controlegroep. Een andere verklaring voor het verslechteren van de 
functie van de aangezichtszenuw na automatisch stimulatie is mogelijk gelegen in de 
stress die ratten zouden kunnen ervaren in de WA. Hiertegen pleit dat de controlegroep 
ook in de WA werd geplaatst (zonder dat hun snorharen werden gestimuleerd) en deze 
ratten een zelfde mate van herstel lieten zien als bij ratten die manueel werden gestimu-
leerd (eerdere studie, niet in dit proefschrift). Concluderend hebben we geen verklaring 
kunnen vinden voor het feit dat regeneratie van de aangezichtszenuw niet verbeterde 
na automatische stimulatie, zoals eerdere studies met manuele stimulatie wel hebben 
aangetoond.
Tijdens onze experimenten zagen wij terugkeer van snorhaarbewegingen bij ratten 
waarvan de aangezichtszenuw niet hersteld kon zijn, omdat een deel van de zenuw was 
verwijderd en in siliconen dopjes gehecht. Onze hypothese is dat de snorhaarspieren 
werden geïnnerveerd door parasympathische vezels van de infraorbitale tak van de 
nervus trigeminus (gevoelszenuw van het aangezicht). Door middel van verschillende 
experimenten (hoofdstuk 2.2) werd deze hypothese bevestigd: (1) snorhaarbewegin-
gen werden opgewekt door elektrische stimulatie van de nervus infraorbitalis, (2) na 
intraveneuze injectie met hexamethonium (autonoom ganglion blokkerend middel) 
verdween de snorhaarbeweging tijdelijk, (3) snorhaarbeweging verdween volledig na 
doornemen van de nervus infraorbitalis, (4) snorhaarbeweging nam snel en fors toe na 
prikkeling van de neus met ijsblokjes (vasodilatatie reflex waarbij meer acetylcholine vrij 
komt) en tot slot (5) immunohistochemische kleuringen toonden axonen aan die met de 
nervus infraorbitalis meeliepen naar de snorhaarspieren. Het terugkeren van snorhaar-
beweging is dus niet alleen het resultaat van regeneratie van de aangezichtszenuw, maar 
ook van innervatie via de nervus infraorbitalis; deze bevinding heeft consequenties voor 
de interpretatie van snorhaarbewegingen na laesies van de aangezichtszenuw bij de rat.
Een andere uitkomstmaat voor regeneratie van de aangezichtszenuw zijn de im-
munohistochemische kenmerken van de snorhaarspieren. Aan de basis van iedere 
snorhaarfollikel bevindt zich een spiertje waarvan contractie resulteert in protractie 
van de snorhaar. Deze spiertjes zijn erg klein en moeilijk te onderzoeken. We gingen op 
zoek naar een alternatieve spier met een zelfde innervatiepatroon om de histologische 
veranderingen na uitval en herstel van de aangezichtszenuw te kunnen bestuderen 
(hoofdstuk 2.3). We onderzochten de elektrofysiologische en mechanische reactie van 
de musclus levator labii superioris (LLS) en de musculus dilatoris naris (DN) op elektrische 
stimulatie van de takken van de aangezichtszenuw. De aangezichtszenuw splitst zich in 
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het gelaat in drie takken: de zygomaticus, de buccalis en de marginalis mandibularis. 
Het bleek dat de LLS voornamelijk geïnnerveerd wordt door de zygomaticus tak van de 
aangezichtszenuw en maar minimaal door de marginalis mandibularis en buccalis tak. 
De DN wordt voornamelijk geïnnerveerd door de marginalis mandibularis en buccalis 
tak. Deze twee laatst genoemde takken zorgen ook voor snorhaarbeweging. We heb-
ben echter aangetoond dat de DN spier zelf niet betrokken is bij snorhaarbeweging, 
omdat het doornemen van de pees van deze spier niet leidde tot het ontbreken van 
snorhaarbewegingen. Wel verwachten we dat de DN in dezelfde mate histologische 
veranderingen laat zien als de kleine spiertjes aan de basis van de snorharen, omdat ze 
een gezamenlijke innervatiepatroon hebben. Daarbij is de DN chirurgisch makkelijker 
te verwijderen dan de LLS en daarmee wat ons betreft de beste alternatieve spier voor 
histologisch onderzoek bij regeneratie van de aangezichtszenuw.
In de internationale literatuur bestaat geen overeenstemming welke kwantitatieve 
meetmethode het meest geschikt is om de functie van het aangezicht te objectiveren. 
Om inzicht te krijgen in de verschillende meetmethoden voerden wij een systematisch 
literatuuronderzoek uit (hoofdstuk 3.1). Ons doel was om een advies uit te kunnen 
brengen welke kwantitatieve meetmethode het meest geschikt is om te gebruiken in de 
dagelijkse, klinische praktijk. Het bleek niet mogelijk te zijn om hiervoor één methode 
aan te wijzen. Voor de dagelijkse praktijk bevelen wij een eenvoudige meetmethode 
aan, welke lineaire afstanden en (a)symmetrie meet in twee dimensies. Drie bestaande 
kwantitatieve meetmethodes voldoen aan deze eis: Facial Analysis Computerized Evalu-
ation (FACE) 2, Facial Assessment by Computer Evaluation (FACE) 3 en Glasgow Facial Palsy 
Scale (GFPS) 4. Om deze drie meetmethodes met elkaar te kunnen vergelijken en een 
gouden standaard te kunnen kiezen is een prospectieve, vergelijkende multi-centrum-
studie nodig. Dynamische reconstructies, vooral van de glimlach, vereisen echter meer 
geavanceerde meetmethodes. Metingen in drie dimensies zouden dan juist de voorkeur 
hebben. Op basis van de huidige literatuur is helaas geen goede, allesomvattende 
meetmethode te kiezen. Benodigde apparatuur en kosten van deze apparatuur zijn op 
dit moment beperkende factoren voor het gebruik van deze methoden in de dagelijks, 
klinische praktijk.
In hoofdstuk 3.2 vergelijken wij twee kwantitatieve meetmethodes voor de beoorde-
ling van synkinesen bij patiënten die een aangezichtsverlamming hebben doorgemaakt. 
Zoals eerder beschreven zijn synkinesen onwillekeurige bewegingen die optreden 
tijdens het maken van een willekeurige beweging. We vergeleken de Facial Assessment 
by Computer Evaluation (FACE) 3 en een alternatieve versie van de Glasgow Facial Plasy 
Scale (GFPS) 4 in de beoordeling van oculaire synkinesen (synkinesen rondom het oog). 
De FACE software bleek een eenvoudige, snelle en betrouwbare methode om de pupil-
lidspleet-grootte te kwantificeren en daarmee een goed meetinstrument voor oculaire 
synkinesen. Onze alternatieve versie van de GFPS bleek hiervoor niet betrouwbaar; er 
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waren te veel discrepanties met onze klinische blik en de FACE resultaten. In hoofdstuk 
3.3 evalueerden we 3D stereofotogrammetrie als kwantitatieve beoordelaar voor orale 
synkinesen. Het verschil tussen onze patiëntengroep en controlegroep was weliswaar 
statisch significant, maar helaas niet klinisch relevant (verschil van 0,112 millimeter) 
voor algemeen gebruik. De 3D stereofotogrammetrie lijkt wel toepasbaar voor onder-
zoeksdoeleinden. Tot slot is meer onderzoek nodig om ook naar andere vormen van 
synkinesen en het effect van behandelingen te bekijken.
In hoofstuk 4.1 beschrijven wij de kwaliteit van leven van patiënten met een aange-
zichtsverlamming die een tertiair centrum bezochten (het Facial Nerve Center in Boston). 
Tevens keken we naar patiëntfactoren die mogelijk geassocieerd zijn met kwaliteit van 
leven. Hiervoor gebruikten we een ziekte-specifieke vragenlijst: de Facial Clinimetric 
Evaluation (FaCE) Scale.5 Een hogere FaCE score wijst op een betere, ziekte-specifieke, 
kwaliteit van leven (0-100). Leeftijd bleek geassocieerd te zijn met de FaCE score: oudere 
patiënten met een aangezichtsverlamming scoorden een lagere ziekte-specifieke kwali-
teit van leven. Geslacht en duur van de aangezichtsverlamming waren geassocieerd met 
de subscore sociale functie: vrouwelijke patiënten en patiënten die al langere tijd een 
aangezichtsverlamming hadden scoorden ook lager op het subdomein sociale functie. 
Wij bevelen aan om een psycholoog toe te voegen aan de multidisciplinaire teams die 
patiënten met een aangezichtsverlamming behandelen, om ook deze aspecten van de 
gevolgen van een aangezichtsverlamming in kaart te brengen en waar nodig voor be-
geleiding zorg te dragen. hoofdstuk 4.2 beschrijft de vertaling en validatie van de FaCE 
naar het Nederlands. De Dutch FaCE Scale laat goede psychometrische waarden (interne 
samenhang, test-hertest betrouwbaarheid, construct validiteit en responsiviteit) zien. 
De FaCE is nu beschikbaar in vijf talen. Dat is een belangrijke ontwikkeling richting een 
internationaal geaccepteerd meetinstrument. hoofdstuk 4.3 beschrijft de vertaling en 
validatie van de Synkinesis Assessment Questionnaire (SAQ) 6. Deze vragenlijst kan wor-
den gebruikt om de ziekte-specifieke kwaliteit van leven bij patiënten met synkinesen te 
meten. Ook de Dutch SAQ is getest op psychometrische waarden, waaruit bleek dat de 
vragenlijst goed scoort op interne samenhang, test-hertest betrouwbaarheid, construct 
validiteit en responsiviteit.
conclusie
Zowel snorhaarbewegingen als histologisch onderzoek van de aangezichtsspieren van 
de rat dienen als uitkomstmaat voor onderzoek naar herstel van de aangezichtszenuw. 
Bij de interpretatie van terugkeer van snorhaarbewegingen na schade aan de aange-
zichtszenuw bij ratten moet rekening worden gehouden met innervatie door de nervus 
infraorbitalis. Voor histologisch onderzoek gaat onze voorkeur uit naar de DN spier. Ten 
eerste omdat het innervatie patroon van deze spier vergelijkbaar is met de innervatie 
van de snorhaarspiertjes. Ten tweede omdat het relatief gemakkelijk is om de DN spier 
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chirurgisch vrij te prepareren. Er is nog onvoldoende bewijs voor beter en sneller herstel 
van de aangezichtszenuw door middel van mechanische stimulatie. Deze interventie 
vereist verder onderzoek, maar ook andere opties zoals toediening van groeifactoren 
moeten worden onderzocht.
Wij adviseren om de functie van het aangezicht bij patiënten met een aangezichts-
verlamming op drie manieren te beoordelen: (1) door gebruik te maken van klinische 
graderingschalen (zoals de House-Brackmann7 en de Sunnybrook8), (2) met behulp van 
kwantitatieve meetmethodes zoals de FACE of GFPS software en (3) met zelfbeoorde-
lingvragenlijsten zoals de (Dutch) FaCE en de (Dutch) SAQ.
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ii. Dutch fAce scAle
U heeft deze of soortgelijke vragen misschien al eerder beantwoord. Beantwoord alstublieft ALLE VRAGEN 
zo goed mogelijk. De volgende uitspraken gaan over hoe u denkt dat uw gezicht beweegt.
(OMCIRKEL slechts EEN nummer) Eén kant Beide kanten Ik heb geen moeite
Als ik mijn gezicht probeer te bewegen, ondervind ik moeite aan 1 2 0
(Als u problemen heeft aan BEIDE kanten, beantwoord dan de vragen in de rest van de vragenlijst over 
de meer aangedane kant, of over beide kanten als ze in gelijke mate aangedaan zijn.) in de AfGelopen 
Week:
(OMCIRKEL slechts EEN nummer per regel) Helemaal 
niet
Alleen als ik mij 
concentreer
Een 
beetje
Bijna 
normaal
Normaal
1.  Als ik glimlach, gaat de aangedane kant van mijn mond omhoog 1 2 3 4 5
2.  Ik kan mijn wenkbrauw optrekken aan de aangedane kant 1 2 3 4 5
3.  Als ik mijn lippen tuit, dan beweegt de aangedane kant van mijn 
mond
1 2 3 4 5
De volgende uitspraken gaan over hoe u zich misschien voelt vanwege de problemen met het bewegen 
van uw gezicht. Vult u alstublieft in hoe vaak elk van de volgende uitspraken op u van toepassing 
waren in de AfGelopen Week.
(OMCIRKEL slechts EEN nummer per regel) Altijd Meestal Soms Zelden Nooit
4.  Delen van mijn gezicht voelen stijf, vermoeid of ongemakkelijk 1 2 3 4 5
5.  Mijn aangedane oog voelt droog of geïrriteerd aan 1 2 3 4 5
6.  ls ik mijn gezicht probeer te bewegen, voel ik spanning, pijn of spasme 1 2 3 4 5
7.  Ik gebruik oogdruppels of zalf in mijn aangedane oog 1 2 3 4 5
8.  Mijn aangedane oog is nat of bevat tranen 1 2 3 4 5
9.  Ik gedraag me anders in het bijzijn van mensen vanwege de 
problemen met het bewegen van mijn gezicht
1 2 3 4 5
10.  Mensen behandelen mij anders vanwege de problemen met het 
bewegen van mijn gezicht
1 2 3 4 5
11.  Ik heb problemen met het verplaatsen van voedsel in mijn mond 1 2 3 4 5
12.  Ik heb problemen met kwijlen of voedsel en drank in mijn mond 
houden of met morsen op mijn kin en kleren
1 2 3 4 5
De volgende uitspraken gaan over hoe u zich misschien heeft gevoeld of hoe het met u ging in de AFGELO-
PEN WEEK vanwege problemen met het bewegen van uw gezicht. Geef alstublieft aan in hoeverre u het 
eens bent met iedere uitspraak:
OMCIRKEL slechts EEN nummer per regel Helemaal mee 
eens
Mee 
eens
Weet ik 
niet
Mee 
oneens
Helemaal mee 
oneens
13.  Mijn gezicht voelt moe aan en/of als ik mijn 
gezicht probeer te bewegen, voel ik spanning, 
pijn of kramp
1 2 3 4 5
14.  Mijn uiterlijk heeft mijn bereidheid om mee 
te doen aan sociale activiteiten of familie en 
vrienden te zien beïnvloed.
1 2 3 4 5
15.  Omdat ik moeite heb met mijn manier van 
eten, heb ik het eten in restaurants of bij 
andere mensen thuis vermeden
1 2 3 4 5
Aanvullende opmerkingen:
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iii. Dutch synkinesis Assessment QuestionnAire
Beantwoord alstublieft de volgende vragen betreffende de functie van uw gezicht, op 
een schaal van 1 tot 5, volgens de volgende schaal:
1 = zelden of helemaal niet
2 = af en toe of een klein beetje
3 = soms of een beetje
4 = meestal of matig
5 = altijd of ernstig
1.  Als ik glimlach, gaat mijn oog dicht 1 2 3 4 5
2.  Als ik praat, gaat mijn oog dicht 1 2 3 4 5
3.  Als ik fluit of mijn lippen tuit, gaat mijn oog dicht 1 2 3 4 5
4.  Als ik glimlach, verstijft mijn hals 1 2 3 4 5
5.  Als ik mijn ogen sluit, verstijft mijn gezicht 1 2 3 4 5
6.  Als ik mijn ogen sluit, beweegt mijn mondhoek 1 2 3 4 5
7.  Als ik mijn ogen sluit, verstijft mijn hals 1 2 3 4 5
8.  Als ik eet, traant mijn oog 1 2 3 4 5
9.  Als ik mijn gezicht beweeg, ontstaat er een kuiltje in mijn kin 1 2 3 4 5
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